data_1bh1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bh1 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.505 2.28 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -29.56 -41.96 0.04 OUTLIER Glycine 0 N--CA 1.51 3.61 0 CA-C-O 121.807 0.67 . . . . 1.0 114.428 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.36 -40.66 10.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -50.61 -37.48 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 123.215 0.322 . . . . 1.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.32 -5.32 59.2 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.935 -0.706 . . . . 1.0 111.363 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -100.38 -6.03 26.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.28 0.987 . . . . 1.0 109.692 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.1 t -87.79 -41.34 14.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.847 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.16 22.11 3.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.708 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -20.9 8.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 115.524 1.676 . . . . 1.0 115.524 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -121.24 -76.65 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.02 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -121.3 -96.35 1.45 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 106.947 -2.461 . . . . 1.0 106.947 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.41 70.95 0.14 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 104.428 -2.434 . . . . 1.0 104.428 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.531 18.3 Cg_endo 59.31 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.861 3.04 . . . . 1.0 111.813 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.64 -15.19 17.12 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.61 1.337 . . . . 1.0 114.61 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.52 -39.68 0.49 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.284 1.587 . . . . 1.0 115.284 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.53 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -51.4 -35.77 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.116 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.416 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.34 5.77 44.48 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.484 0.659 . . . . 1.0 109.769 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -63.11 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.581 -1.19 . . . . 1.0 110.038 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.16 -44.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.268 -0.878 . . . . 1.0 109.946 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -28.32 69.14 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 116.923 -1.911 . . . . 1.0 108.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.416 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 2.9 ttt180 -73.86 -28.55 61.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.701 -1.599 . . . . 1.0 108.265 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.03 -22.9 20.54 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.273 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -36.4 10.85 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.721 0.637 . . . . 1.0 112.721 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -100.18 66.7 1.33 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-N 113.294 -1.776 . . . . 1.0 107.071 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 4' ' ' ALA . 7.9 pt . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.25 -68.66 0.0 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 116.125 1.21 . . . . 1.0 116.125 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 2' ' ' ILE . . . -97.7 -26.78 14.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.82 -19.75 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.75 -11.86 38.29 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.352 -0.84 . . . . 1.0 110.731 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.29 -2.66 33.13 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.747 0.784 . . . . 1.0 110.006 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.4 -49.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.427 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.05 19.07 5.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.538 1.31 . . . . 1.0 114.538 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -16.71 14.34 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.172 -1.376 . . . . 1.0 109.912 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 m -115.9 -61.83 1.68 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.08 -120.81 1.71 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 106.399 -2.681 . . . . 1.0 106.399 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -156.26 63.4 3.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 113.269 -1.465 . . . . 1.0 107.601 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.545 1.0 OUTLIER 61.26 -100.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 123.03 2.487 . . . . 1.0 108.056 175.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.57 -8.85 22.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -49.96 -42.67 49.22 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 119.481 -0.888 . . . . 1.0 112.306 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.03 -26.12 31.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 113.628 -1.624 . . . . 1.0 109.835 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.98 3.62 41.74 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.042 0.925 . . . . 1.0 109.95 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.59 -61.44 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.353 -0.839 . . . . 1.0 111.155 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -43.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.466 -1.294 . . . . 1.0 110.078 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -32.66 74.21 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.919 -1.513 . . . . 1.0 107.622 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -16.85 60.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 124.452 1.095 . . . . 1.0 110.213 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -41.17 11.39 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -47.17 52.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.245 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -84.83 68.06 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-N 113.728 -1.578 . . . . 1.0 108.305 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.28 -71.77 0.21 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.92 -46.4 7.86 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.982 -1.087 . . . . 1.0 108.313 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 t -29.86 -33.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.972 1.42 . . . . 1.0 114.696 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.95 -49.68 17.06 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.526 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -45.12 -43.3 9.63 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.528 1.156 . . . . 1.0 108.689 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 t -46.37 -56.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.675 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.15 6.44 1.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.504 -1.68 . . . . 1.0 113.564 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.34 -2.14 18.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.909 -1.886 . . . . 1.0 105.909 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.2 m -120.08 -61.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.679 -1.971 . . . . 1.0 105.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.73 -122.99 0.9 Allowed Glycine 0 N--CA 1.481 1.66 0 N-CA-C 107.908 -2.077 . . . . 1.0 107.908 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 pt? -150.32 32.88 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 111.838 -2.181 . . . . 1.0 109.66 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.536 41.9 Cg_exo 94.77 175.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.758 2.972 . . . . 1.0 109.208 -167.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -26.74 -25.3 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 118.648 2.833 . . . . 1.0 118.648 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 14' ' ' PRO . 2.9 mm? -43.26 -38.77 2.72 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.664 0.745 . . . . 1.0 112.405 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -30.69 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 114.299 -1.319 . . . . 1.0 111.79 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.483 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 3.65 42.14 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.213 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -78.4 0.53 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.164 -1.791 . . . . 1.0 106.164 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.74 -36.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 117.973 -1.491 . . . . 1.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -74.86 -9.53 58.63 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 116.923 -1.911 . . . . 1.0 109.94 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 11.2 ttm180 -90.2 -50.66 5.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 103.694 -2.706 . . . . 1.0 103.694 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -41.81 95.2 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.576 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.42 -28.85 8.92 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.788 -1.165 . . . . 1.0 113.204 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -101.33 -29.63 11.95 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 119.799 -0.76 . . . . 1.0 111.075 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 -179.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 113.686 0.995 . . . . 1.0 113.686 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.23 -65.59 0.01 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 116.148 1.219 . . . . 1.0 116.148 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.75 -29.85 13.13 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.963 -0.695 . . . . 1.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.58 -26.08 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.96 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.9 mt -90.09 -14.29 34.04 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.94 1.84 40.19 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.303 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -90.75 -47.63 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.456 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -87.84 19.36 3.55 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.515 -1.22 . . . . 1.0 112.709 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 -18.17 19.5 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.064 -1.425 . . . . 1.0 109.23 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -122.95 -61.88 1.4 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.76 -118.42 1.48 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 61.01 4.47 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.549 5.8 Cg_endo 62.88 -99.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 123.325 2.683 . . . . 1.0 108.975 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.67 -10.07 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.351 1.241 . . . . 1.0 114.351 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.81 -44.36 19.21 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -24.92 35.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.684 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.9 m -100.87 4.99 43.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -61.1 1.42 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.842 -1.17 . . . . 1.0 107.842 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -49.94 13.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.023 -1.071 . . . . 1.0 110.23 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -9.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.866 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -90.79 -23.7 20.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 105.874 -1.898 . . . . 1.0 105.874 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -90.15 -58.61 2.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.97 1.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 115.595 1.702 . . . . 1.0 115.595 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' LYS . 2.5 mt-30 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.613 -1.625 . . . . 1.0 106.613 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-N 113.799 -1.546 . . . . 1.0 107.817 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 5' ' ' VAL . 2.1 pp . . . . . 0 N--CA 1.51 2.569 0 N-CA-C 113.138 0.792 . . . . 1.0 113.138 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -15.26 -53.18 0.01 OUTLIER Glycine 0 N--CA 1.51 3.575 0 N-CA-C 117.479 1.751 . . . . 1.0 117.479 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.11 -30.03 12.17 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.883 -0.658 . . . . 1.0 110.561 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 2' ' ' ILE . 6.1 t -54.56 -42.27 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.97 -16.99 55.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.459 -1.246 . . . . 1.0 111.451 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.08 -3.21 29.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.424 1.078 . . . . 1.0 110.51 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -90.35 -54.62 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 19.09 0.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.587 -1.188 . . . . 1.0 113.82 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -23.75 12.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.188 -1.369 . . . . 1.0 107.456 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 t -112.31 -29.31 7.58 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.801 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -101.51 0.2 Allowed Glycine 0 N--CA 1.483 1.819 0 CA-C-N 114.383 -1.28 . . . . 1.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.15 66.23 1.6 Allowed Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.535 25.5 Cg_endo 58.16 -85.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.12 3.213 . . . . 1.0 110.95 173.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.45 -15.26 17.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -46.55 -42.74 16.32 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.574 1.694 . . . . 1.0 115.574 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -23.39 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 114.587 -1.188 . . . . 1.0 108.984 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -101.38 1.32 38.32 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.338 -0.846 . . . . 1.0 109.111 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -70.98 0.73 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -30.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.481 -1.288 . . . . 1.0 112.494 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -80.45 -27.17 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 116.798 -1.961 . . . . 1.0 107.627 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -30.33 64.66 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -33.48 16.22 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.102 -1.039 . . . . 1.0 108.569 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -60.82 -7.38 2.3 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.746 -0.781 . . . . 1.0 112.603 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -100.25 -9.79 22.02 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.673 -1.232 . . . . 1.0 107.673 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 179.898 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 N--CA 1.506 2.375 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -7.16 -68.76 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 N-CA-C 116.395 1.318 . . . . 1.0 116.395 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.75 -21.99 15.02 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 120.896 0.379 . . . . 1.0 110.702 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.41 -29.58 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.711 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.6 mt -89.46 -6.91 56.06 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.4 -0.92 . . . . 1.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -93.99 -36.9 11.94 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -49.32 -36.23 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.99 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.72 17.64 7.4 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.774 -1.557 . . . . 1.0 113.508 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -108.66 -13.54 14.78 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.302 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -63.09 1.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.678 -0.809 . . . . 1.0 109.042 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.44 -97.47 0.27 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 108.966 -1.654 . . . . 1.0 108.966 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.52 65.33 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 104.687 -2.338 . . . . 1.0 104.687 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.538 11.5 Cg_endo 60.19 -93.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.334 2.689 . . . . 1.0 110.346 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -13.1 18.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -36.79 -42.27 0.37 Allowed 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 115.948 1.832 . . . . 1.0 115.948 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.515 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -51.77 -37.13 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.61 -1.177 . . . . 1.0 112.046 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -97.29 7.17 47.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.727 0.775 . . . . 1.0 109.866 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -67.28 0.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.985 -1.461 . . . . 1.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -41.66 13.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 118.989 -1.085 . . . . 1.0 110.165 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -69.97 -16.15 63.15 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.299 -1.76 . . . . 1.0 109.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 4.3 ttt180 -90.54 -23.51 20.88 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.546 -0.862 . . . . 1.0 108.892 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -91.25 -51.61 5.22 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.711 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -47.88 -9.94 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 114.684 1.364 . . . . 1.0 114.684 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 23' ' ' LYS . 3.2 pt20 -100.22 -23.36 14.84 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.926 0.766 . . . . 1.0 112.178 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 . . . . . 0 N--CA 1.504 2.261 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 112.713 0.634 . . . . 1.0 112.713 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -5.38 -71.64 0.01 OUTLIER Glycine 0 N--CA 1.507 3.367 0 N-CA-C 117.221 1.648 . . . . 1.0 117.221 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.2 -17.31 17.43 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 119.544 -0.862 . . . . 1.0 111.414 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -55.99 -48.43 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.631 -2.359 . . . . 1.0 104.631 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 mt -55.99 -17.71 7.46 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 114.201 -1.363 . . . . 1.0 112.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -100.05 -25.53 14.27 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.783 -0.767 . . . . 1.0 109.059 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -58.52 -28.8 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.34 13.89 14.24 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.922 -1.035 . . . . 1.0 111.358 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -101.12 -3.16 29.71 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.657 -0.817 . . . . 1.0 108.801 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -78.97 0.6 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.524 -2.028 . . . . 1.0 105.524 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.31 -85.46 0.07 OUTLIER Glycine 0 N--CA 1.491 2.352 1 N-CA-C 102.237 -4.345 . . . . 1.0 102.237 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 79.86 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 104.441 -2.429 . . . . 1.0 104.441 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.544 9.4 Cg_endo 64.07 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.745 2.297 . . . . 1.0 110.836 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.62 -4.7 27.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 114.521 1.304 . . . . 1.0 114.521 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' CB ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.32 -24.7 1.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.633 1.716 . . . . 1.0 115.633 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -32.53 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -100.6 9.84 41.97 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.999 0.904 . . . . 1.0 108.909 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -101.37 -69.62 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 113.93 -1.486 . . . . 1.0 108.7 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -38.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 118.559 -1.256 . . . . 1.0 109.609 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -12.49 61.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.495 -1.682 . . . . 1.0 108.76 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -90.02 -60.38 1.95 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -57.92 -33.22 68.55 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.447 -0.901 . . . . 1.0 112.976 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -71.58 -11.79 61.03 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 116.207 -2.197 . . . . 1.0 110.693 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -101.48 -45.16 5.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.621 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 113.071 0.767 . . . . 1.0 113.071 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -6.5 -72.7 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.554 1.782 . . . . 1.0 117.554 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.89 -12.12 20.11 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.823 -0.751 . . . . 1.0 110.58 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -61.0 -41.69 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 103.31 -2.848 . . . . 1.0 103.31 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.41 -16.28 22.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 113.707 -1.588 . . . . 1.0 110.797 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -100.64 -2.11 33.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 123.664 0.602 . . . . 1.0 110.506 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 t -90.4 -46.71 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.04 0.448 . . . . 1.0 110.612 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.435 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.44 19.98 4.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.399 1.095 . . . . 1.0 113.251 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 -17.41 15.17 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 113.844 -1.526 . . . . 1.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.84 -64.64 1.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 104.384 -2.45 . . . . 1.0 104.384 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.53 -122.27 1.57 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 1.0 104.426 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mt -152.64 67.27 6.59 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 105.812 -1.922 . . . . 1.0 105.812 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.533 18.5 Cg_endo 56.84 -81.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.934 3.09 . . . . 1.0 112.3 173.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.18 -14.33 17.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -46.23 -43.6 15.55 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.325 1.232 . . . . 1.0 114.325 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -24.28 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.511 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.33 3.19 43.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 -69.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.404 0.621 . . . . 1.0 109.654 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -35.08 8.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 118.586 -0.721 . . . . 1.0 111.142 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -24.03 63.91 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 116.134 -2.227 . . . . 1.0 105.052 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -61.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -36.21 22.19 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.237 1.018 . . . . 1.0 110.738 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.83 -21.33 66.03 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.114 -0.948 . . . . 1.0 112.762 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -101.62 -45.37 5.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.551 1.157 . . . . 1.0 110.248 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-N 114.789 -1.096 . . . . 1.0 110.012 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -9.88 -58.75 0.01 OUTLIER Glycine 0 N--CA 1.508 3.467 0 N-CA-C 117.713 1.845 . . . . 1.0 117.713 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.1 -27.5 13.51 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.577 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 2' ' ' ILE . 9.5 t -54.49 -44.77 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.15 -17.04 23.39 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.996 -1.456 . . . . 1.0 111.822 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -100.24 -6.04 26.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.019 0.824 . . . . 1.0 110.022 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 10' ' ' THR . 34.4 t -90.61 -51.12 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.92 11.63 0.51 Allowed 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 114.322 -1.308 . . . . 1.0 112.611 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -105.13 -12.4 16.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.216 -1.402 . . . . 1.0 107.216 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 -31.96 4.23 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.95 -111.21 0.47 Allowed Glycine 0 N--CA 1.481 1.689 1 N-CA-C 101.822 -4.511 . . . . 1.0 101.822 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.64 66.82 8.45 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 104.456 -2.424 . . . . 1.0 104.456 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.534 12.0 Cg_endo 61.56 -83.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.848 3.032 . . . . 1.0 111.577 169.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.21 -18.94 16.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.28 -37.41 16.23 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.547 -1.261 . . . . 1.0 114.098 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.34 -30.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.513 0.673 . . . . 1.0 109.357 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -100.25 10.32 41.42 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.499 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -102.77 -64.3 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.139 -1.392 . . . . 1.0 108.435 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.05 -39.54 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 118.334 -1.347 . . . . 1.0 111.608 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -72.48 -27.62 62.39 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 116.511 -2.076 . . . . 1.0 108.83 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -61.12 -36.51 79.93 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.403 -1.319 . . . . 1.0 107.574 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -35.61 14.6 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.797 -1.161 . . . . 1.0 110.587 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -21.61 61.91 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 118.778 -1.169 . . . . 1.0 110.574 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -100.68 2.57 41.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.346 1.029 . . . . 1.0 110.648 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 107.228 -1.397 . . . . 1.0 107.228 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.9 pt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 122.202 1.001 . . . . 1.0 109.632 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.12 -34.93 4.09 Favored Glycine 0 N--CA 1.502 3.093 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.81 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 6' ' ' LEU . . . -100.09 -51.38 3.69 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 104.625 -2.361 . . . . 1.0 104.625 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -28.28 -30.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 126.126 2.141 . . . . 1.0 114.258 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' ALA . 20.3 mt -90.49 -56.0 3.37 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.605 -0.838 . . . . 1.0 109.179 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -46.41 -41.89 14.35 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 124.074 1.893 . . . . 1.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.9 t -46.9 -45.65 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 111.049 -2.796 . . . . 1.0 110.235 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.36 16.52 9.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.333 -1.303 . . . . 1.0 113.481 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -45.3 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.939 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -84.31 -41.44 16.81 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.16 -1.416 . . . . 1.0 109.844 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.87 -114.95 0.49 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.999 -1.64 . . . . 1.0 108.999 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -169.72 57.78 0.31 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.548 18.6 Cg_endo 59.08 -102.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 124.616 3.544 . . . . 1.0 108.496 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -7.7 24.13 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.794 1.035 . . . . 1.0 113.794 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.22 -42.75 41.38 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 117.949 -1.5 . . . . 1.0 112.545 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.413 ' CD1' ' H ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.91 -40.93 88.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.745 -1.182 . . . . 1.0 108.504 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.413 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -71.1 -7.29 45.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -74.82 0.6 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.684 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -30.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 119.039 -1.064 . . . . 1.0 112.86 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -79.22 -9.47 59.58 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 116.865 -1.934 . . . . 1.0 108.138 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -90.67 -62.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.431 1 N-CA-C 98.926 -4.472 . . . . 1.0 98.926 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -42.48 -63.8 0.71 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.376 -1.284 . . . . 1.0 112.78 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -18.82 0.1 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.519 2.044 . . . . 1.0 116.519 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -101.24 14.8 30.82 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.764 0.792 . . . . 1.0 111.709 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 N--CA 1.49 1.528 0 CA-C-N 113.866 -1.515 . . . . 1.0 107.998 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.506 2.353 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.93 -60.98 0.01 OUTLIER Glycine 0 N--CA 1.504 3.2 0 N-CA-C 117.712 1.845 . . . . 1.0 117.712 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.32 -43.7 8.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -35.6 -55.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.795 1.31 . . . . 1.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.7 mt -49.29 -38.97 29.18 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.2 -35.42 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.767 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.446 ' CG1' ' HG3' ' A' ' 14' ' ' PRO . 1.4 t -61.08 -32.8 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.385 1.088 . . . . 1.0 109.077 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mt -72.82 -2.14 19.41 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.576 -1.193 . . . . 1.0 108.787 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 m -98.98 -10.21 22.99 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.449 -1.685 . . . . 1.0 106.449 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -105.23 -45.56 4.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.406 -1.701 . . . . 1.0 106.406 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.39 -133.44 2.91 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 106.094 -2.802 . . . . 1.0 106.094 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.13 68.19 7.22 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 112.39 -1.905 . . . . 1.0 107.39 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.446 ' HG3' ' CG1' ' A' ' 8' ' ' VAL 2.527 47.7 Cg_endo 54.15 -83.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 125.209 3.939 . . . . 1.0 112.824 171.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.42 -17.7 16.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.28 -46.26 17.83 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -26.06 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.078 0.942 . . . . 1.0 109.466 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.0 m -101.26 5.78 42.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.091 -0.959 . . . . 1.0 110.73 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.58 -67.57 0.86 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 123.44 0.462 . . . . 1.0 109.935 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.91 -34.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 118.405 -1.318 . . . . 1.0 111.347 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -69.35 -16.76 63.6 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 116.717 -1.993 . . . . 1.0 107.163 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -91.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.369 -1.715 . . . . 1.0 106.369 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -47.79 -40.09 19.95 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.1 -0.954 . . . . 1.0 108.957 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.73 39.88 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.412 -0.915 . . . . 1.0 109.767 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -100.31 -26.14 14.0 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 121.0 0.429 . . . . 1.0 110.993 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.142 0 CA-C-O 122.321 1.058 . . . . 1.0 113.185 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt . . . . . 0 N--CA 1.505 2.294 0 N-CA-C 112.366 0.506 . . . . 1.0 112.366 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -15.64 -60.62 0.01 OUTLIER Glycine 0 N--CA 1.506 3.319 0 N-CA-C 117.094 1.598 . . . . 1.0 117.094 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.76 -24.82 20.26 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.284 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 2' ' ' ILE . 36.6 t -58.93 -48.39 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.8 mt -38.1 -59.31 0.87 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.409 -1.269 . . . . 1.0 111.219 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -42.48 -53.16 4.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.207 -1.815 . . . . 1.0 109.825 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.41 ' CG1' ' HG2' ' A' ' 14' ' ' PRO . 10.7 t -44.92 -57.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.114 -1.403 . . . . 1.0 109.146 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.67 -19.22 65.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.215 -2.266 . . . . 1.0 111.864 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -0.21 54.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 118.61 -1.236 . . . . 1.0 107.827 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -107.08 -61.92 1.48 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.397 -2.446 . . . . 1.0 104.397 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -127.7 1.77 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 106.366 -2.693 . . . . 1.0 106.366 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 4.8 mt -159.45 58.89 1.26 Allowed Pre-proline 0 N--CA 1.497 1.896 0 CA-C-N 112.783 -1.708 . . . . 1.0 107.707 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HG2' ' CG1' ' A' ' 8' ' ' VAL 2.537 38.9 Cg_endo 55.94 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 124.825 3.684 . . . . 1.0 111.081 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.68 -12.38 19.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.469 0.914 . . . . 1.0 113.469 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -46.22 -45.14 16.78 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.751 -1.179 . . . . 1.0 113.177 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 pp -56.81 -32.3 38.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.016 -1.902 . . . . 1.0 110.202 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.93 8.81 42.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.246 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.93 -70.67 0.73 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 -39.93 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 117.539 -1.664 . . . . 1.0 109.811 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -23.15 67.25 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 117.71 -1.596 . . . . 1.0 108.795 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -82.66 -14.6 54.38 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.967 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -43.93 9.9 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.139 -2.171 . . . . 1.0 105.139 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -22.05 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.792 -1.549 . . . . 1.0 113.111 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.43 6.98 44.49 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.334 1.021 . . . . 1.0 112.69 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 122.3 1.048 . . . . 1.0 108.735 179.902 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 121.433 0.635 . . . . 1.0 111.866 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.53 -27.91 6.58 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.671 -1.252 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.92 -47.08 5.15 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.785 -1.931 . . . . 1.0 105.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -36.48 -56.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 115.052 -0.976 . . . . 1.0 111.071 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.0 mt -51.53 -33.32 31.43 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.791 -1.55 . . . . 1.0 113.187 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' NZ ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.95 -31.9 66.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.538 -1.21 . . . . 1.0 111.908 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 t -64.23 -38.22 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.18 -24.19 67.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.5 -1.227 . . . . 1.0 107.933 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.94 -11.89 59.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.035 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 -12.67 18.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.64 123.22 1.88 Allowed Glycine 0 N--CA 1.478 1.486 0 N-CA-C 106.713 -2.555 . . . . 1.0 106.713 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.51 100.86 0.23 Allowed Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 121.51 0.671 . . . . 1.0 111.148 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.514 10.4 Cg_endo 31.89 -84.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 1 C-N-CA 127.118 5.212 . . . . 1.0 115.611 -163.062 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -7.84 22.75 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.95 1.833 . . . . 1.0 115.95 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.6 -41.22 0.66 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.577 1.325 . . . . 1.0 114.577 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.491 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -50.31 -37.79 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.139 -1.392 . . . . 1.0 111.253 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.49 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 6.81 43.87 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.111 -0.635 . . . . 1.0 109.329 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.406 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.75 -64.09 1.08 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -44.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.053 -1.459 . . . . 1.0 110.955 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -61.68 -24.55 66.83 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.08 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.473 1.108 . . . . 1.0 109.044 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -90.91 -14.85 30.85 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.87 -0.732 . . . . 1.0 112.12 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -91.27 -26.31 19.05 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.664 -1.214 . . . . 1.0 109.08 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.13 -27.34 13.29 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.489 -0.884 . . . . 1.0 110.086 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.498 1.972 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.727 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.506 2.334 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -6.62 -78.49 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.21 -5.64 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.263 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t -63.19 -44.6 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 103.962 -2.607 . . . . 1.0 103.962 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.5 mt -43.32 -47.71 6.73 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 123.028 1.394 . . . . 1.0 108.369 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -50.6 -47.38 58.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 112.365 -2.198 . . . . 1.0 110.699 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.548 HG11 ' CG ' ' A' ' 14' ' ' PRO . 51.0 t -53.99 -34.85 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.257 -1.338 . . . . 1.0 111.067 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.38 6.31 43.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 112.623 -2.08 . . . . 1.0 111.736 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.17 -3.7 17.09 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -118.62 -59.36 1.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.9 -114.61 1.18 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.335 -1.906 . . . . 1.0 108.335 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.4 mt 179.44 61.25 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 103.153 -2.906 . . . . 1.0 103.153 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.548 ' CG ' HG11 ' A' ' 8' ' ' VAL 2.52 73.4 Cg_endo 50.92 -73.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 1 C-N-CA 125.483 4.122 . . . . 1.0 113.985 -178.643 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -101.87 -22.72 14.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.861 1.06 . . . . 1.0 113.861 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -45.38 -46.31 13.11 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.657 1.725 . . . . 1.0 115.657 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.75 -25.31 37.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.831 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.6 m -101.53 3.12 39.83 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.895 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -71.33 0.71 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.98 -37.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 117.682 -1.607 . . . . 1.0 111.622 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.9 mtpt -71.77 -4.7 29.21 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 115.43 -2.508 . . . . 1.0 109.224 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -52.32 4.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -27.57 66.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 114.223 -1.353 . . . . 1.0 111.171 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -7.32 56.15 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.862 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -101.04 -48.84 4.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.727 1.267 . . . . 1.0 107.739 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 122.53 1.157 . . . . 1.0 110.611 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.4 pt . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 119.898 -0.096 . . . . 1.0 110.951 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -38.91 -28.7 0.07 OUTLIER Glycine 0 N--CA 1.508 3.474 0 O-C-N 123.914 0.759 . . . . 1.0 112.908 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.69 -52.15 3.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.1 t -49.48 -24.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 124.006 0.816 . . . . 1.0 111.851 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.62 -39.97 15.61 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -47.98 -45.08 31.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.96 1.362 . . . . 1.0 109.847 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -54.15 -36.46 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 113.586 -1.643 . . . . 1.0 110.633 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.87 13.88 15.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 113.824 -1.534 . . . . 1.0 111.612 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -11.48 19.12 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.548 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -113.39 -68.11 0.95 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.537 -2.394 . . . . 1.0 104.537 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.33 -120.14 1.62 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.309 -2.317 . . . . 1.0 107.309 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -160.74 60.71 1.36 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 107.343 -1.354 . . . . 1.0 107.343 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.523 15.9 Cg_endo 52.95 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.24 3.294 . . . . 1.0 112.658 174.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -102.39 -18.61 15.31 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -50.43 -46.24 56.36 Favored 'General case' 0 N--CA 1.515 2.799 0 CA-C-O 123.657 1.694 . . . . 1.0 113.405 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.615 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -60.77 -24.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.871 -2.422 . . . . 1.0 107.143 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.424 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.64 3.4 42.47 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.347 -1.297 . . . . 1.0 109.066 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -63.21 1.17 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.678 0.751 . . . . 1.0 109.469 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.68 -43.91 15.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 118.827 -1.149 . . . . 1.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.91 -19.43 65.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 117.513 -1.675 . . . . 1.0 108.439 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 20.6 ttt180 -84.29 -19.92 32.98 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.92 -33.53 15.57 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.459 -1.246 . . . . 1.0 107.989 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.55 53.27 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.168 -0.613 . . . . 1.0 112.478 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.67 11.48 39.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.622 0.576 . . . . 1.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 107.22 -1.4 . . . . 1.0 107.22 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.857 0.837 . . . . 1.0 112.013 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.84 -102.5 1.81 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 105.245 -3.142 . . . . 1.0 105.245 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -33.16 -44.83 0.13 Allowed 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 122.311 1.053 . . . . 1.0 112.588 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.57 -27.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.837 -1.983 . . . . 1.0 114.619 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.51 -7.83 54.11 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -100.2 -26.14 14.03 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 t -60.74 -34.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 122.865 1.317 . . . . 1.0 108.625 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mt -71.52 -4.34 26.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.68 -1.6 . . . . 1.0 109.061 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -2.84 31.12 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -117.12 -45.59 2.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.01 -0.737 . . . . 1.0 109.01 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.32 -118.99 2.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.355 -2.298 . . . . 1.0 107.355 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.49 65.13 0.15 Allowed Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 103.3 -2.852 . . . . 1.0 103.3 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.524 59.4 Cg_endo 51.33 -78.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 1 C-N-CA 126.264 4.643 . . . . 1.0 112.71 -178.28 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.23 -21.8 14.82 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.452 -0.899 . . . . 1.0 113.338 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -40.61 -43.28 1.87 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.979 1.844 . . . . 1.0 115.979 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -58.6 -37.55 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.405 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 3.7 m -91.3 6.01 46.96 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.117 -1.033 . . . . 1.0 109.144 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.08 -69.08 0.79 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -89.86 -38.93 11.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 118.331 -1.347 . . . . 1.0 111.095 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -26.59 65.55 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 117.11 -1.836 . . . . 1.0 108.684 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' NH1' ' O ' ' A' ' 18' ' ' SER . 4.3 ttp180 -67.83 -55.78 11.64 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -52.27 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.679 -1.601 . . . . 1.0 108.078 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -20.81 1.86 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.565 1.691 . . . . 1.0 115.565 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.56 3.62 42.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.975 0.797 . . . . 1.0 113.059 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 122.155 0.979 . . . . 1.0 110.482 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 N--CA 1.499 1.995 0 N-CA-C 110.223 -0.288 . . . . 1.0 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.4 -70.95 2.56 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.445 -1.862 . . . . 1.0 108.445 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.2 3.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.77 -1.215 . . . . 1.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -35.53 -34.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 114.872 1.434 . . . . 1.0 114.872 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' H ' ' CD2' ' A' ' 6' ' ' LEU . 2.6 pt? -86.55 -35.34 19.57 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.028 -1.469 . . . . 1.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 2.4 mmpt? -52.61 -41.67 63.88 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 123.774 1.75 . . . . 1.0 106.557 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -50.42 -43.54 22.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 111.596 -2.547 . . . . 1.0 108.458 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.61 8.52 33.78 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.031 -1.441 . . . . 1.0 114.7 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -115.05 -30.15 6.45 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-O 121.868 0.842 . . . . 1.0 108.938 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -93.58 -13.03 28.19 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.09 -85.6 0.21 Allowed Glycine 0 N--CA 1.494 2.517 0 O-C-N 124.699 1.249 . . . . 1.0 111.557 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.05 69.43 0.13 Allowed Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 105.736 -1.95 . . . . 1.0 105.736 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.525 73.1 Cg_endo 42.09 -76.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 1 C-N-CA 126.645 4.897 . . . . 1.0 114.002 -172.404 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.96 -14.48 17.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.265 1.58 . . . . 1.0 115.265 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -41.4 -43.24 2.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.552 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -55.23 -33.01 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.568 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -100.29 5.57 44.54 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.44 0.638 . . . . 1.0 109.85 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.98 -64.21 1.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -48.02 14.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 118.395 -1.322 . . . . 1.0 109.25 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -62.78 -9.82 10.78 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 117.235 -1.786 . . . . 1.0 110.352 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.96 -65.26 1.03 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -58.61 -31.13 67.79 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.347 -1.341 . . . . 1.0 111.137 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.82 -15.54 63.13 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.097 -1.441 . . . . 1.0 110.049 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -101.19 -41.6 6.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.636 0.731 . . . . 1.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 . . . . . 0 N--CA 1.495 1.795 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.823 -179.444 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.506 2.326 0 N-CA-C 113.029 0.751 . . . . 1.0 113.029 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -32.77 -52.17 0.47 Allowed Glycine 0 N--CA 1.503 3.122 0 N-CA-C 116.063 1.185 . . . . 1.0 116.063 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.32 4.67 44.2 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.001 -0.679 . . . . 1.0 112.319 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.02 -55.49 6.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 104.137 -2.542 . . . . 1.0 104.137 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.7 mt -37.64 -60.9 0.66 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.833 0.708 . . . . 1.0 111.09 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -45.07 -49.18 11.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.046 -1.434 . . . . 1.0 110.738 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.3 t -52.34 -49.71 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.939 0.876 . . . . 1.0 109.465 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.4 -12.15 28.43 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 114.127 -1.397 . . . . 1.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.45 12.17 33.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.992 -1.485 . . . . 1.0 106.992 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -63.1 1.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 103.307 -2.849 . . . . 1.0 103.307 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.55 -131.99 2.01 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 105.205 -3.158 . . . . 1.0 105.205 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.6 mt -158.88 55.88 0.87 Allowed Pre-proline 0 N--CA 1.498 1.954 0 CA-C-N 111.795 -2.202 . . . . 1.0 107.768 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.529 59.1 Cg_endo 52.11 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 1 C-N-CA 125.789 4.326 . . . . 1.0 112.947 177.879 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 -15.12 17.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.07 1.137 . . . . 1.0 114.07 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -47.51 -47.27 27.78 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 122.208 1.004 . . . . 1.0 113.246 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -56.11 -30.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 113.46 -1.7 . . . . 1.0 109.183 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 1.8 m -101.0 8.78 42.84 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.629 -0.828 . . . . 1.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -70.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -40.68 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 117.412 -1.715 . . . . 1.0 110.317 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -12.3 59.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 117.012 -1.875 . . . . 1.0 109.525 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.413 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 15.0 ttt180 -86.38 -55.81 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 101.83 -3.396 . . . . 1.0 101.83 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -46.26 -55.17 7.58 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.256 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -12.84 5.38 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.786 1.402 . . . . 1.0 114.786 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -101.54 6.39 42.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.476 0.485 . . . . 1.0 111.101 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 122.362 1.077 . . . . 1.0 110.359 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.508 2.464 0 N-CA-C 113.145 0.795 . . . . 1.0 113.145 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -27.12 -36.89 0.01 OUTLIER Glycine 0 N--CA 1.506 3.354 0 N-CA-C 117.292 1.677 . . . . 1.0 117.292 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.05 -49.59 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.116 -1.439 . . . . 1.0 107.116 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 t -40.13 -54.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 124.535 1.147 . . . . 1.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.6 mt -46.01 -50.83 14.53 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 122.345 1.069 . . . . 1.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -45.51 -47.14 14.22 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 112.869 -1.968 . . . . 1.0 110.171 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 t -54.38 -47.64 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 113.312 -1.767 . . . . 1.0 109.287 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.83 -5.12 19.05 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.35 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 8.75 34.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.225 -2.139 . . . . 1.0 105.225 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.83 -64.37 1.22 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.93 -126.24 2.37 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 106.434 -2.666 . . . . 1.0 106.434 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -171.09 60.53 0.32 Allowed Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 122.657 1.218 . . . . 1.0 108.405 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.522 95.9 Cg_endo 41.78 -82.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 1 C-N-CA 126.607 4.871 . . . . 1.0 114.006 -173.707 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.56 -12.8 17.5 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -47.67 -48.41 29.09 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.405 -1.318 . . . . 1.0 113.05 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -42.24 85.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -6.24 39.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.767 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.105 -0.952 . . . . 1.0 108.877 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -90.22 -36.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.693 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.25 -16.55 61.4 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.028 -1.869 . . . . 1.0 108.51 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 -24.35 20.35 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.466 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -91.1 -35.16 14.75 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.487 -0.885 . . . . 1.0 109.065 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -13.01 16.53 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.006 0.431 . . . . 1.0 111.805 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -100.98 8.08 43.21 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.848 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.517 0.675 . . . . 1.0 109.498 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.205 0 N-CA-C 112.653 0.612 . . . . 1.0 112.653 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.89 -56.02 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.817 1.887 . . . . 1.0 117.817 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.84 -32.59 11.27 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.932 0.396 . . . . 1.0 111.095 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -51.09 -49.07 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.8 mt -54.8 -19.2 5.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 113.596 -1.638 . . . . 1.0 112.661 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -96.67 -28.06 14.5 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.7 t -52.54 -50.03 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.5 6.16 0.23 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.947 -1.933 . . . . 1.0 113.409 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -102.13 -9.04 20.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.491 -1.3 . . . . 1.0 107.491 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m -115.52 -60.91 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.557 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.5 -113.55 0.76 Allowed Glycine 0 N--CA 1.503 3.148 0 C-N-CA 119.394 -1.384 . . . . 1.0 109.795 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -178.42 60.91 0.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 104.465 -2.42 . . . . 1.0 104.465 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.518 55.0 Cg_endo 53.87 -75.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 1 C-N-CA 125.744 4.296 . . . . 1.0 114.474 176.608 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.15 -21.97 14.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 115.367 1.618 . . . . 1.0 115.367 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -38.85 -40.29 0.62 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.448 2.018 . . . . 1.0 116.448 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.549 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -51.01 -39.5 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 113.164 -1.834 . . . . 1.0 111.673 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -101.08 9.89 41.59 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 1.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -66.73 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.886 -1.506 . . . . 1.0 108.783 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -35.61 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.189 -0.604 . . . . 1.0 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -76.73 -4.17 41.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.768 -1.573 . . . . 1.0 107.828 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -90.4 -76.59 0.43 Allowed 'General case' 0 C--N 1.306 -1.309 1 N-CA-C 95.734 -5.654 . . . . 1.0 95.734 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -37.33 -62.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 114.875 1.435 . . . . 1.0 114.875 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -22.05 32.79 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.38 -50.8 3.5 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 N--CA 1.503 2.195 0 N-CA-C 113.48 0.918 . . . . 1.0 113.48 -179.694 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.746 0 N-CA-C 106.009 -2.836 . . . . 1.0 106.009 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 pt -110.88 -15.65 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-N 118.866 1.333 . . . . 1.0 114.379 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -29.56 -41.96 0.04 OUTLIER Glycine 0 N--CA 1.51 3.61 0 CA-C-O 121.807 0.67 . . . . 1.0 114.428 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.36 -40.66 10.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -50.61 -37.48 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 123.215 0.322 . . . . 1.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.32 -5.32 59.2 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.935 -0.706 . . . . 1.0 111.363 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -100.38 -6.03 26.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.28 0.987 . . . . 1.0 109.692 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.1 t -87.79 -41.34 14.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.847 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.16 22.11 3.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.708 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -20.9 8.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 115.524 1.676 . . . . 1.0 115.524 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -121.24 -76.65 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.02 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -121.3 -96.35 1.45 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 106.947 -2.461 . . . . 1.0 106.947 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.41 70.95 0.14 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 104.428 -2.434 . . . . 1.0 104.428 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.531 18.3 Cg_endo 59.31 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.861 3.04 . . . . 1.0 111.813 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.64 -15.19 17.12 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.61 1.337 . . . . 1.0 114.61 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.52 -39.68 0.49 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.284 1.587 . . . . 1.0 115.284 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.53 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -51.4 -35.77 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.116 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.416 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.34 5.77 44.48 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.484 0.659 . . . . 1.0 109.769 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -63.11 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.581 -1.19 . . . . 1.0 110.038 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.16 -44.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.268 -0.878 . . . . 1.0 109.946 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -28.32 69.14 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 116.923 -1.911 . . . . 1.0 108.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 2.9 ttt180 -73.86 -28.55 61.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.701 -1.599 . . . . 1.0 108.265 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.03 -22.9 20.54 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.273 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -36.4 10.85 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.721 0.637 . . . . 1.0 112.721 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -100.18 66.7 1.33 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.57 42.74 2.92 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.294 -1.776 . . . . 1.0 107.071 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.662 0 O-C-N 118.595 -2.565 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 N-CA-C 105.819 -2.912 . . . . 1.0 105.819 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 4' ' ' ALA . 7.9 pt -120.38 -119.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 118.42 1.11 . . . . 1.0 108.994 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.25 -68.66 0.0 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 116.125 1.21 . . . . 1.0 116.125 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 2' ' ' ILE . . . -97.7 -26.78 14.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.82 -19.75 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.75 -11.86 38.29 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.352 -0.84 . . . . 1.0 110.731 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.29 -2.66 33.13 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.747 0.784 . . . . 1.0 110.006 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.4 -49.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.427 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.05 19.07 5.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.538 1.31 . . . . 1.0 114.538 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -16.71 14.34 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.172 -1.376 . . . . 1.0 109.912 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 m -115.9 -61.83 1.68 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.08 -120.81 1.71 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 106.399 -2.681 . . . . 1.0 106.399 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -156.26 63.4 3.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 113.269 -1.465 . . . . 1.0 107.601 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.545 1.0 OUTLIER 61.26 -100.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 123.03 2.487 . . . . 1.0 108.056 175.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.57 -8.85 22.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -49.96 -42.67 49.22 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 119.481 -0.888 . . . . 1.0 112.306 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.03 -26.12 31.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 113.628 -1.624 . . . . 1.0 109.835 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.98 3.62 41.74 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.042 0.925 . . . . 1.0 109.95 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.59 -61.44 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.353 -0.839 . . . . 1.0 111.155 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -43.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.466 -1.294 . . . . 1.0 110.078 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -32.66 74.21 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.919 -1.513 . . . . 1.0 107.622 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -16.85 60.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 124.452 1.095 . . . . 1.0 110.213 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -41.17 11.39 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -47.17 52.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.245 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -84.83 68.06 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -120.46 -116.23 0.32 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.728 -1.578 . . . . 1.0 108.305 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.592 0 O-C-N 117.676 -3.14 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 N-CA-C 106.961 -2.456 . . . . 1.0 106.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.54 -154.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.28 -71.77 0.21 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.92 -46.4 7.86 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.982 -1.087 . . . . 1.0 108.313 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 t -29.86 -33.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.972 1.42 . . . . 1.0 114.696 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.95 -49.68 17.06 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.526 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -45.12 -43.3 9.63 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.528 1.156 . . . . 1.0 108.689 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 t -46.37 -56.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.675 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.15 6.44 1.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.504 -1.68 . . . . 1.0 113.564 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.34 -2.14 18.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.909 -1.886 . . . . 1.0 105.909 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.2 m -120.08 -61.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.679 -1.971 . . . . 1.0 105.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.73 -122.99 0.9 Allowed Glycine 0 N--CA 1.481 1.66 0 N-CA-C 107.908 -2.077 . . . . 1.0 107.908 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 pt? -150.32 32.88 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 111.838 -2.181 . . . . 1.0 109.66 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.536 41.9 Cg_exo 94.77 175.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.758 2.972 . . . . 1.0 109.208 -167.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -26.74 -25.3 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 118.648 2.833 . . . . 1.0 118.648 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 14' ' ' PRO . 2.9 mm? -43.26 -38.77 2.72 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.664 0.745 . . . . 1.0 112.405 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -30.69 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 114.299 -1.319 . . . . 1.0 111.79 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.483 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 3.65 42.14 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.213 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -78.4 0.53 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.164 -1.791 . . . . 1.0 106.164 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.74 -36.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 117.973 -1.491 . . . . 1.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -74.86 -9.53 58.63 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 116.923 -1.911 . . . . 1.0 109.94 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 11.2 ttm180 -90.2 -50.66 5.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 103.694 -2.706 . . . . 1.0 103.694 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -41.81 95.2 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.576 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.42 -28.85 8.92 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.788 -1.165 . . . . 1.0 113.204 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -101.33 -29.63 11.95 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 119.799 -0.76 . . . . 1.0 111.075 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -115.46 93.84 4.45 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.61 0 O-C-N 119.067 -2.271 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.44 0 N-CA-C 105.747 -2.941 . . . . 1.0 105.747 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pt -121.39 -24.45 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 113.686 0.995 . . . . 1.0 113.686 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.23 -65.59 0.01 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 116.148 1.219 . . . . 1.0 116.148 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.75 -29.85 13.13 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.963 -0.695 . . . . 1.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.58 -26.08 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.96 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.9 mt -90.09 -14.29 34.04 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.94 1.84 40.19 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.303 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -90.75 -47.63 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -87.84 19.36 3.55 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.515 -1.22 . . . . 1.0 112.709 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 -18.17 19.5 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.064 -1.425 . . . . 1.0 109.23 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -122.95 -61.88 1.4 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.76 -118.42 1.48 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 61.01 4.47 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.549 5.8 Cg_endo 62.88 -99.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 123.325 2.683 . . . . 1.0 108.975 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.67 -10.07 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.351 1.241 . . . . 1.0 114.351 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.81 -44.36 19.21 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -24.92 35.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.684 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.9 m -100.87 4.99 43.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -61.1 1.42 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.842 -1.17 . . . . 1.0 107.842 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -49.94 13.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.023 -1.071 . . . . 1.0 110.23 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -9.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.866 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -90.79 -23.7 20.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 105.874 -1.898 . . . . 1.0 105.874 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -90.15 -58.61 2.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.97 1.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 115.595 1.702 . . . . 1.0 115.595 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' LYS . 2.5 mt-30 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.613 -1.625 . . . . 1.0 106.613 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.53 -116.15 0.26 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 113.799 -1.546 . . . . 1.0 107.817 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.54 0 O-C-N 117.664 -3.147 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.713 0 N-CA-C 106.077 -2.809 . . . . 1.0 106.077 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -109.03 -27.12 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 CA-C-N 119.222 1.511 . . . . 1.0 113.138 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -15.26 -53.18 0.01 OUTLIER Glycine 0 N--CA 1.51 3.575 0 N-CA-C 117.479 1.751 . . . . 1.0 117.479 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.11 -30.03 12.17 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.883 -0.658 . . . . 1.0 110.561 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 2' ' ' ILE . 6.1 t -54.56 -42.27 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.97 -16.99 55.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.459 -1.246 . . . . 1.0 111.451 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.08 -3.21 29.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.424 1.078 . . . . 1.0 110.51 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -90.35 -54.62 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 19.09 0.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.587 -1.188 . . . . 1.0 113.82 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -23.75 12.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.188 -1.369 . . . . 1.0 107.456 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 t -112.31 -29.31 7.58 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.801 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -101.51 0.2 Allowed Glycine 0 N--CA 1.483 1.819 0 CA-C-N 114.383 -1.28 . . . . 1.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.15 66.23 1.6 Allowed Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.535 25.5 Cg_endo 58.16 -85.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.12 3.213 . . . . 1.0 110.95 173.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.45 -15.26 17.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -46.55 -42.74 16.32 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.574 1.694 . . . . 1.0 115.574 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -23.39 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 114.587 -1.188 . . . . 1.0 108.984 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -101.38 1.32 38.32 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.338 -0.846 . . . . 1.0 109.111 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -70.98 0.73 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -30.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.481 -1.288 . . . . 1.0 112.494 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -80.45 -27.17 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 116.798 -1.961 . . . . 1.0 107.627 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -30.33 64.66 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -33.48 16.22 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.102 -1.039 . . . . 1.0 108.569 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -60.82 -7.38 2.3 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.746 -0.781 . . . . 1.0 112.603 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -100.25 -9.79 22.02 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.673 -1.232 . . . . 1.0 107.673 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -120.25 98.96 6.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 118.142 -2.849 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.681 0 N-CA-C 106.315 -2.714 . . . . 1.0 106.315 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 pt -112.3 -28.1 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 CA-C-N 118.447 1.123 . . . . 1.0 113.802 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -7.16 -68.76 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 N-CA-C 116.395 1.318 . . . . 1.0 116.395 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.75 -21.99 15.02 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 120.896 0.379 . . . . 1.0 110.702 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.41 -29.58 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.711 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.6 mt -89.46 -6.91 56.06 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.4 -0.92 . . . . 1.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -93.99 -36.9 11.94 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -49.32 -36.23 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.99 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.72 17.64 7.4 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.774 -1.557 . . . . 1.0 113.508 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -108.66 -13.54 14.78 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.302 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -63.09 1.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.678 -0.809 . . . . 1.0 109.042 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.44 -97.47 0.27 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 108.966 -1.654 . . . . 1.0 108.966 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.52 65.33 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 104.687 -2.338 . . . . 1.0 104.687 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.538 11.5 Cg_endo 60.19 -93.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.334 2.689 . . . . 1.0 110.346 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -13.1 18.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -36.79 -42.27 0.37 Allowed 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 115.948 1.832 . . . . 1.0 115.948 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.515 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -51.77 -37.13 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.61 -1.177 . . . . 1.0 112.046 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -97.29 7.17 47.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.727 0.775 . . . . 1.0 109.866 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -67.28 0.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.985 -1.461 . . . . 1.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -41.66 13.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 118.989 -1.085 . . . . 1.0 110.165 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -69.97 -16.15 63.15 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.299 -1.76 . . . . 1.0 109.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 4.3 ttt180 -90.54 -23.51 20.88 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.546 -0.862 . . . . 1.0 108.892 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -91.25 -51.61 5.22 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.711 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -47.88 -9.94 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 114.684 1.364 . . . . 1.0 114.684 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 23' ' ' LYS . 3.2 pt20 -100.22 -23.36 14.84 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.926 0.766 . . . . 1.0 112.178 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 23.11 49.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.542 0 O-C-N 117.724 -3.11 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.619 0 N-CA-C 105.816 -2.913 . . . . 1.0 105.816 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.66 -29.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 118.366 1.083 . . . . 1.0 112.713 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -5.38 -71.64 0.01 OUTLIER Glycine 0 N--CA 1.507 3.367 0 N-CA-C 117.221 1.648 . . . . 1.0 117.221 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.2 -17.31 17.43 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 119.544 -0.862 . . . . 1.0 111.414 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -55.99 -48.43 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.631 -2.359 . . . . 1.0 104.631 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 mt -55.99 -17.71 7.46 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 114.201 -1.363 . . . . 1.0 112.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -100.05 -25.53 14.27 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.783 -0.767 . . . . 1.0 109.059 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -58.52 -28.8 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.34 13.89 14.24 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.922 -1.035 . . . . 1.0 111.358 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -101.12 -3.16 29.71 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.657 -0.817 . . . . 1.0 108.801 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -78.97 0.6 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.524 -2.028 . . . . 1.0 105.524 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.31 -85.46 0.07 OUTLIER Glycine 0 N--CA 1.491 2.352 1 N-CA-C 102.237 -4.345 . . . . 1.0 102.237 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 79.86 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 104.441 -2.429 . . . . 1.0 104.441 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.544 9.4 Cg_endo 64.07 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.745 2.297 . . . . 1.0 110.836 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.62 -4.7 27.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 114.521 1.304 . . . . 1.0 114.521 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' CB ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.32 -24.7 1.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.633 1.716 . . . . 1.0 115.633 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -32.53 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -100.6 9.84 41.97 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.999 0.904 . . . . 1.0 108.909 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -101.37 -69.62 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 113.93 -1.486 . . . . 1.0 108.7 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -38.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 118.559 -1.256 . . . . 1.0 109.609 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -12.49 61.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.495 -1.682 . . . . 1.0 108.76 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -90.02 -60.38 1.95 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -57.92 -33.22 68.55 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.447 -0.901 . . . . 1.0 112.976 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -71.58 -11.79 61.03 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 116.207 -2.197 . . . . 1.0 110.693 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -101.48 -45.16 5.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -115.11 98.17 6.64 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.621 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.766 0 O-C-N 118.888 -2.383 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.786 0 N-CA-C 105.915 -2.874 . . . . 1.0 105.915 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -111.35 -21.58 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 118.964 1.382 . . . . 1.0 113.071 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -6.5 -72.7 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.554 1.782 . . . . 1.0 117.554 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.89 -12.12 20.11 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.823 -0.751 . . . . 1.0 110.58 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -61.0 -41.69 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 103.31 -2.848 . . . . 1.0 103.31 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.41 -16.28 22.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 113.707 -1.588 . . . . 1.0 110.797 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -100.64 -2.11 33.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 123.664 0.602 . . . . 1.0 110.506 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 t -90.4 -46.71 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.04 0.448 . . . . 1.0 110.612 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.44 19.98 4.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.399 1.095 . . . . 1.0 113.251 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 -17.41 15.17 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 113.844 -1.526 . . . . 1.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.84 -64.64 1.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 104.384 -2.45 . . . . 1.0 104.384 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.53 -122.27 1.57 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 1.0 104.426 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mt -152.64 67.27 6.59 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 105.812 -1.922 . . . . 1.0 105.812 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.533 18.5 Cg_endo 56.84 -81.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.934 3.09 . . . . 1.0 112.3 173.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.18 -14.33 17.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -46.23 -43.6 15.55 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.325 1.232 . . . . 1.0 114.325 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -24.28 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.511 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.33 3.19 43.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 -69.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.404 0.621 . . . . 1.0 109.654 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -35.08 8.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 118.586 -0.721 . . . . 1.0 111.142 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -24.03 63.91 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 116.134 -2.227 . . . . 1.0 105.052 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -61.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -36.21 22.19 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.237 1.018 . . . . 1.0 110.738 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.83 -21.33 66.03 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.114 -0.948 . . . . 1.0 112.762 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -101.62 -45.37 5.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.551 1.157 . . . . 1.0 110.248 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.48 128.67 44.81 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.789 -1.096 . . . . 1.0 110.012 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.735 0 O-C-N 118.334 -2.729 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.503 0 N-CA-C 106.028 -2.829 . . . . 1.0 106.028 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -113.36 -36.56 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 118.613 1.207 . . . . 1.0 112.652 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -9.88 -58.75 0.01 OUTLIER Glycine 0 N--CA 1.508 3.467 0 N-CA-C 117.713 1.845 . . . . 1.0 117.713 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.1 -27.5 13.51 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.577 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 2' ' ' ILE . 9.5 t -54.49 -44.77 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.15 -17.04 23.39 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.996 -1.456 . . . . 1.0 111.822 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -100.24 -6.04 26.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.019 0.824 . . . . 1.0 110.022 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 10' ' ' THR . 34.4 t -90.61 -51.12 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.92 11.63 0.51 Allowed 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 114.322 -1.308 . . . . 1.0 112.611 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -105.13 -12.4 16.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.216 -1.402 . . . . 1.0 107.216 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 -31.96 4.23 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.95 -111.21 0.47 Allowed Glycine 0 N--CA 1.481 1.689 1 N-CA-C 101.822 -4.511 . . . . 1.0 101.822 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.64 66.82 8.45 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 104.456 -2.424 . . . . 1.0 104.456 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.534 12.0 Cg_endo 61.56 -83.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.848 3.032 . . . . 1.0 111.577 169.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.21 -18.94 16.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.28 -37.41 16.23 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.547 -1.261 . . . . 1.0 114.098 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.34 -30.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.513 0.673 . . . . 1.0 109.357 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -100.25 10.32 41.42 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.499 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -102.77 -64.3 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.139 -1.392 . . . . 1.0 108.435 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.05 -39.54 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 118.334 -1.347 . . . . 1.0 111.608 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -72.48 -27.62 62.39 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 116.511 -2.076 . . . . 1.0 108.83 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -61.12 -36.51 79.93 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.403 -1.319 . . . . 1.0 107.574 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -35.61 14.6 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.797 -1.161 . . . . 1.0 110.587 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -21.61 61.91 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 118.778 -1.169 . . . . 1.0 110.574 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -100.68 2.57 41.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.346 1.029 . . . . 1.0 110.648 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -116.15 29.61 7.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.228 -1.397 . . . . 1.0 107.228 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.694 0 O-C-N 119.28 -2.138 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.56 0 N-CA-C 106.639 -2.584 . . . . 1.0 106.639 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.9 pt -81.67 70.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.202 1.001 . . . . 1.0 109.632 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.12 -34.93 4.09 Favored Glycine 0 N--CA 1.502 3.093 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.81 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 6' ' ' LEU . . . -100.09 -51.38 3.69 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 104.625 -2.361 . . . . 1.0 104.625 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -28.28 -30.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 126.126 2.141 . . . . 1.0 114.258 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' ALA . 20.3 mt -90.49 -56.0 3.37 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.605 -0.838 . . . . 1.0 109.179 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -46.41 -41.89 14.35 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 124.074 1.893 . . . . 1.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.9 t -46.9 -45.65 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 111.049 -2.796 . . . . 1.0 110.235 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.36 16.52 9.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.333 -1.303 . . . . 1.0 113.481 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -45.3 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.939 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -84.31 -41.44 16.81 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.16 -1.416 . . . . 1.0 109.844 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.87 -114.95 0.49 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.999 -1.64 . . . . 1.0 108.999 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -169.72 57.78 0.31 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.548 18.6 Cg_endo 59.08 -102.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 124.616 3.544 . . . . 1.0 108.496 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -7.7 24.13 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.794 1.035 . . . . 1.0 113.794 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.22 -42.75 41.38 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 117.949 -1.5 . . . . 1.0 112.545 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.413 ' CD1' ' H ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.91 -40.93 88.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.745 -1.182 . . . . 1.0 108.504 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.413 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -71.1 -7.29 45.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -74.82 0.6 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.684 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -30.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 119.039 -1.064 . . . . 1.0 112.86 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -79.22 -9.47 59.58 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 116.865 -1.934 . . . . 1.0 108.138 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -90.67 -62.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.431 1 N-CA-C 98.926 -4.472 . . . . 1.0 98.926 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -42.48 -63.8 0.71 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.376 -1.284 . . . . 1.0 112.78 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -18.82 0.1 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.519 2.044 . . . . 1.0 116.519 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -101.24 14.8 30.82 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.764 0.792 . . . . 1.0 111.709 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -118.22 133.22 56.09 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.866 -1.515 . . . . 1.0 107.998 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.62 0 O-C-N 118.212 -2.805 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.825 0 N-CA-C 106.211 -2.756 . . . . 1.0 106.211 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 pp -115.16 -5.61 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-N 118.424 1.112 . . . . 1.0 113.124 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.93 -60.98 0.01 OUTLIER Glycine 0 N--CA 1.504 3.2 0 N-CA-C 117.712 1.845 . . . . 1.0 117.712 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.32 -43.7 8.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -35.6 -55.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.795 1.31 . . . . 1.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.7 mt -49.29 -38.97 29.18 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.2 -35.42 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.767 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' CG1' ' HG3' ' A' ' 14' ' ' PRO . 1.4 t -61.08 -32.8 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.385 1.088 . . . . 1.0 109.077 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mt -72.82 -2.14 19.41 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.576 -1.193 . . . . 1.0 108.787 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 m -98.98 -10.21 22.99 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.449 -1.685 . . . . 1.0 106.449 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -105.23 -45.56 4.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.406 -1.701 . . . . 1.0 106.406 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.39 -133.44 2.91 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 106.094 -2.802 . . . . 1.0 106.094 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.13 68.19 7.22 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 112.39 -1.905 . . . . 1.0 107.39 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.446 ' HG3' ' CG1' ' A' ' 8' ' ' VAL 2.527 47.7 Cg_endo 54.15 -83.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 125.209 3.939 . . . . 1.0 112.824 171.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.42 -17.7 16.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.28 -46.26 17.83 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -26.06 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.078 0.942 . . . . 1.0 109.466 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.0 m -101.26 5.78 42.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.091 -0.959 . . . . 1.0 110.73 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.58 -67.57 0.86 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 123.44 0.462 . . . . 1.0 109.935 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.91 -34.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 118.405 -1.318 . . . . 1.0 111.347 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -69.35 -16.76 63.6 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 116.717 -1.993 . . . . 1.0 107.163 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -91.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.369 -1.715 . . . . 1.0 106.369 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -47.79 -40.09 19.95 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.1 -0.954 . . . . 1.0 108.957 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.73 39.88 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.412 -0.915 . . . . 1.0 109.767 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -100.31 -26.14 14.0 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 121.0 0.429 . . . . 1.0 110.993 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.72 6.4 31.83 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.321 1.058 . . . . 1.0 113.185 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.674 0 O-C-N 118.651 -2.531 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.645 0 N-CA-C 106.067 -2.813 . . . . 1.0 106.067 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt -112.67 -42.3 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 CA-C-N 118.463 1.132 . . . . 1.0 112.366 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -15.64 -60.62 0.01 OUTLIER Glycine 0 N--CA 1.506 3.319 0 N-CA-C 117.094 1.598 . . . . 1.0 117.094 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.76 -24.82 20.26 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.284 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 2' ' ' ILE . 36.6 t -58.93 -48.39 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.8 mt -38.1 -59.31 0.87 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.409 -1.269 . . . . 1.0 111.219 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -42.48 -53.16 4.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.207 -1.815 . . . . 1.0 109.825 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.41 ' CG1' ' HG2' ' A' ' 14' ' ' PRO . 10.7 t -44.92 -57.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.114 -1.403 . . . . 1.0 109.146 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.67 -19.22 65.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.215 -2.266 . . . . 1.0 111.864 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -0.21 54.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 118.61 -1.236 . . . . 1.0 107.827 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -107.08 -61.92 1.48 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.397 -2.446 . . . . 1.0 104.397 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -127.7 1.77 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 106.366 -2.693 . . . . 1.0 106.366 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 4.8 mt -159.45 58.89 1.26 Allowed Pre-proline 0 N--CA 1.497 1.896 0 CA-C-N 112.783 -1.708 . . . . 1.0 107.707 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HG2' ' CG1' ' A' ' 8' ' ' VAL 2.537 38.9 Cg_endo 55.94 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 124.825 3.684 . . . . 1.0 111.081 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.68 -12.38 19.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.469 0.914 . . . . 1.0 113.469 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -46.22 -45.14 16.78 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.751 -1.179 . . . . 1.0 113.177 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 pp -56.81 -32.3 38.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.016 -1.902 . . . . 1.0 110.202 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.93 8.81 42.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.246 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.93 -70.67 0.73 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 -39.93 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 117.539 -1.664 . . . . 1.0 109.811 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -23.15 67.25 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 117.71 -1.596 . . . . 1.0 108.795 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -82.66 -14.6 54.38 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.967 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -43.93 9.9 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.139 -2.171 . . . . 1.0 105.139 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -22.05 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.792 -1.549 . . . . 1.0 113.111 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.43 6.98 44.49 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.334 1.021 . . . . 1.0 112.69 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -112.79 -35.72 5.39 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.3 1.048 . . . . 1.0 108.735 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 118.873 -2.392 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.625 0 N-CA-C 105.564 -3.015 . . . . 1.0 105.564 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 pt -112.95 52.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 118.856 1.328 . . . . 1.0 111.866 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.53 -27.91 6.58 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.671 -1.252 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.92 -47.08 5.15 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.785 -1.931 . . . . 1.0 105.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -36.48 -56.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 115.052 -0.976 . . . . 1.0 111.071 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.0 mt -51.53 -33.32 31.43 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.791 -1.55 . . . . 1.0 113.187 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' NZ ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.95 -31.9 66.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.538 -1.21 . . . . 1.0 111.908 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 t -64.23 -38.22 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.18 -24.19 67.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.5 -1.227 . . . . 1.0 107.933 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.94 -11.89 59.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.035 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 -12.67 18.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.64 123.22 1.88 Allowed Glycine 0 N--CA 1.478 1.486 0 N-CA-C 106.713 -2.555 . . . . 1.0 106.713 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.51 100.86 0.23 Allowed Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 121.51 0.671 . . . . 1.0 111.148 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.514 10.4 Cg_endo 31.89 -84.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 1 C-N-CA 127.118 5.212 . . . . 1.0 115.611 -163.062 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -7.84 22.75 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.95 1.833 . . . . 1.0 115.95 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.6 -41.22 0.66 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.577 1.325 . . . . 1.0 114.577 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -50.31 -37.79 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.139 -1.392 . . . . 1.0 111.253 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.49 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 6.81 43.87 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.111 -0.635 . . . . 1.0 109.329 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.406 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.75 -64.09 1.08 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -44.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.053 -1.459 . . . . 1.0 110.955 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -61.68 -24.55 66.83 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.08 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.473 1.108 . . . . 1.0 109.044 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -90.91 -14.85 30.85 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.87 -0.732 . . . . 1.0 112.12 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -91.27 -26.31 19.05 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.664 -1.214 . . . . 1.0 109.08 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.13 -27.34 13.29 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.489 -0.884 . . . . 1.0 110.086 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -111.25 98.42 7.49 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.699 0 O-C-N 118.907 -2.37 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.609 0 N-CA-C 105.751 -2.94 . . . . 1.0 105.751 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -109.98 -10.12 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 CA-C-N 119.108 1.454 . . . . 1.0 113.349 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -6.62 -78.49 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.21 -5.64 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.263 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t -63.19 -44.6 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 103.962 -2.607 . . . . 1.0 103.962 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.5 mt -43.32 -47.71 6.73 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 123.028 1.394 . . . . 1.0 108.369 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -50.6 -47.38 58.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 112.365 -2.198 . . . . 1.0 110.699 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.548 HG11 ' CG ' ' A' ' 14' ' ' PRO . 51.0 t -53.99 -34.85 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.257 -1.338 . . . . 1.0 111.067 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.38 6.31 43.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 112.623 -2.08 . . . . 1.0 111.736 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.17 -3.7 17.09 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -118.62 -59.36 1.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.9 -114.61 1.18 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.335 -1.906 . . . . 1.0 108.335 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.4 mt 179.44 61.25 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 103.153 -2.906 . . . . 1.0 103.153 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' CG ' HG11 ' A' ' 8' ' ' VAL 2.52 73.4 Cg_endo 50.92 -73.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 1 C-N-CA 125.483 4.122 . . . . 1.0 113.985 -178.643 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -101.87 -22.72 14.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.861 1.06 . . . . 1.0 113.861 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -45.38 -46.31 13.11 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.657 1.725 . . . . 1.0 115.657 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.75 -25.31 37.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.831 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.6 m -101.53 3.12 39.83 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.895 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -71.33 0.71 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.98 -37.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 117.682 -1.607 . . . . 1.0 111.622 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.9 mtpt -71.77 -4.7 29.21 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 115.43 -2.508 . . . . 1.0 109.224 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -52.32 4.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -27.57 66.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 114.223 -1.353 . . . . 1.0 111.171 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -7.32 56.15 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.862 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -101.04 -48.84 4.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.727 1.267 . . . . 1.0 107.739 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 84.0 2.08 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.53 1.157 . . . . 1.0 110.611 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.686 0 O-C-N 118.569 -2.582 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.653 0 N-CA-C 105.769 -2.932 . . . . 1.0 105.769 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.4 pt -59.28 -39.97 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 118.806 1.303 . . . . 1.0 110.951 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -38.91 -28.7 0.07 OUTLIER Glycine 0 N--CA 1.508 3.474 0 O-C-N 123.914 0.759 . . . . 1.0 112.908 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.69 -52.15 3.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.1 t -49.48 -24.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 124.006 0.816 . . . . 1.0 111.851 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.62 -39.97 15.61 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -47.98 -45.08 31.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.96 1.362 . . . . 1.0 109.847 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -54.15 -36.46 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 113.586 -1.643 . . . . 1.0 110.633 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.87 13.88 15.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 113.824 -1.534 . . . . 1.0 111.612 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -11.48 19.12 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.548 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -113.39 -68.11 0.95 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.537 -2.394 . . . . 1.0 104.537 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.33 -120.14 1.62 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.309 -2.317 . . . . 1.0 107.309 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -160.74 60.71 1.36 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 107.343 -1.354 . . . . 1.0 107.343 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.523 15.9 Cg_endo 52.95 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.24 3.294 . . . . 1.0 112.658 174.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -102.39 -18.61 15.31 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -50.43 -46.24 56.36 Favored 'General case' 0 N--CA 1.515 2.799 0 CA-C-O 123.657 1.694 . . . . 1.0 113.405 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.615 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -60.77 -24.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.871 -2.422 . . . . 1.0 107.143 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.424 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.64 3.4 42.47 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.347 -1.297 . . . . 1.0 109.066 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -63.21 1.17 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.678 0.751 . . . . 1.0 109.469 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.68 -43.91 15.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 118.827 -1.149 . . . . 1.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.91 -19.43 65.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 117.513 -1.675 . . . . 1.0 108.439 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 20.6 ttt180 -84.29 -19.92 32.98 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.92 -33.53 15.57 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.459 -1.246 . . . . 1.0 107.989 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.55 53.27 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.168 -0.613 . . . . 1.0 112.478 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.67 11.48 39.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.622 0.576 . . . . 1.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -120.66 143.06 48.9 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.22 -1.4 . . . . 1.0 107.22 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.633 0 O-C-N 118.215 -2.803 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.707 0 N-CA-C 105.203 -3.159 . . . . 1.0 105.203 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.5 pt -110.86 75.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 119.202 1.501 . . . . 1.0 112.013 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.84 -102.5 1.81 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 105.245 -3.142 . . . . 1.0 105.245 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -33.16 -44.83 0.13 Allowed 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 122.311 1.053 . . . . 1.0 112.588 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.57 -27.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.837 -1.983 . . . . 1.0 114.619 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.51 -7.83 54.11 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -100.2 -26.14 14.03 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 t -60.74 -34.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 122.865 1.317 . . . . 1.0 108.625 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mt -71.52 -4.34 26.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.68 -1.6 . . . . 1.0 109.061 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -2.84 31.12 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -117.12 -45.59 2.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.01 -0.737 . . . . 1.0 109.01 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.32 -118.99 2.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.355 -2.298 . . . . 1.0 107.355 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.49 65.13 0.15 Allowed Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 103.3 -2.852 . . . . 1.0 103.3 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.524 59.4 Cg_endo 51.33 -78.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 1 C-N-CA 126.264 4.643 . . . . 1.0 112.71 -178.28 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.23 -21.8 14.82 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.452 -0.899 . . . . 1.0 113.338 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -40.61 -43.28 1.87 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.979 1.844 . . . . 1.0 115.979 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -58.6 -37.55 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.405 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 3.7 m -91.3 6.01 46.96 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.117 -1.033 . . . . 1.0 109.144 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.08 -69.08 0.79 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -89.86 -38.93 11.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 118.331 -1.347 . . . . 1.0 111.095 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -26.59 65.55 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 117.11 -1.836 . . . . 1.0 108.684 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' NH1' ' O ' ' A' ' 18' ' ' SER . 4.3 ttp180 -67.83 -55.78 11.64 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -52.27 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.679 -1.601 . . . . 1.0 108.078 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -20.81 1.86 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.565 1.691 . . . . 1.0 115.565 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.56 3.62 42.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.975 0.797 . . . . 1.0 113.059 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -121.02 177.38 5.14 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.155 0.979 . . . . 1.0 110.482 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.473 0 O-C-N 119.247 -2.158 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.675 0 N-CA-C 105.688 -2.965 . . . . 1.0 105.688 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.02 -125.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-N 118.243 1.022 . . . . 1.0 110.223 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.4 -70.95 2.56 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.445 -1.862 . . . . 1.0 108.445 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.2 3.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.77 -1.215 . . . . 1.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -35.53 -34.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 114.872 1.434 . . . . 1.0 114.872 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' H ' ' CD2' ' A' ' 6' ' ' LEU . 2.6 pt? -86.55 -35.34 19.57 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.028 -1.469 . . . . 1.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 2.4 mmpt? -52.61 -41.67 63.88 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 123.774 1.75 . . . . 1.0 106.557 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -50.42 -43.54 22.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 111.596 -2.547 . . . . 1.0 108.458 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.61 8.52 33.78 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.031 -1.441 . . . . 1.0 114.7 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -115.05 -30.15 6.45 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-O 121.868 0.842 . . . . 1.0 108.938 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -93.58 -13.03 28.19 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.09 -85.6 0.21 Allowed Glycine 0 N--CA 1.494 2.517 0 O-C-N 124.699 1.249 . . . . 1.0 111.557 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.05 69.43 0.13 Allowed Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 105.736 -1.95 . . . . 1.0 105.736 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.525 73.1 Cg_endo 42.09 -76.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 1 C-N-CA 126.645 4.897 . . . . 1.0 114.002 -172.404 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.96 -14.48 17.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.265 1.58 . . . . 1.0 115.265 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -41.4 -43.24 2.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.552 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -55.23 -33.01 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.568 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -100.29 5.57 44.54 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.44 0.638 . . . . 1.0 109.85 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.98 -64.21 1.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -48.02 14.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 118.395 -1.322 . . . . 1.0 109.25 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -62.78 -9.82 10.78 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 117.235 -1.786 . . . . 1.0 110.352 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.96 -65.26 1.03 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -58.61 -31.13 67.79 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.347 -1.341 . . . . 1.0 111.137 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.82 -15.54 63.13 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.097 -1.441 . . . . 1.0 110.049 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -101.19 -41.6 6.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.636 0.731 . . . . 1.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -114.41 71.8 0.77 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.823 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.599 0 O-C-N 118.779 -2.45 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 N-CA-C 105.795 -2.922 . . . . 1.0 105.795 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -111.01 -10.83 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 CA-C-N 119.285 1.543 . . . . 1.0 113.029 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -32.77 -52.17 0.47 Allowed Glycine 0 N--CA 1.503 3.122 0 N-CA-C 116.063 1.185 . . . . 1.0 116.063 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.32 4.67 44.2 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.001 -0.679 . . . . 1.0 112.319 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.02 -55.49 6.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 104.137 -2.542 . . . . 1.0 104.137 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.7 mt -37.64 -60.9 0.66 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.833 0.708 . . . . 1.0 111.09 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -45.07 -49.18 11.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.046 -1.434 . . . . 1.0 110.738 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.3 t -52.34 -49.71 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.939 0.876 . . . . 1.0 109.465 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.4 -12.15 28.43 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 114.127 -1.397 . . . . 1.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.45 12.17 33.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.992 -1.485 . . . . 1.0 106.992 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -63.1 1.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 103.307 -2.849 . . . . 1.0 103.307 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.55 -131.99 2.01 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 105.205 -3.158 . . . . 1.0 105.205 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.6 mt -158.88 55.88 0.87 Allowed Pre-proline 0 N--CA 1.498 1.954 0 CA-C-N 111.795 -2.202 . . . . 1.0 107.768 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.529 59.1 Cg_endo 52.11 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 1 C-N-CA 125.789 4.326 . . . . 1.0 112.947 177.879 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 -15.12 17.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.07 1.137 . . . . 1.0 114.07 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -47.51 -47.27 27.78 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 122.208 1.004 . . . . 1.0 113.246 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -56.11 -30.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 113.46 -1.7 . . . . 1.0 109.183 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 1.8 m -101.0 8.78 42.84 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.629 -0.828 . . . . 1.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -70.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -40.68 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 117.412 -1.715 . . . . 1.0 110.317 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -12.3 59.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 117.012 -1.875 . . . . 1.0 109.525 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.413 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 15.0 ttt180 -86.38 -55.81 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 101.83 -3.396 . . . . 1.0 101.83 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -46.26 -55.17 7.58 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.256 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -12.84 5.38 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.786 1.402 . . . . 1.0 114.786 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -101.54 6.39 42.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.476 0.485 . . . . 1.0 111.101 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -118.66 -37.85 3.21 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.362 1.077 . . . . 1.0 110.359 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.581 0 O-C-N 118.299 -2.751 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.791 0 N-CA-C 105.607 -2.997 . . . . 1.0 105.607 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pp -107.53 -28.91 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.464 0 CA-C-N 118.803 1.302 . . . . 1.0 113.145 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -27.12 -36.89 0.01 OUTLIER Glycine 0 N--CA 1.506 3.354 0 N-CA-C 117.292 1.677 . . . . 1.0 117.292 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.05 -49.59 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.116 -1.439 . . . . 1.0 107.116 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 t -40.13 -54.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 124.535 1.147 . . . . 1.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.6 mt -46.01 -50.83 14.53 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 122.345 1.069 . . . . 1.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -45.51 -47.14 14.22 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 112.869 -1.968 . . . . 1.0 110.171 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 t -54.38 -47.64 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 113.312 -1.767 . . . . 1.0 109.287 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.83 -5.12 19.05 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.35 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 8.75 34.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.225 -2.139 . . . . 1.0 105.225 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.83 -64.37 1.22 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.93 -126.24 2.37 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 106.434 -2.666 . . . . 1.0 106.434 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -171.09 60.53 0.32 Allowed Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 122.657 1.218 . . . . 1.0 108.405 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.522 95.9 Cg_endo 41.78 -82.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 1 C-N-CA 126.607 4.871 . . . . 1.0 114.006 -173.707 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.56 -12.8 17.5 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -47.67 -48.41 29.09 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.405 -1.318 . . . . 1.0 113.05 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -42.24 85.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -6.24 39.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.767 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.105 -0.952 . . . . 1.0 108.877 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -90.22 -36.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.693 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.25 -16.55 61.4 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.028 -1.869 . . . . 1.0 108.51 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 -24.35 20.35 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.466 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -91.1 -35.16 14.75 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.487 -0.885 . . . . 1.0 109.065 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -13.01 16.53 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.006 0.431 . . . . 1.0 111.805 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -100.98 8.08 43.21 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.848 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.93 178.35 4.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.517 0.675 . . . . 1.0 109.498 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.528 0 O-C-N 118.975 -2.328 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.783 0 N-CA-C 106.33 -2.708 . . . . 1.0 106.33 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.41 -34.47 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-N 118.32 1.06 . . . . 1.0 112.653 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.89 -56.02 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.817 1.887 . . . . 1.0 117.817 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.84 -32.59 11.27 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.932 0.396 . . . . 1.0 111.095 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -51.09 -49.07 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.8 mt -54.8 -19.2 5.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 113.596 -1.638 . . . . 1.0 112.661 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -96.67 -28.06 14.5 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.7 t -52.54 -50.03 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.5 6.16 0.23 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.947 -1.933 . . . . 1.0 113.409 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -102.13 -9.04 20.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.491 -1.3 . . . . 1.0 107.491 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m -115.52 -60.91 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.557 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.5 -113.55 0.76 Allowed Glycine 0 N--CA 1.503 3.148 0 C-N-CA 119.394 -1.384 . . . . 1.0 109.795 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -178.42 60.91 0.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 104.465 -2.42 . . . . 1.0 104.465 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.518 55.0 Cg_endo 53.87 -75.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 1 C-N-CA 125.744 4.296 . . . . 1.0 114.474 176.608 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.15 -21.97 14.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 115.367 1.618 . . . . 1.0 115.367 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -38.85 -40.29 0.62 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.448 2.018 . . . . 1.0 116.448 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.549 ' CD1' ' H ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -51.01 -39.5 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 113.164 -1.834 . . . . 1.0 111.673 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -101.08 9.89 41.59 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 1.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -66.73 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.886 -1.506 . . . . 1.0 108.783 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -35.61 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.189 -0.604 . . . . 1.0 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -76.73 -4.17 41.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.768 -1.573 . . . . 1.0 107.828 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -90.4 -76.59 0.43 Allowed 'General case' 0 C--N 1.306 -1.309 1 N-CA-C 95.734 -5.654 . . . . 1.0 95.734 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -37.33 -62.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 114.875 1.435 . . . . 1.0 114.875 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -22.05 32.79 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.38 -50.8 3.5 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -112.59 -2.59 14.54 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 113.48 0.918 . . . . 1.0 113.48 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.783 0 O-C-N 117.735 -3.103 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.638 HD12 HD11 ' A' ' 6' ' ' LEU . 23.2 pt . . . . . 0 N--CA 1.505 2.28 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -29.56 -41.96 0.04 OUTLIER Glycine 0 N--CA 1.51 3.61 0 CA-C-O 121.807 0.67 . . . . 1.0 114.428 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.711 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -93.36 -40.66 10.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -50.61 -37.48 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 123.215 0.322 . . . . 1.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 2' ' ' ILE . 15.9 mt -86.32 -5.32 59.2 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.935 -0.706 . . . . 1.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -100.38 -6.03 26.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.28 0.987 . . . . 1.0 109.692 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 4' ' ' ALA . 98.1 t -87.79 -41.34 14.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.847 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.16 22.11 3.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.708 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -20.9 8.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 115.524 1.676 . . . . 1.0 115.524 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -121.24 -76.65 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.02 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -121.3 -96.35 1.45 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 106.947 -2.461 . . . . 1.0 106.947 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.41 70.95 0.14 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 104.428 -2.434 . . . . 1.0 104.428 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HG2' HG22 ' A' ' 8' ' ' VAL 2.531 18.3 Cg_endo 59.31 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.861 3.04 . . . . 1.0 111.813 176.061 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.64 -15.19 17.12 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.61 1.337 . . . . 1.0 114.61 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.52 -39.68 0.49 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.284 1.587 . . . . 1.0 115.284 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.799 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -51.4 -35.77 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.116 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.416 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.34 5.77 44.48 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.484 0.659 . . . . 1.0 109.769 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -63.11 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.581 -1.19 . . . . 1.0 110.038 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.16 -44.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.268 -0.878 . . . . 1.0 109.946 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -28.32 69.14 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 116.923 -1.911 . . . . 1.0 108.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.416 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 2.9 ttt180 -73.86 -28.55 61.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.701 -1.599 . . . . 1.0 108.265 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.03 -22.9 20.54 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.273 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -36.4 10.85 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.721 0.637 . . . . 1.0 112.721 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -100.18 66.7 1.33 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-N 113.294 -1.776 . . . . 1.0 107.071 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 4' ' ' ALA . 7.9 pt . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.25 -68.66 0.0 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 116.125 1.21 . . . . 1.0 116.125 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 2' ' ' ILE . . . -97.7 -26.78 14.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.82 -19.75 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.75 -11.86 38.29 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.352 -0.84 . . . . 1.0 110.731 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.29 -2.66 33.13 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.747 0.784 . . . . 1.0 110.006 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.4 -49.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.427 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.05 19.07 5.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.538 1.31 . . . . 1.0 114.538 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -16.71 14.34 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.172 -1.376 . . . . 1.0 109.912 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 m -115.9 -61.83 1.68 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.08 -120.81 1.71 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 106.399 -2.681 . . . . 1.0 106.399 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -156.26 63.4 3.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 113.269 -1.465 . . . . 1.0 107.601 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.446 ' O ' HD11 ' A' ' 17' ' ' ILE 2.545 1.0 OUTLIER 61.26 -100.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 123.03 2.487 . . . . 1.0 108.056 175.51 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.57 -8.85 22.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -49.96 -42.67 49.22 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 119.481 -0.888 . . . . 1.0 112.306 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 18' ' ' SER . 1.3 pp -59.03 -26.12 31.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 113.628 -1.624 . . . . 1.0 109.835 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.645 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -100.98 3.62 41.74 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.042 0.925 . . . . 1.0 109.95 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.59 -61.44 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.353 -0.839 . . . . 1.0 111.155 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -43.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.466 -1.294 . . . . 1.0 110.078 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -32.66 74.21 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.919 -1.513 . . . . 1.0 107.622 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -16.85 60.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 124.452 1.095 . . . . 1.0 110.213 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -41.17 11.39 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -47.17 52.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.245 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -84.83 68.06 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-N 113.728 -1.578 . . . . 1.0 108.305 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.28 -71.77 0.21 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.92 -46.4 7.86 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.982 -1.087 . . . . 1.0 108.313 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 5' ' ' VAL . 5.3 t -29.86 -33.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.972 1.42 . . . . 1.0 114.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.95 -49.68 17.06 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.526 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -45.12 -43.3 9.63 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.528 1.156 . . . . 1.0 108.689 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 8' ' ' VAL . 17.6 t -46.37 -56.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.675 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.15 6.44 1.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.504 -1.68 . . . . 1.0 113.564 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.34 -2.14 18.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.909 -1.886 . . . . 1.0 105.909 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.2 m -120.08 -61.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.679 -1.971 . . . . 1.0 105.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.73 -122.99 0.9 Allowed Glycine 0 N--CA 1.481 1.66 0 N-CA-C 107.908 -2.077 . . . . 1.0 107.908 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 13' ' ' LEU . 2.1 pt? -150.32 32.88 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 111.838 -2.181 . . . . 1.0 109.66 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.536 41.9 Cg_exo 94.77 175.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.758 2.972 . . . . 1.0 109.208 -167.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -26.74 -25.3 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 118.648 2.833 . . . . 1.0 118.648 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 14' ' ' PRO . 2.9 mm? -43.26 -38.77 2.72 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.664 0.745 . . . . 1.0 112.405 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -30.69 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 114.299 -1.319 . . . . 1.0 111.79 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.484 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 3.65 42.14 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.213 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -78.4 0.53 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.164 -1.791 . . . . 1.0 106.164 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.74 -36.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 117.973 -1.491 . . . . 1.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -74.86 -9.53 58.63 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 116.923 -1.911 . . . . 1.0 109.94 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.484 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 11.2 ttm180 -90.2 -50.66 5.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 103.694 -2.706 . . . . 1.0 103.694 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -41.81 95.2 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.576 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.42 -28.85 8.92 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.788 -1.165 . . . . 1.0 113.204 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -101.33 -29.63 11.95 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 119.799 -0.76 . . . . 1.0 111.075 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 -179.968 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 6' ' ' LEU . 2.7 pt . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 113.686 0.995 . . . . 1.0 113.686 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.23 -65.59 0.01 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 116.148 1.219 . . . . 1.0 116.148 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.75 -29.85 13.13 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.963 -0.695 . . . . 1.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 5' ' ' VAL . 2.1 t -53.58 -26.08 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.96 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 2' ' ' ILE . 73.9 mt -90.09 -14.29 34.04 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.94 1.84 40.19 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.303 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -90.75 -47.63 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -87.84 19.36 3.55 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.515 -1.22 . . . . 1.0 112.709 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 -18.17 19.5 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.064 -1.425 . . . . 1.0 109.23 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -122.95 -61.88 1.4 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.76 -118.42 1.48 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 61.01 4.47 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 17' ' ' ILE 2.549 5.8 Cg_endo 62.88 -99.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 123.325 2.683 . . . . 1.0 108.975 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.67 -10.07 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.351 1.241 . . . . 1.0 114.351 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.81 -44.36 19.21 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.59 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -61.79 -24.92 35.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.684 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.515 ' H ' HD12 ' A' ' 17' ' ' ILE . 50.9 m -100.87 4.99 43.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -61.1 1.42 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.842 -1.17 . . . . 1.0 107.842 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -49.94 13.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.023 -1.071 . . . . 1.0 110.23 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -9.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.866 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -90.79 -23.7 20.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 105.874 -1.898 . . . . 1.0 105.874 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.15 -58.61 2.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.97 1.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 115.595 1.702 . . . . 1.0 115.595 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.613 -1.625 . . . . 1.0 106.613 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-N 113.799 -1.546 . . . . 1.0 107.817 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.755 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp . . . . . 0 N--CA 1.51 2.569 0 N-CA-C 113.138 0.792 . . . . 1.0 113.138 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.755 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -15.26 -53.18 0.01 OUTLIER Glycine 0 N--CA 1.51 3.575 0 N-CA-C 117.479 1.751 . . . . 1.0 117.479 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.11 -30.03 12.17 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.883 -0.658 . . . . 1.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 2' ' ' ILE . 6.1 t -54.56 -42.27 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 2' ' ' ILE . 43.7 mt -61.97 -16.99 55.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.459 -1.246 . . . . 1.0 111.451 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.08 -3.21 29.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.424 1.078 . . . . 1.0 110.51 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 4' ' ' ALA . 44.0 t -90.35 -54.62 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -79.12 19.09 0.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.587 -1.188 . . . . 1.0 113.82 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -23.75 12.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.188 -1.369 . . . . 1.0 107.456 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.404 HG23 ' HD3' ' A' ' 14' ' ' PRO . 2.5 t -112.31 -29.31 7.58 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.801 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -101.51 0.2 Allowed Glycine 0 N--CA 1.483 1.819 0 CA-C-N 114.383 -1.28 . . . . 1.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.15 66.23 1.6 Allowed Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.774 ' O ' HD11 ' A' ' 17' ' ' ILE 2.535 25.5 Cg_endo 58.16 -85.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.12 3.213 . . . . 1.0 110.95 173.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.45 -15.26 17.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -46.55 -42.74 16.32 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.574 1.694 . . . . 1.0 115.574 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.774 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.9 -23.39 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 114.587 -1.188 . . . . 1.0 108.984 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -101.38 1.32 38.32 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.338 -0.846 . . . . 1.0 109.111 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -70.98 0.73 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -30.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.481 -1.288 . . . . 1.0 112.494 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 16.0 mtpt -80.45 -27.17 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 116.798 -1.961 . . . . 1.0 107.627 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -30.33 64.66 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -33.48 16.22 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.102 -1.039 . . . . 1.0 108.569 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -60.82 -7.38 2.3 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.746 -0.781 . . . . 1.0 112.603 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -100.25 -9.79 22.02 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.673 -1.232 . . . . 1.0 107.673 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 179.898 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 N--CA 1.506 2.375 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -7.16 -68.76 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 N-CA-C 116.395 1.318 . . . . 1.0 116.395 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.75 -21.99 15.02 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 120.896 0.379 . . . . 1.0 110.702 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.41 -29.58 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.711 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.6 mt -89.46 -6.91 56.06 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.4 -0.92 . . . . 1.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -93.99 -36.9 11.94 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 4' ' ' ALA . 78.6 t -49.32 -36.23 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.99 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.72 17.64 7.4 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.774 -1.557 . . . . 1.0 113.508 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -108.66 -13.54 14.78 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.302 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -63.09 1.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.678 -0.809 . . . . 1.0 109.042 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.44 -97.47 0.27 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 108.966 -1.654 . . . . 1.0 108.966 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.52 65.33 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 104.687 -2.338 . . . . 1.0 104.687 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.538 11.5 Cg_endo 60.19 -93.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.334 2.689 . . . . 1.0 110.346 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -13.1 18.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -36.79 -42.27 0.37 Allowed 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 115.948 1.832 . . . . 1.0 115.948 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.747 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -51.77 -37.13 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.61 -1.177 . . . . 1.0 112.046 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -97.29 7.17 47.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.727 0.775 . . . . 1.0 109.866 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -67.28 0.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.985 -1.461 . . . . 1.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -41.66 13.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 118.989 -1.085 . . . . 1.0 110.165 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -69.97 -16.15 63.15 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.299 -1.76 . . . . 1.0 109.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 4.3 ttt180 -90.54 -23.51 20.88 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.546 -0.862 . . . . 1.0 108.892 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -51.61 5.22 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.711 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -47.88 -9.94 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 114.684 1.364 . . . . 1.0 114.684 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.22 -23.36 14.84 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.926 0.766 . . . . 1.0 112.178 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 . . . . . 0 N--CA 1.504 2.261 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 112.713 0.634 . . . . 1.0 112.713 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -5.38 -71.64 0.01 OUTLIER Glycine 0 N--CA 1.507 3.367 0 N-CA-C 117.221 1.648 . . . . 1.0 117.221 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.2 -17.31 17.43 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 119.544 -0.862 . . . . 1.0 111.414 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -55.99 -48.43 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.631 -2.359 . . . . 1.0 104.631 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 mt -55.99 -17.71 7.46 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 114.201 -1.363 . . . . 1.0 112.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -100.05 -25.53 14.27 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.783 -0.767 . . . . 1.0 109.059 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' A' ' 14' ' ' PRO . 4.1 t -58.52 -28.8 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.34 13.89 14.24 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.922 -1.035 . . . . 1.0 111.358 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -101.12 -3.16 29.71 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.657 -0.817 . . . . 1.0 108.801 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -78.97 0.6 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.524 -2.028 . . . . 1.0 105.524 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.31 -85.46 0.07 OUTLIER Glycine 0 N--CA 1.491 2.352 1 N-CA-C 102.237 -4.345 . . . . 1.0 102.237 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 79.86 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 104.441 -2.429 . . . . 1.0 104.441 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.565 ' HD2' HG13 ' A' ' 8' ' ' VAL 2.544 9.4 Cg_endo 64.07 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.745 2.297 . . . . 1.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.62 -4.7 27.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 114.521 1.304 . . . . 1.0 114.521 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.32 -24.7 1.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.633 1.716 . . . . 1.0 115.633 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -65.53 -32.53 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -100.6 9.84 41.97 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.999 0.904 . . . . 1.0 108.909 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -101.37 -69.62 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 113.93 -1.486 . . . . 1.0 108.7 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.482 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -90.52 -38.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 118.559 -1.256 . . . . 1.0 109.609 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -12.49 61.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.495 -1.682 . . . . 1.0 108.76 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -90.02 -60.38 1.95 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -57.92 -33.22 68.55 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.447 -0.901 . . . . 1.0 112.976 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 3.6 ttp180 -71.58 -11.79 61.03 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 116.207 -2.197 . . . . 1.0 110.693 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -101.48 -45.16 5.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.621 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 3' ' ' GLY . 1.7 pp . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 113.071 0.767 . . . . 1.0 113.071 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.673 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -6.5 -72.7 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.554 1.782 . . . . 1.0 117.554 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.89 -12.12 20.11 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.823 -0.751 . . . . 1.0 110.58 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -61.0 -41.69 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 103.31 -2.848 . . . . 1.0 103.31 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.41 -16.28 22.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 113.707 -1.588 . . . . 1.0 110.797 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -100.64 -2.11 33.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 123.664 0.602 . . . . 1.0 110.506 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.576 HG13 ' HG2' ' A' ' 14' ' ' PRO . 11.5 t -90.4 -46.71 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.04 0.448 . . . . 1.0 110.612 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.519 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.44 19.98 4.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.399 1.095 . . . . 1.0 113.251 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 -17.41 15.17 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 113.844 -1.526 . . . . 1.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.84 -64.64 1.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 104.384 -2.45 . . . . 1.0 104.384 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.53 -122.27 1.57 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 1.0 104.426 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mt -152.64 67.27 6.59 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 105.812 -1.922 . . . . 1.0 105.812 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.689 ' O ' HD11 ' A' ' 17' ' ' ILE 2.533 18.5 Cg_endo 56.84 -81.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.934 3.09 . . . . 1.0 112.3 173.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.18 -14.33 17.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -46.23 -43.6 15.55 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.325 1.232 . . . . 1.0 114.325 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.689 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -62.36 -24.28 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.511 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -100.33 3.19 43.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 -69.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.404 0.621 . . . . 1.0 109.654 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -35.08 8.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 118.586 -0.721 . . . . 1.0 111.142 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -24.03 63.91 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 116.134 -2.227 . . . . 1.0 105.052 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -61.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -36.21 22.19 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.237 1.018 . . . . 1.0 110.738 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.83 -21.33 66.03 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.114 -0.948 . . . . 1.0 112.762 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -101.62 -45.37 5.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.551 1.157 . . . . 1.0 110.248 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-N 114.789 -1.096 . . . . 1.0 110.012 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.535 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -9.88 -58.75 0.01 OUTLIER Glycine 0 N--CA 1.508 3.467 0 N-CA-C 117.713 1.845 . . . . 1.0 117.713 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.1 -27.5 13.51 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.577 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 2' ' ' ILE . 9.5 t -54.49 -44.77 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.15 -17.04 23.39 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.996 -1.456 . . . . 1.0 111.822 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -100.24 -6.04 26.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.019 0.824 . . . . 1.0 110.022 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 10' ' ' THR . 34.4 t -90.61 -51.12 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.436 HD23 HG12 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -71.92 11.63 0.51 Allowed 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 114.322 -1.308 . . . . 1.0 112.611 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -105.13 -12.4 16.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.216 -1.402 . . . . 1.0 107.216 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 -31.96 4.23 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.95 -111.21 0.47 Allowed Glycine 0 N--CA 1.481 1.689 1 N-CA-C 101.822 -4.511 . . . . 1.0 101.822 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -149.64 66.82 8.45 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 104.456 -2.424 . . . . 1.0 104.456 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.534 12.0 Cg_endo 61.56 -83.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.848 3.032 . . . . 1.0 111.577 169.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.21 -18.94 16.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.28 -37.41 16.23 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.547 -1.261 . . . . 1.0 114.098 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.733 HD12 ' H ' ' A' ' 18' ' ' SER . 1.1 pp -57.34 -30.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.513 0.673 . . . . 1.0 109.357 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.733 ' H ' HD12 ' A' ' 17' ' ' ILE . 2.7 m -100.25 10.32 41.42 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.499 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -102.77 -64.3 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.139 -1.392 . . . . 1.0 108.435 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.05 -39.54 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 118.334 -1.347 . . . . 1.0 111.608 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -72.48 -27.62 62.39 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 116.511 -2.076 . . . . 1.0 108.83 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -61.12 -36.51 79.93 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.403 -1.319 . . . . 1.0 107.574 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -35.61 14.6 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.797 -1.161 . . . . 1.0 110.587 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -21.61 61.91 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 118.778 -1.169 . . . . 1.0 110.574 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -100.68 2.57 41.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.346 1.029 . . . . 1.0 110.648 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 107.228 -1.397 . . . . 1.0 107.228 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.9 pt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 122.202 1.001 . . . . 1.0 109.632 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.12 -34.93 4.09 Favored Glycine 0 N--CA 1.502 3.093 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.81 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.09 -51.38 3.69 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 104.625 -2.361 . . . . 1.0 104.625 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 5' ' ' VAL . 2.8 t -28.28 -30.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 126.126 2.141 . . . . 1.0 114.258 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' ALA . 20.3 mt -90.49 -56.0 3.37 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.605 -0.838 . . . . 1.0 109.179 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -46.41 -41.89 14.35 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 124.074 1.893 . . . . 1.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 4' ' ' ALA . 71.9 t -46.9 -45.65 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 111.049 -2.796 . . . . 1.0 110.235 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.36 16.52 9.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.333 -1.303 . . . . 1.0 113.481 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -45.3 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.939 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -84.31 -41.44 16.81 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.16 -1.416 . . . . 1.0 109.844 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.87 -114.95 0.49 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.999 -1.64 . . . . 1.0 108.999 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -169.72 57.78 0.31 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 17' ' ' ILE 2.548 18.6 Cg_endo 59.08 -102.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 124.616 3.544 . . . . 1.0 108.496 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -7.7 24.13 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.794 1.035 . . . . 1.0 113.794 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.22 -42.75 41.38 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 117.949 -1.5 . . . . 1.0 112.545 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.865 HD12 ' H ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.91 -40.93 88.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.745 -1.182 . . . . 1.0 108.504 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.865 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -71.1 -7.29 45.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -74.82 0.6 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.684 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -30.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 119.039 -1.064 . . . . 1.0 112.86 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -79.22 -9.47 59.58 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 116.865 -1.934 . . . . 1.0 108.138 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -90.67 -62.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.431 1 N-CA-C 98.926 -4.472 . . . . 1.0 98.926 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -42.48 -63.8 0.71 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.376 -1.284 . . . . 1.0 112.78 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -18.82 0.1 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.519 2.044 . . . . 1.0 116.519 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -101.24 14.8 30.82 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.764 0.792 . . . . 1.0 111.709 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 N--CA 1.49 1.528 0 CA-C-N 113.866 -1.515 . . . . 1.0 107.998 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 3' ' ' GLY . 1.2 pp . . . . . 0 N--CA 1.506 2.353 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.511 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -11.93 -60.98 0.01 OUTLIER Glycine 0 N--CA 1.504 3.2 0 N-CA-C 117.712 1.845 . . . . 1.0 117.712 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.32 -43.7 8.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -35.6 -55.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.795 1.31 . . . . 1.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.499 ' CD1' HD13 ' A' ' 2' ' ' ILE . 26.7 mt -49.29 -38.97 29.18 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' NZ ' HG21 ' A' ' 10' ' ' THR . 0.7 OUTLIER -68.2 -35.42 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.767 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.459 ' CG1' ' HG3' ' A' ' 14' ' ' PRO . 1.4 t -61.08 -32.8 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.385 1.088 . . . . 1.0 109.077 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mt -72.82 -2.14 19.41 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.576 -1.193 . . . . 1.0 108.787 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.516 HG21 ' NZ ' ' A' ' 7' ' ' LYS . 3.7 m -98.98 -10.21 22.99 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.449 -1.685 . . . . 1.0 106.449 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -105.23 -45.56 4.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.406 -1.701 . . . . 1.0 106.406 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.39 -133.44 2.91 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 106.094 -2.802 . . . . 1.0 106.094 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.13 68.19 7.22 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 112.39 -1.905 . . . . 1.0 107.39 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.718 ' O ' HD11 ' A' ' 17' ' ' ILE 2.527 47.7 Cg_endo 54.15 -83.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 125.209 3.939 . . . . 1.0 112.824 171.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.42 -17.7 16.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.28 -46.26 17.83 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -58.9 -26.06 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.078 0.942 . . . . 1.0 109.466 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.577 ' H ' HD12 ' A' ' 17' ' ' ILE . 74.0 m -101.26 5.78 42.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.091 -0.959 . . . . 1.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.58 -67.57 0.86 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 123.44 0.462 . . . . 1.0 109.935 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.91 -34.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 118.405 -1.318 . . . . 1.0 111.347 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 5.6 mtpt -69.35 -16.76 63.6 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 116.717 -1.993 . . . . 1.0 107.163 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -91.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.369 -1.715 . . . . 1.0 106.369 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -47.79 -40.09 19.95 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.1 -0.954 . . . . 1.0 108.957 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.73 39.88 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.412 -0.915 . . . . 1.0 109.767 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 8.6 pt20 -100.31 -26.14 14.0 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 121.0 0.429 . . . . 1.0 110.993 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.142 0 CA-C-O 122.321 1.058 . . . . 1.0 113.185 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt . . . . . 0 N--CA 1.505 2.294 0 N-CA-C 112.366 0.506 . . . . 1.0 112.366 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -15.64 -60.62 0.01 OUTLIER Glycine 0 N--CA 1.506 3.319 0 N-CA-C 117.094 1.598 . . . . 1.0 117.094 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.76 -24.82 20.26 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.284 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 2' ' ' ILE . 36.6 t -58.93 -48.39 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.8 mt -38.1 -59.31 0.87 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.409 -1.269 . . . . 1.0 111.219 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -42.48 -53.16 4.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.207 -1.815 . . . . 1.0 109.825 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 14' ' ' PRO . 10.7 t -44.92 -57.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.114 -1.403 . . . . 1.0 109.146 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.67 -19.22 65.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.215 -2.266 . . . . 1.0 111.864 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -0.21 54.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 118.61 -1.236 . . . . 1.0 107.827 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -107.08 -61.92 1.48 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.397 -2.446 . . . . 1.0 104.397 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -127.7 1.77 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 106.366 -2.693 . . . . 1.0 106.366 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 4.8 mt -159.45 58.89 1.26 Allowed Pre-proline 0 N--CA 1.497 1.896 0 CA-C-N 112.783 -1.708 . . . . 1.0 107.707 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.618 ' O ' HD11 ' A' ' 17' ' ' ILE 2.537 38.9 Cg_endo 55.94 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 124.825 3.684 . . . . 1.0 111.081 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.68 -12.38 19.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.469 0.914 . . . . 1.0 113.469 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -46.22 -45.14 16.78 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.751 -1.179 . . . . 1.0 113.177 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.712 HD12 ' H ' ' A' ' 18' ' ' SER . 1.3 pp -56.81 -32.3 38.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.016 -1.902 . . . . 1.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.712 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -100.93 8.81 42.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.246 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.93 -70.67 0.73 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 -39.93 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 117.539 -1.664 . . . . 1.0 109.811 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -23.15 67.25 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 117.71 -1.596 . . . . 1.0 108.795 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -82.66 -14.6 54.38 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.967 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -43.93 9.9 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.139 -2.171 . . . . 1.0 105.139 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -22.05 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.792 -1.549 . . . . 1.0 113.111 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.43 6.98 44.49 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.334 1.021 . . . . 1.0 112.69 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 122.3 1.048 . . . . 1.0 108.735 179.902 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 121.433 0.635 . . . . 1.0 111.866 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.53 -27.91 6.58 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.671 -1.252 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.92 -47.08 5.15 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.785 -1.931 . . . . 1.0 105.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 5' ' ' VAL . 17.0 t -36.48 -56.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 115.052 -0.976 . . . . 1.0 111.071 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.0 mt -51.53 -33.32 31.43 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.791 -1.55 . . . . 1.0 113.187 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' NZ ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.95 -31.9 66.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.538 -1.21 . . . . 1.0 111.908 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 t -64.23 -38.22 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 9' ' ' LEU . 1.3 mt -62.18 -24.19 67.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.5 -1.227 . . . . 1.0 107.933 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.94 -11.89 59.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.035 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 -12.67 18.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' HG13 ' A' ' 17' ' ' ILE . . . 141.64 123.22 1.88 Allowed Glycine 0 N--CA 1.478 1.486 0 N-CA-C 106.713 -2.555 . . . . 1.0 106.713 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.51 100.86 0.23 Allowed Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 121.51 0.671 . . . . 1.0 111.148 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.514 10.4 Cg_endo 31.89 -84.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 1 C-N-CA 127.118 5.212 . . . . 1.0 115.611 -163.062 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -7.84 22.75 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.95 1.833 . . . . 1.0 115.95 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.6 -41.22 0.66 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.577 1.325 . . . . 1.0 114.577 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.748 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -50.31 -37.79 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.139 -1.392 . . . . 1.0 111.253 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.49 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 6.81 43.87 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.111 -0.635 . . . . 1.0 109.329 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.411 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.75 -64.09 1.08 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -44.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.053 -1.459 . . . . 1.0 110.955 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 10.8 mtpt -61.68 -24.55 66.83 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.473 1.108 . . . . 1.0 109.044 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -90.91 -14.85 30.85 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.87 -0.732 . . . . 1.0 112.12 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -91.27 -26.31 19.05 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.664 -1.214 . . . . 1.0 109.08 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.13 -27.34 13.29 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.489 -0.884 . . . . 1.0 110.086 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.498 1.972 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.727 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 6' ' ' LEU . 1.7 pp . . . . . 0 N--CA 1.506 2.334 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.593 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -6.62 -78.49 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.21 -5.64 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.263 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 23.6 t -63.19 -44.6 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 103.962 -2.607 . . . . 1.0 103.962 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 2' ' ' ILE . 15.5 mt -43.32 -47.71 6.73 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 123.028 1.394 . . . . 1.0 108.369 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 1.3 tptp -50.6 -47.38 58.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 112.365 -2.198 . . . . 1.0 110.699 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.566 HG13 ' CG ' ' A' ' 14' ' ' PRO . 51.0 t -53.99 -34.85 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.257 -1.338 . . . . 1.0 111.067 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.38 6.31 43.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 112.623 -2.08 . . . . 1.0 111.736 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -109.17 -3.7 17.09 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -118.62 -59.36 1.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.9 -114.61 1.18 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.335 -1.906 . . . . 1.0 108.335 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.4 mt 179.44 61.25 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 103.153 -2.906 . . . . 1.0 103.153 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.756 ' O ' HD11 ' A' ' 17' ' ' ILE 2.52 73.4 Cg_endo 50.92 -73.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 1 C-N-CA 125.483 4.122 . . . . 1.0 113.985 -178.643 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -101.87 -22.72 14.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.861 1.06 . . . . 1.0 113.861 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -45.38 -46.31 13.11 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.657 1.725 . . . . 1.0 115.657 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.756 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -62.75 -25.31 37.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.831 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 17' ' ' ILE . 68.6 m -101.53 3.12 39.83 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.895 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -71.33 0.71 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.98 -37.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 117.682 -1.607 . . . . 1.0 111.622 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.9 mtpt -71.77 -4.7 29.21 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 115.43 -2.508 . . . . 1.0 109.224 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -52.32 4.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -27.57 66.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 114.223 -1.353 . . . . 1.0 111.171 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -7.32 56.15 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.862 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -101.04 -48.84 4.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.727 1.267 . . . . 1.0 107.739 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 122.53 1.157 . . . . 1.0 110.611 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.4 pt . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 119.898 -0.096 . . . . 1.0 110.951 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -38.91 -28.7 0.07 OUTLIER Glycine 0 N--CA 1.508 3.474 0 O-C-N 123.914 0.759 . . . . 1.0 112.908 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -99.69 -52.15 3.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.1 t -49.48 -24.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 124.006 0.816 . . . . 1.0 111.851 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.62 -39.97 15.61 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -47.98 -45.08 31.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.96 1.362 . . . . 1.0 109.847 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 4' ' ' ALA . 1.6 t -54.15 -36.46 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 113.586 -1.643 . . . . 1.0 110.633 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -90.87 13.88 15.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 113.824 -1.534 . . . . 1.0 111.612 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -11.48 19.12 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.548 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -113.39 -68.11 0.95 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.537 -2.394 . . . . 1.0 104.537 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.33 -120.14 1.62 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.309 -2.317 . . . . 1.0 107.309 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -160.74 60.71 1.36 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 107.343 -1.354 . . . . 1.0 107.343 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.523 15.9 Cg_endo 52.95 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.24 3.294 . . . . 1.0 112.658 174.026 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -102.39 -18.61 15.31 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -50.43 -46.24 56.36 Favored 'General case' 0 N--CA 1.515 2.799 0 CA-C-O 123.657 1.694 . . . . 1.0 113.405 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.827 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -60.77 -24.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.871 -2.422 . . . . 1.0 107.143 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.424 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.64 3.4 42.47 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.347 -1.297 . . . . 1.0 109.066 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -63.21 1.17 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.678 0.751 . . . . 1.0 109.469 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.68 -43.91 15.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 118.827 -1.149 . . . . 1.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.91 -19.43 65.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 117.513 -1.675 . . . . 1.0 108.439 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 20.6 ttt180 -84.29 -19.92 32.98 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.92 -33.53 15.57 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.459 -1.246 . . . . 1.0 107.989 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.55 53.27 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.168 -0.613 . . . . 1.0 112.478 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.67 11.48 39.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.622 0.576 . . . . 1.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 107.22 -1.4 . . . . 1.0 107.22 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.857 0.837 . . . . 1.0 112.013 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.84 -102.5 1.81 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 105.245 -3.142 . . . . 1.0 105.245 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -33.16 -44.83 0.13 Allowed 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 122.311 1.053 . . . . 1.0 112.588 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.57 -27.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.837 -1.983 . . . . 1.0 114.619 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.51 -7.83 54.11 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -100.2 -26.14 14.03 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 t -60.74 -34.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 122.865 1.317 . . . . 1.0 108.625 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 2.5 mt -71.52 -4.34 26.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.68 -1.6 . . . . 1.0 109.061 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -2.84 31.12 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -117.12 -45.59 2.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.01 -0.737 . . . . 1.0 109.01 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.32 -118.99 2.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.355 -2.298 . . . . 1.0 107.355 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.49 65.13 0.15 Allowed Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 103.3 -2.852 . . . . 1.0 103.3 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.593 ' O ' HD11 ' A' ' 17' ' ' ILE 2.524 59.4 Cg_endo 51.33 -78.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 1 C-N-CA 126.264 4.643 . . . . 1.0 112.71 -178.28 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.23 -21.8 14.82 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.452 -0.899 . . . . 1.0 113.338 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -40.61 -43.28 1.87 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.979 1.844 . . . . 1.0 115.979 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.701 HD12 ' H ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -58.6 -37.55 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.701 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.7 m -91.3 6.01 46.96 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.117 -1.033 . . . . 1.0 109.144 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.08 -69.08 0.79 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -89.86 -38.93 11.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 118.331 -1.347 . . . . 1.0 111.095 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -26.59 65.55 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 117.11 -1.836 . . . . 1.0 108.684 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' NH1' ' O ' ' A' ' 18' ' ' SER . 4.3 ttp180 -67.83 -55.78 11.64 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -52.27 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.679 -1.601 . . . . 1.0 108.078 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -20.81 1.86 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.565 1.691 . . . . 1.0 115.565 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.56 3.62 42.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.975 0.797 . . . . 1.0 113.059 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 122.155 0.979 . . . . 1.0 110.482 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 N--CA 1.499 1.995 0 N-CA-C 110.223 -0.288 . . . . 1.0 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.4 -70.95 2.56 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.445 -1.862 . . . . 1.0 108.445 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.2 3.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.77 -1.215 . . . . 1.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 5' ' ' VAL . 2.1 t -35.53 -34.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 114.872 1.434 . . . . 1.0 114.872 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -86.55 -35.34 19.57 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.028 -1.469 . . . . 1.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -52.61 -41.67 63.88 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 123.774 1.75 . . . . 1.0 106.557 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' CD ' ' A' ' 14' ' ' PRO . 95.9 t -50.42 -43.54 22.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 111.596 -2.547 . . . . 1.0 108.458 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.61 8.52 33.78 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.031 -1.441 . . . . 1.0 114.7 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -30.15 6.45 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-O 121.868 0.842 . . . . 1.0 108.938 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -93.58 -13.03 28.19 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.09 -85.6 0.21 Allowed Glycine 0 N--CA 1.494 2.517 0 O-C-N 124.699 1.249 . . . . 1.0 111.557 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.05 69.43 0.13 Allowed Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 105.736 -1.95 . . . . 1.0 105.736 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.447 ' CD ' ' HA ' ' A' ' 8' ' ' VAL 2.525 73.1 Cg_endo 42.09 -76.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 1 C-N-CA 126.645 4.897 . . . . 1.0 114.002 -172.404 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.96 -14.48 17.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.265 1.58 . . . . 1.0 115.265 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -41.4 -43.24 2.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.736 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -55.23 -33.01 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.568 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -100.29 5.57 44.54 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.44 0.638 . . . . 1.0 109.85 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.98 -64.21 1.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -48.02 14.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 118.395 -1.322 . . . . 1.0 109.25 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -62.78 -9.82 10.78 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 117.235 -1.786 . . . . 1.0 110.352 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.96 -65.26 1.03 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -58.61 -31.13 67.79 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.347 -1.341 . . . . 1.0 111.137 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.82 -15.54 63.13 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.097 -1.441 . . . . 1.0 110.049 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -101.19 -41.6 6.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.636 0.731 . . . . 1.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 . . . . . 0 N--CA 1.495 1.795 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.823 -179.444 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp . . . . . 0 N--CA 1.506 2.326 0 N-CA-C 113.029 0.751 . . . . 1.0 113.029 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.652 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -32.77 -52.17 0.47 Allowed Glycine 0 N--CA 1.503 3.122 0 N-CA-C 116.063 1.185 . . . . 1.0 116.063 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.32 4.67 44.2 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.001 -0.679 . . . . 1.0 112.319 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 26.1 t -92.02 -55.49 6.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 104.137 -2.542 . . . . 1.0 104.137 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 2' ' ' ILE . 56.7 mt -37.64 -60.9 0.66 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.833 0.708 . . . . 1.0 111.09 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -45.07 -49.18 11.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.046 -1.434 . . . . 1.0 110.738 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 5' ' ' VAL . 96.3 t -52.34 -49.71 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.939 0.876 . . . . 1.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 11.8 mt -63.4 -12.15 28.43 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 114.127 -1.397 . . . . 1.0 110.758 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.45 12.17 33.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.992 -1.485 . . . . 1.0 106.992 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -63.1 1.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 103.307 -2.849 . . . . 1.0 103.307 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.55 -131.99 2.01 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 105.205 -3.158 . . . . 1.0 105.205 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.6 mt -158.88 55.88 0.87 Allowed Pre-proline 0 N--CA 1.498 1.954 0 CA-C-N 111.795 -2.202 . . . . 1.0 107.768 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.642 ' O ' HD11 ' A' ' 17' ' ' ILE 2.529 59.1 Cg_endo 52.11 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 1 C-N-CA 125.789 4.326 . . . . 1.0 112.947 177.879 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 -15.12 17.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.07 1.137 . . . . 1.0 114.07 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -47.51 -47.27 27.78 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 122.208 1.004 . . . . 1.0 113.246 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.766 HD12 ' H ' ' A' ' 18' ' ' SER . 1.1 pp -56.11 -30.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 113.46 -1.7 . . . . 1.0 109.183 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.766 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.8 m -101.0 8.78 42.84 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.629 -0.828 . . . . 1.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -70.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -40.68 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 117.412 -1.715 . . . . 1.0 110.317 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -12.3 59.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 117.012 -1.875 . . . . 1.0 109.525 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 15.0 ttt180 -86.38 -55.81 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 101.83 -3.396 . . . . 1.0 101.83 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -46.26 -55.17 7.58 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.256 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -12.84 5.38 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.786 1.402 . . . . 1.0 114.786 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -101.54 6.39 42.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.476 0.485 . . . . 1.0 111.101 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 122.362 1.077 . . . . 1.0 110.359 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.631 HD12 ' H ' ' A' ' 3' ' ' GLY . 1.3 pp . . . . . 0 N--CA 1.508 2.464 0 N-CA-C 113.145 0.795 . . . . 1.0 113.145 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.631 ' H ' HD12 ' A' ' 2' ' ' ILE . . . -27.12 -36.89 0.01 OUTLIER Glycine 0 N--CA 1.506 3.354 0 N-CA-C 117.292 1.677 . . . . 1.0 117.292 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.05 -49.59 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.116 -1.439 . . . . 1.0 107.116 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 5' ' ' VAL . 14.0 t -40.13 -54.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 124.535 1.147 . . . . 1.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.6 mt -46.01 -50.83 14.53 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 122.345 1.069 . . . . 1.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -45.51 -47.14 14.22 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 112.869 -1.968 . . . . 1.0 110.171 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 t -54.38 -47.64 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 113.312 -1.767 . . . . 1.0 109.287 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.83 -5.12 19.05 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.35 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 8.75 34.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.225 -2.139 . . . . 1.0 105.225 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.83 -64.37 1.22 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.93 -126.24 2.37 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 106.434 -2.666 . . . . 1.0 106.434 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -171.09 60.53 0.32 Allowed Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 122.657 1.218 . . . . 1.0 108.405 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.582 ' O ' HD11 ' A' ' 17' ' ' ILE 2.522 95.9 Cg_endo 41.78 -82.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 1 C-N-CA 126.607 4.871 . . . . 1.0 114.006 -173.707 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.56 -12.8 17.5 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -47.67 -48.41 29.09 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.405 -1.318 . . . . 1.0 113.05 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -58.86 -42.24 85.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.5 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -71.66 -6.24 39.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.767 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.105 -0.952 . . . . 1.0 108.877 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -90.22 -36.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.693 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.25 -16.55 61.4 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.028 -1.869 . . . . 1.0 108.51 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 -24.35 20.35 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.466 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -91.1 -35.16 14.75 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.487 -0.885 . . . . 1.0 109.065 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -13.01 16.53 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.006 0.431 . . . . 1.0 111.805 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -100.98 8.08 43.21 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.848 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.517 0.675 . . . . 1.0 109.498 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.509 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.205 0 N-CA-C 112.653 0.612 . . . . 1.0 112.653 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.89 -56.02 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.817 1.887 . . . . 1.0 117.817 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.84 -32.59 11.27 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.932 0.396 . . . . 1.0 111.095 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 5' ' ' VAL . 3.4 t -51.09 -49.07 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.8 mt -54.8 -19.2 5.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 113.596 -1.638 . . . . 1.0 112.661 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -96.67 -28.06 14.5 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.7 t -52.54 -50.03 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.5 6.16 0.23 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.947 -1.933 . . . . 1.0 113.409 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -102.13 -9.04 20.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.491 -1.3 . . . . 1.0 107.491 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m -115.52 -60.91 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.557 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.5 -113.55 0.76 Allowed Glycine 0 N--CA 1.503 3.148 0 C-N-CA 119.394 -1.384 . . . . 1.0 109.795 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -178.42 60.91 0.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 104.465 -2.42 . . . . 1.0 104.465 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.518 55.0 Cg_endo 53.87 -75.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 1 C-N-CA 125.744 4.296 . . . . 1.0 114.474 176.608 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.15 -21.97 14.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 115.367 1.618 . . . . 1.0 115.367 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -38.85 -40.29 0.62 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.448 2.018 . . . . 1.0 116.448 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.852 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -51.01 -39.5 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 113.164 -1.834 . . . . 1.0 111.673 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -101.08 9.89 41.59 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 1.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -66.73 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.886 -1.506 . . . . 1.0 108.783 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -35.61 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.189 -0.604 . . . . 1.0 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 10.5 mttt -76.73 -4.17 41.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.768 -1.573 . . . . 1.0 107.828 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -90.4 -76.59 0.43 Allowed 'General case' 0 C--N 1.306 -1.309 1 N-CA-C 95.734 -5.654 . . . . 1.0 95.734 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -37.33 -62.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 114.875 1.435 . . . . 1.0 114.875 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -22.05 32.79 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.38 -50.8 3.5 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 N--CA 1.503 2.195 0 N-CA-C 113.48 0.918 . . . . 1.0 113.48 -179.694 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.746 0 N-CA-C 106.009 -2.836 . . . . 1.0 106.009 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.638 HD12 HD11 ' A' ' 6' ' ' LEU . 23.2 pt -110.88 -15.65 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-N 118.866 1.333 . . . . 1.0 114.379 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -29.56 -41.96 0.04 OUTLIER Glycine 0 N--CA 1.51 3.61 0 CA-C-O 121.807 0.67 . . . . 1.0 114.428 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.711 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -93.36 -40.66 10.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -50.61 -37.48 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 123.215 0.322 . . . . 1.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 2' ' ' ILE . 15.9 mt -86.32 -5.32 59.2 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.935 -0.706 . . . . 1.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -100.38 -6.03 26.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.28 0.987 . . . . 1.0 109.692 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 4' ' ' ALA . 98.1 t -87.79 -41.34 14.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.847 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.16 22.11 3.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.708 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -20.9 8.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 115.524 1.676 . . . . 1.0 115.524 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -121.24 -76.65 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.02 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -121.3 -96.35 1.45 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 106.947 -2.461 . . . . 1.0 106.947 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.41 70.95 0.14 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 104.428 -2.434 . . . . 1.0 104.428 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HG2' HG22 ' A' ' 8' ' ' VAL 2.531 18.3 Cg_endo 59.31 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.861 3.04 . . . . 1.0 111.813 176.061 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.64 -15.19 17.12 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.61 1.337 . . . . 1.0 114.61 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.52 -39.68 0.49 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.284 1.587 . . . . 1.0 115.284 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.799 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -51.4 -35.77 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.116 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.416 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.34 5.77 44.48 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.484 0.659 . . . . 1.0 109.769 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -63.11 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.581 -1.19 . . . . 1.0 110.038 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.16 -44.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.268 -0.878 . . . . 1.0 109.946 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -28.32 69.14 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 116.923 -1.911 . . . . 1.0 108.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 2.9 ttt180 -73.86 -28.55 61.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.701 -1.599 . . . . 1.0 108.265 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.03 -22.9 20.54 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.273 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -36.4 10.85 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.721 0.637 . . . . 1.0 112.721 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -100.18 66.7 1.33 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.57 42.74 2.92 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.294 -1.776 . . . . 1.0 107.071 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.662 0 O-C-N 118.595 -2.565 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 N-CA-C 105.819 -2.912 . . . . 1.0 105.819 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 4' ' ' ALA . 7.9 pt -120.38 -119.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 118.42 1.11 . . . . 1.0 108.994 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.25 -68.66 0.0 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 116.125 1.21 . . . . 1.0 116.125 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 2' ' ' ILE . . . -97.7 -26.78 14.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.82 -19.75 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.75 -11.86 38.29 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.352 -0.84 . . . . 1.0 110.731 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.29 -2.66 33.13 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.747 0.784 . . . . 1.0 110.006 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.4 -49.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.427 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.05 19.07 5.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.538 1.31 . . . . 1.0 114.538 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -16.71 14.34 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.172 -1.376 . . . . 1.0 109.912 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 m -115.9 -61.83 1.68 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.08 -120.81 1.71 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 106.399 -2.681 . . . . 1.0 106.399 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -156.26 63.4 3.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 113.269 -1.465 . . . . 1.0 107.601 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.446 ' O ' HD11 ' A' ' 17' ' ' ILE 2.545 1.0 OUTLIER 61.26 -100.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 123.03 2.487 . . . . 1.0 108.056 175.51 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.57 -8.85 22.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -49.96 -42.67 49.22 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 119.481 -0.888 . . . . 1.0 112.306 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 18' ' ' SER . 1.3 pp -59.03 -26.12 31.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 113.628 -1.624 . . . . 1.0 109.835 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.645 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -100.98 3.62 41.74 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.042 0.925 . . . . 1.0 109.95 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.59 -61.44 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.353 -0.839 . . . . 1.0 111.155 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -43.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.466 -1.294 . . . . 1.0 110.078 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -32.66 74.21 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.919 -1.513 . . . . 1.0 107.622 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -16.85 60.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 124.452 1.095 . . . . 1.0 110.213 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -41.17 11.39 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -47.17 52.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.245 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -84.83 68.06 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.68 HE21 ' N ' ' A' ' 27' ' ' NH2 . 0.0 OUTLIER -120.46 -116.23 0.32 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.728 -1.578 . . . . 1.0 108.305 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . 0.68 ' N ' HE21 ' A' ' 26' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.592 0 O-C-N 117.676 -3.14 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 N-CA-C 106.961 -2.456 . . . . 1.0 106.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.54 -154.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.28 -71.77 0.21 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.92 -46.4 7.86 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.982 -1.087 . . . . 1.0 108.313 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 5' ' ' VAL . 5.3 t -29.86 -33.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.972 1.42 . . . . 1.0 114.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.95 -49.68 17.06 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.526 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -45.12 -43.3 9.63 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.528 1.156 . . . . 1.0 108.689 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 8' ' ' VAL . 17.6 t -46.37 -56.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.675 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.15 6.44 1.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.504 -1.68 . . . . 1.0 113.564 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.34 -2.14 18.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.909 -1.886 . . . . 1.0 105.909 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.2 m -120.08 -61.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.679 -1.971 . . . . 1.0 105.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.73 -122.99 0.9 Allowed Glycine 0 N--CA 1.481 1.66 0 N-CA-C 107.908 -2.077 . . . . 1.0 107.908 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 13' ' ' LEU . 2.1 pt? -150.32 32.88 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 111.838 -2.181 . . . . 1.0 109.66 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.536 41.9 Cg_exo 94.77 175.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.758 2.972 . . . . 1.0 109.208 -167.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -26.74 -25.3 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 118.648 2.833 . . . . 1.0 118.648 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 14' ' ' PRO . 2.9 mm? -43.26 -38.77 2.72 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.664 0.745 . . . . 1.0 112.405 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -30.69 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 114.299 -1.319 . . . . 1.0 111.79 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.484 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 3.65 42.14 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.213 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -78.4 0.53 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.164 -1.791 . . . . 1.0 106.164 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.74 -36.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 117.973 -1.491 . . . . 1.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -74.86 -9.53 58.63 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 116.923 -1.911 . . . . 1.0 109.94 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 11.2 ttm180 -90.2 -50.66 5.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 103.694 -2.706 . . . . 1.0 103.694 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -41.81 95.2 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.576 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.42 -28.85 8.92 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.788 -1.165 . . . . 1.0 113.204 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -101.33 -29.63 11.95 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 119.799 -0.76 . . . . 1.0 111.075 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -115.46 93.84 4.45 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.61 0 O-C-N 119.067 -2.271 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.44 0 N-CA-C 105.747 -2.941 . . . . 1.0 105.747 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 6' ' ' LEU . 2.7 pt -121.39 -24.45 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 113.686 0.995 . . . . 1.0 113.686 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.23 -65.59 0.01 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 116.148 1.219 . . . . 1.0 116.148 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.75 -29.85 13.13 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.963 -0.695 . . . . 1.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 5' ' ' VAL . 2.1 t -53.58 -26.08 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.96 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 2' ' ' ILE . 73.9 mt -90.09 -14.29 34.04 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.94 1.84 40.19 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.303 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -90.75 -47.63 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -87.84 19.36 3.55 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.515 -1.22 . . . . 1.0 112.709 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 -18.17 19.5 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.064 -1.425 . . . . 1.0 109.23 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -122.95 -61.88 1.4 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.76 -118.42 1.48 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 61.01 4.47 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 17' ' ' ILE 2.549 5.8 Cg_endo 62.88 -99.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 123.325 2.683 . . . . 1.0 108.975 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.67 -10.07 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.351 1.241 . . . . 1.0 114.351 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.81 -44.36 19.21 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.59 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -61.79 -24.92 35.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.684 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.515 ' H ' HD12 ' A' ' 17' ' ' ILE . 50.9 m -100.87 4.99 43.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -61.1 1.42 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.842 -1.17 . . . . 1.0 107.842 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -49.94 13.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.023 -1.071 . . . . 1.0 110.23 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -9.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.866 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -90.79 -23.7 20.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 105.874 -1.898 . . . . 1.0 105.874 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.15 -58.61 2.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.97 1.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 115.595 1.702 . . . . 1.0 115.595 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.613 -1.625 . . . . 1.0 106.613 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.679 HE21 ' N ' ' A' ' 27' ' ' NH2 . 0.0 OUTLIER -127.53 -116.15 0.26 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 113.799 -1.546 . . . . 1.0 107.817 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . 0.679 ' N ' HE21 ' A' ' 26' ' ' GLN . . . . . . . . 0 C--N 1.301 -1.54 0 O-C-N 117.664 -3.147 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.713 0 N-CA-C 106.077 -2.809 . . . . 1.0 106.077 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.755 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp -109.03 -27.12 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 CA-C-N 119.222 1.511 . . . . 1.0 113.138 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.755 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -15.26 -53.18 0.01 OUTLIER Glycine 0 N--CA 1.51 3.575 0 N-CA-C 117.479 1.751 . . . . 1.0 117.479 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.11 -30.03 12.17 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.883 -0.658 . . . . 1.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 2' ' ' ILE . 6.1 t -54.56 -42.27 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 2' ' ' ILE . 43.7 mt -61.97 -16.99 55.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.459 -1.246 . . . . 1.0 111.451 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.08 -3.21 29.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.424 1.078 . . . . 1.0 110.51 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 4' ' ' ALA . 44.0 t -90.35 -54.62 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -79.12 19.09 0.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.587 -1.188 . . . . 1.0 113.82 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -23.75 12.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.188 -1.369 . . . . 1.0 107.456 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.404 HG23 ' HD3' ' A' ' 14' ' ' PRO . 2.5 t -112.31 -29.31 7.58 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.801 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -101.51 0.2 Allowed Glycine 0 N--CA 1.483 1.819 0 CA-C-N 114.383 -1.28 . . . . 1.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.15 66.23 1.6 Allowed Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.774 ' O ' HD11 ' A' ' 17' ' ' ILE 2.535 25.5 Cg_endo 58.16 -85.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.12 3.213 . . . . 1.0 110.95 173.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.45 -15.26 17.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -46.55 -42.74 16.32 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.574 1.694 . . . . 1.0 115.574 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.774 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.9 -23.39 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 114.587 -1.188 . . . . 1.0 108.984 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -101.38 1.32 38.32 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.338 -0.846 . . . . 1.0 109.111 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -70.98 0.73 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -30.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.481 -1.288 . . . . 1.0 112.494 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 16.0 mtpt -80.45 -27.17 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 116.798 -1.961 . . . . 1.0 107.627 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -30.33 64.66 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -33.48 16.22 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.102 -1.039 . . . . 1.0 108.569 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -60.82 -7.38 2.3 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.746 -0.781 . . . . 1.0 112.603 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -100.25 -9.79 22.02 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.673 -1.232 . . . . 1.0 107.673 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -120.25 98.96 6.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 118.142 -2.849 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.681 0 N-CA-C 106.315 -2.714 . . . . 1.0 106.315 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 pt -112.3 -28.1 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 CA-C-N 118.447 1.123 . . . . 1.0 113.802 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -7.16 -68.76 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 N-CA-C 116.395 1.318 . . . . 1.0 116.395 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.75 -21.99 15.02 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 120.896 0.379 . . . . 1.0 110.702 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.41 -29.58 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.711 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.6 mt -89.46 -6.91 56.06 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.4 -0.92 . . . . 1.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -93.99 -36.9 11.94 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 4' ' ' ALA . 78.6 t -49.32 -36.23 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.99 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.72 17.64 7.4 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.774 -1.557 . . . . 1.0 113.508 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -108.66 -13.54 14.78 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.302 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -63.09 1.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.678 -0.809 . . . . 1.0 109.042 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.44 -97.47 0.27 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 108.966 -1.654 . . . . 1.0 108.966 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.52 65.33 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 104.687 -2.338 . . . . 1.0 104.687 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.538 11.5 Cg_endo 60.19 -93.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.334 2.689 . . . . 1.0 110.346 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -13.1 18.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -36.79 -42.27 0.37 Allowed 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 115.948 1.832 . . . . 1.0 115.948 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.747 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -51.77 -37.13 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.61 -1.177 . . . . 1.0 112.046 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -97.29 7.17 47.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.727 0.775 . . . . 1.0 109.866 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -67.28 0.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.985 -1.461 . . . . 1.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -41.66 13.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 118.989 -1.085 . . . . 1.0 110.165 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -69.97 -16.15 63.15 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.299 -1.76 . . . . 1.0 109.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 4.3 ttt180 -90.54 -23.51 20.88 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.546 -0.862 . . . . 1.0 108.892 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -51.61 5.22 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.711 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -47.88 -9.94 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 114.684 1.364 . . . . 1.0 114.684 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.22 -23.36 14.84 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.926 0.766 . . . . 1.0 112.178 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 23.11 49.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.542 0 O-C-N 117.724 -3.11 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.619 0 N-CA-C 105.816 -2.913 . . . . 1.0 105.816 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -110.66 -29.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 118.366 1.083 . . . . 1.0 112.713 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -5.38 -71.64 0.01 OUTLIER Glycine 0 N--CA 1.507 3.367 0 N-CA-C 117.221 1.648 . . . . 1.0 117.221 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.2 -17.31 17.43 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 119.544 -0.862 . . . . 1.0 111.414 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -55.99 -48.43 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.631 -2.359 . . . . 1.0 104.631 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 mt -55.99 -17.71 7.46 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 114.201 -1.363 . . . . 1.0 112.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -100.05 -25.53 14.27 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.783 -0.767 . . . . 1.0 109.059 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' A' ' 14' ' ' PRO . 4.1 t -58.52 -28.8 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.34 13.89 14.24 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.922 -1.035 . . . . 1.0 111.358 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -101.12 -3.16 29.71 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.657 -0.817 . . . . 1.0 108.801 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -78.97 0.6 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.524 -2.028 . . . . 1.0 105.524 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.31 -85.46 0.07 OUTLIER Glycine 0 N--CA 1.491 2.352 1 N-CA-C 102.237 -4.345 . . . . 1.0 102.237 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 79.86 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 104.441 -2.429 . . . . 1.0 104.441 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.565 ' HD2' HG13 ' A' ' 8' ' ' VAL 2.544 9.4 Cg_endo 64.07 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.745 2.297 . . . . 1.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.62 -4.7 27.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 114.521 1.304 . . . . 1.0 114.521 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.32 -24.7 1.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.633 1.716 . . . . 1.0 115.633 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -65.53 -32.53 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -100.6 9.84 41.97 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.999 0.904 . . . . 1.0 108.909 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -101.37 -69.62 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 113.93 -1.486 . . . . 1.0 108.7 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.482 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -90.52 -38.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 118.559 -1.256 . . . . 1.0 109.609 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -12.49 61.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.495 -1.682 . . . . 1.0 108.76 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -90.02 -60.38 1.95 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -57.92 -33.22 68.55 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.447 -0.901 . . . . 1.0 112.976 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 3.6 ttp180 -71.58 -11.79 61.03 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 116.207 -2.197 . . . . 1.0 110.693 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -101.48 -45.16 5.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -115.11 98.17 6.64 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.621 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.766 0 O-C-N 118.888 -2.383 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.786 0 N-CA-C 105.915 -2.874 . . . . 1.0 105.915 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 3' ' ' GLY . 1.7 pp -111.35 -21.58 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 118.964 1.382 . . . . 1.0 113.071 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.673 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -6.5 -72.7 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.554 1.782 . . . . 1.0 117.554 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.89 -12.12 20.11 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.823 -0.751 . . . . 1.0 110.58 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -61.0 -41.69 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 103.31 -2.848 . . . . 1.0 103.31 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.41 -16.28 22.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 113.707 -1.588 . . . . 1.0 110.797 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -100.64 -2.11 33.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 123.664 0.602 . . . . 1.0 110.506 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.576 HG13 ' HG2' ' A' ' 14' ' ' PRO . 11.5 t -90.4 -46.71 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.04 0.448 . . . . 1.0 110.612 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.519 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.44 19.98 4.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.399 1.095 . . . . 1.0 113.251 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 -17.41 15.17 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 113.844 -1.526 . . . . 1.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.84 -64.64 1.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 104.384 -2.45 . . . . 1.0 104.384 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.53 -122.27 1.57 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 1.0 104.426 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mt -152.64 67.27 6.59 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 105.812 -1.922 . . . . 1.0 105.812 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.689 ' O ' HD11 ' A' ' 17' ' ' ILE 2.533 18.5 Cg_endo 56.84 -81.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.934 3.09 . . . . 1.0 112.3 173.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.18 -14.33 17.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -46.23 -43.6 15.55 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.325 1.232 . . . . 1.0 114.325 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.689 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -62.36 -24.28 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.511 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -100.33 3.19 43.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 -69.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.404 0.621 . . . . 1.0 109.654 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -35.08 8.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 118.586 -0.721 . . . . 1.0 111.142 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -24.03 63.91 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 116.134 -2.227 . . . . 1.0 105.052 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -61.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -36.21 22.19 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.237 1.018 . . . . 1.0 110.738 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.83 -21.33 66.03 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.114 -0.948 . . . . 1.0 112.762 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -101.62 -45.37 5.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.551 1.157 . . . . 1.0 110.248 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.48 128.67 44.81 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.789 -1.096 . . . . 1.0 110.012 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.735 0 O-C-N 118.334 -2.729 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.503 0 N-CA-C 106.028 -2.829 . . . . 1.0 106.028 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.777 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -113.36 -36.56 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 118.613 1.207 . . . . 1.0 112.652 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -9.88 -58.75 0.01 OUTLIER Glycine 0 N--CA 1.508 3.467 0 N-CA-C 117.713 1.845 . . . . 1.0 117.713 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.1 -27.5 13.51 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.577 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 2' ' ' ILE . 9.5 t -54.49 -44.77 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.15 -17.04 23.39 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.996 -1.456 . . . . 1.0 111.822 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -100.24 -6.04 26.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.019 0.824 . . . . 1.0 110.022 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 10' ' ' THR . 34.4 t -90.61 -51.12 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.436 HD23 HG12 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -71.92 11.63 0.51 Allowed 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 114.322 -1.308 . . . . 1.0 112.611 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -105.13 -12.4 16.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.216 -1.402 . . . . 1.0 107.216 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 -31.96 4.23 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.95 -111.21 0.47 Allowed Glycine 0 N--CA 1.481 1.689 1 N-CA-C 101.822 -4.511 . . . . 1.0 101.822 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -149.64 66.82 8.45 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 104.456 -2.424 . . . . 1.0 104.456 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.534 12.0 Cg_endo 61.56 -83.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.848 3.032 . . . . 1.0 111.577 169.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.21 -18.94 16.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.28 -37.41 16.23 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.547 -1.261 . . . . 1.0 114.098 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.733 HD12 ' H ' ' A' ' 18' ' ' SER . 1.1 pp -57.34 -30.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.513 0.673 . . . . 1.0 109.357 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.733 ' H ' HD12 ' A' ' 17' ' ' ILE . 2.7 m -100.25 10.32 41.42 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.499 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -102.77 -64.3 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.139 -1.392 . . . . 1.0 108.435 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.05 -39.54 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 118.334 -1.347 . . . . 1.0 111.608 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -72.48 -27.62 62.39 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 116.511 -2.076 . . . . 1.0 108.83 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -61.12 -36.51 79.93 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.403 -1.319 . . . . 1.0 107.574 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -35.61 14.6 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.797 -1.161 . . . . 1.0 110.587 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -21.61 61.91 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 118.778 -1.169 . . . . 1.0 110.574 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -100.68 2.57 41.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.346 1.029 . . . . 1.0 110.648 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -116.15 29.61 7.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.228 -1.397 . . . . 1.0 107.228 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.694 0 O-C-N 119.28 -2.138 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.56 0 N-CA-C 106.639 -2.584 . . . . 1.0 106.639 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.9 pt -81.67 70.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.202 1.001 . . . . 1.0 109.632 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.12 -34.93 4.09 Favored Glycine 0 N--CA 1.502 3.093 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.81 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.09 -51.38 3.69 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 104.625 -2.361 . . . . 1.0 104.625 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 5' ' ' VAL . 2.8 t -28.28 -30.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 126.126 2.141 . . . . 1.0 114.258 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' ALA . 20.3 mt -90.49 -56.0 3.37 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.605 -0.838 . . . . 1.0 109.179 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -46.41 -41.89 14.35 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 124.074 1.893 . . . . 1.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 4' ' ' ALA . 71.9 t -46.9 -45.65 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 111.049 -2.796 . . . . 1.0 110.235 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.36 16.52 9.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.333 -1.303 . . . . 1.0 113.481 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -45.3 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.939 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -84.31 -41.44 16.81 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.16 -1.416 . . . . 1.0 109.844 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.87 -114.95 0.49 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.999 -1.64 . . . . 1.0 108.999 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -169.72 57.78 0.31 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 17' ' ' ILE 2.548 18.6 Cg_endo 59.08 -102.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 124.616 3.544 . . . . 1.0 108.496 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -7.7 24.13 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.794 1.035 . . . . 1.0 113.794 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.22 -42.75 41.38 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 117.949 -1.5 . . . . 1.0 112.545 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.865 HD12 ' H ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.91 -40.93 88.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.745 -1.182 . . . . 1.0 108.504 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.865 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -71.1 -7.29 45.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -74.82 0.6 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.684 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -30.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 119.039 -1.064 . . . . 1.0 112.86 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -79.22 -9.47 59.58 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 116.865 -1.934 . . . . 1.0 108.138 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -90.67 -62.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.431 1 N-CA-C 98.926 -4.472 . . . . 1.0 98.926 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -42.48 -63.8 0.71 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.376 -1.284 . . . . 1.0 112.78 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -18.82 0.1 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.519 2.044 . . . . 1.0 116.519 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -101.24 14.8 30.82 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.764 0.792 . . . . 1.0 111.709 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -118.22 133.22 56.09 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.866 -1.515 . . . . 1.0 107.998 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.62 0 O-C-N 118.212 -2.805 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.825 0 N-CA-C 106.211 -2.756 . . . . 1.0 106.211 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 3' ' ' GLY . 1.2 pp -115.16 -5.61 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-N 118.424 1.112 . . . . 1.0 113.124 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.511 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -11.93 -60.98 0.01 OUTLIER Glycine 0 N--CA 1.504 3.2 0 N-CA-C 117.712 1.845 . . . . 1.0 117.712 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.32 -43.7 8.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -35.6 -55.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.795 1.31 . . . . 1.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.499 ' CD1' HD13 ' A' ' 2' ' ' ILE . 26.7 mt -49.29 -38.97 29.18 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' NZ ' HG21 ' A' ' 10' ' ' THR . 0.7 OUTLIER -68.2 -35.42 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.767 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.459 ' CG1' ' HG3' ' A' ' 14' ' ' PRO . 1.4 t -61.08 -32.8 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.385 1.088 . . . . 1.0 109.077 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mt -72.82 -2.14 19.41 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.576 -1.193 . . . . 1.0 108.787 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.516 HG21 ' NZ ' ' A' ' 7' ' ' LYS . 3.7 m -98.98 -10.21 22.99 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.449 -1.685 . . . . 1.0 106.449 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -105.23 -45.56 4.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.406 -1.701 . . . . 1.0 106.406 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.39 -133.44 2.91 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 106.094 -2.802 . . . . 1.0 106.094 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.13 68.19 7.22 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 112.39 -1.905 . . . . 1.0 107.39 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.718 ' O ' HD11 ' A' ' 17' ' ' ILE 2.527 47.7 Cg_endo 54.15 -83.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 125.209 3.939 . . . . 1.0 112.824 171.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.42 -17.7 16.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.28 -46.26 17.83 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -58.9 -26.06 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.078 0.942 . . . . 1.0 109.466 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.577 ' H ' HD12 ' A' ' 17' ' ' ILE . 74.0 m -101.26 5.78 42.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.091 -0.959 . . . . 1.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.58 -67.57 0.86 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 123.44 0.462 . . . . 1.0 109.935 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.91 -34.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 118.405 -1.318 . . . . 1.0 111.347 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 5.6 mtpt -69.35 -16.76 63.6 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 116.717 -1.993 . . . . 1.0 107.163 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -91.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.369 -1.715 . . . . 1.0 106.369 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -47.79 -40.09 19.95 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.1 -0.954 . . . . 1.0 108.957 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.73 39.88 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.412 -0.915 . . . . 1.0 109.767 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 8.6 pt20 -100.31 -26.14 14.0 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 121.0 0.429 . . . . 1.0 110.993 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.72 6.4 31.83 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.321 1.058 . . . . 1.0 113.185 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.674 0 O-C-N 118.651 -2.531 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.645 0 N-CA-C 106.067 -2.813 . . . . 1.0 106.067 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt -112.67 -42.3 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 CA-C-N 118.463 1.132 . . . . 1.0 112.366 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -15.64 -60.62 0.01 OUTLIER Glycine 0 N--CA 1.506 3.319 0 N-CA-C 117.094 1.598 . . . . 1.0 117.094 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.76 -24.82 20.26 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.284 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 2' ' ' ILE . 36.6 t -58.93 -48.39 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.8 mt -38.1 -59.31 0.87 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.409 -1.269 . . . . 1.0 111.219 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -42.48 -53.16 4.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.207 -1.815 . . . . 1.0 109.825 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 14' ' ' PRO . 10.7 t -44.92 -57.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.114 -1.403 . . . . 1.0 109.146 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.67 -19.22 65.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.215 -2.266 . . . . 1.0 111.864 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -0.21 54.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 118.61 -1.236 . . . . 1.0 107.827 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -107.08 -61.92 1.48 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.397 -2.446 . . . . 1.0 104.397 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -127.7 1.77 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 106.366 -2.693 . . . . 1.0 106.366 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 4.8 mt -159.45 58.89 1.26 Allowed Pre-proline 0 N--CA 1.497 1.896 0 CA-C-N 112.783 -1.708 . . . . 1.0 107.707 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.618 ' O ' HD11 ' A' ' 17' ' ' ILE 2.537 38.9 Cg_endo 55.94 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 124.825 3.684 . . . . 1.0 111.081 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.68 -12.38 19.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.469 0.914 . . . . 1.0 113.469 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -46.22 -45.14 16.78 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.751 -1.179 . . . . 1.0 113.177 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.712 HD12 ' H ' ' A' ' 18' ' ' SER . 1.3 pp -56.81 -32.3 38.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.016 -1.902 . . . . 1.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.712 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -100.93 8.81 42.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.246 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.93 -70.67 0.73 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 -39.93 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 117.539 -1.664 . . . . 1.0 109.811 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -23.15 67.25 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 117.71 -1.596 . . . . 1.0 108.795 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -82.66 -14.6 54.38 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.967 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -43.93 9.9 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.139 -2.171 . . . . 1.0 105.139 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -22.05 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.792 -1.549 . . . . 1.0 113.111 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.43 6.98 44.49 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.334 1.021 . . . . 1.0 112.69 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -112.79 -35.72 5.39 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.3 1.048 . . . . 1.0 108.735 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 118.873 -2.392 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.625 0 N-CA-C 105.564 -3.015 . . . . 1.0 105.564 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 pt -112.95 52.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 118.856 1.328 . . . . 1.0 111.866 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.53 -27.91 6.58 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.671 -1.252 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.92 -47.08 5.15 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.785 -1.931 . . . . 1.0 105.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 5' ' ' VAL . 17.0 t -36.48 -56.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 115.052 -0.976 . . . . 1.0 111.071 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.0 mt -51.53 -33.32 31.43 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.791 -1.55 . . . . 1.0 113.187 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' NZ ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.95 -31.9 66.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.538 -1.21 . . . . 1.0 111.908 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 t -64.23 -38.22 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 9' ' ' LEU . 1.3 mt -62.18 -24.19 67.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.5 -1.227 . . . . 1.0 107.933 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.94 -11.89 59.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.035 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 -12.67 18.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' HG13 ' A' ' 17' ' ' ILE . . . 141.64 123.22 1.88 Allowed Glycine 0 N--CA 1.478 1.486 0 N-CA-C 106.713 -2.555 . . . . 1.0 106.713 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.51 100.86 0.23 Allowed Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 121.51 0.671 . . . . 1.0 111.148 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.514 10.4 Cg_endo 31.89 -84.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 1 C-N-CA 127.118 5.212 . . . . 1.0 115.611 -163.062 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -7.84 22.75 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.95 1.833 . . . . 1.0 115.95 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.6 -41.22 0.66 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.577 1.325 . . . . 1.0 114.577 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.748 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -50.31 -37.79 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.139 -1.392 . . . . 1.0 111.253 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.49 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 6.81 43.87 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.111 -0.635 . . . . 1.0 109.329 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.411 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.75 -64.09 1.08 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -44.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.053 -1.459 . . . . 1.0 110.955 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 10.8 mtpt -61.68 -24.55 66.83 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.473 1.108 . . . . 1.0 109.044 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -90.91 -14.85 30.85 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.87 -0.732 . . . . 1.0 112.12 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -91.27 -26.31 19.05 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.664 -1.214 . . . . 1.0 109.08 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.13 -27.34 13.29 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.489 -0.884 . . . . 1.0 110.086 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -111.25 98.42 7.49 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.699 0 O-C-N 118.907 -2.37 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.609 0 N-CA-C 105.751 -2.94 . . . . 1.0 105.751 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 6' ' ' LEU . 1.7 pp -109.98 -10.12 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 CA-C-N 119.108 1.454 . . . . 1.0 113.349 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.593 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -6.62 -78.49 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.21 -5.64 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.263 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 23.6 t -63.19 -44.6 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 103.962 -2.607 . . . . 1.0 103.962 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 2' ' ' ILE . 15.5 mt -43.32 -47.71 6.73 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 123.028 1.394 . . . . 1.0 108.369 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 1.3 tptp -50.6 -47.38 58.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 112.365 -2.198 . . . . 1.0 110.699 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.566 HG13 ' CG ' ' A' ' 14' ' ' PRO . 51.0 t -53.99 -34.85 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.257 -1.338 . . . . 1.0 111.067 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.38 6.31 43.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 112.623 -2.08 . . . . 1.0 111.736 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -109.17 -3.7 17.09 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -118.62 -59.36 1.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.9 -114.61 1.18 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.335 -1.906 . . . . 1.0 108.335 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.4 mt 179.44 61.25 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 103.153 -2.906 . . . . 1.0 103.153 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.756 ' O ' HD11 ' A' ' 17' ' ' ILE 2.52 73.4 Cg_endo 50.92 -73.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 1 C-N-CA 125.483 4.122 . . . . 1.0 113.985 -178.643 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -101.87 -22.72 14.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.861 1.06 . . . . 1.0 113.861 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -45.38 -46.31 13.11 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.657 1.725 . . . . 1.0 115.657 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.756 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -62.75 -25.31 37.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.831 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 17' ' ' ILE . 68.6 m -101.53 3.12 39.83 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.895 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -71.33 0.71 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.98 -37.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 117.682 -1.607 . . . . 1.0 111.622 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.9 mtpt -71.77 -4.7 29.21 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 115.43 -2.508 . . . . 1.0 109.224 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -52.32 4.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -27.57 66.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 114.223 -1.353 . . . . 1.0 111.171 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -7.32 56.15 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.862 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -101.04 -48.84 4.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.727 1.267 . . . . 1.0 107.739 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 84.0 2.08 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.53 1.157 . . . . 1.0 110.611 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.686 0 O-C-N 118.569 -2.582 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.653 0 N-CA-C 105.769 -2.932 . . . . 1.0 105.769 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.4 pt -59.28 -39.97 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 118.806 1.303 . . . . 1.0 110.951 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -38.91 -28.7 0.07 OUTLIER Glycine 0 N--CA 1.508 3.474 0 O-C-N 123.914 0.759 . . . . 1.0 112.908 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -99.69 -52.15 3.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.1 t -49.48 -24.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 124.006 0.816 . . . . 1.0 111.851 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.62 -39.97 15.61 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -47.98 -45.08 31.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.96 1.362 . . . . 1.0 109.847 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 4' ' ' ALA . 1.6 t -54.15 -36.46 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 113.586 -1.643 . . . . 1.0 110.633 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -90.87 13.88 15.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 113.824 -1.534 . . . . 1.0 111.612 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -11.48 19.12 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.548 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -113.39 -68.11 0.95 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.537 -2.394 . . . . 1.0 104.537 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.33 -120.14 1.62 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.309 -2.317 . . . . 1.0 107.309 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -160.74 60.71 1.36 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 107.343 -1.354 . . . . 1.0 107.343 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.523 15.9 Cg_endo 52.95 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.24 3.294 . . . . 1.0 112.658 174.026 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -102.39 -18.61 15.31 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -50.43 -46.24 56.36 Favored 'General case' 0 N--CA 1.515 2.799 0 CA-C-O 123.657 1.694 . . . . 1.0 113.405 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.827 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -60.77 -24.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.871 -2.422 . . . . 1.0 107.143 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.424 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.64 3.4 42.47 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.347 -1.297 . . . . 1.0 109.066 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -63.21 1.17 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.678 0.751 . . . . 1.0 109.469 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.68 -43.91 15.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 118.827 -1.149 . . . . 1.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.91 -19.43 65.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 117.513 -1.675 . . . . 1.0 108.439 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 20.6 ttt180 -84.29 -19.92 32.98 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.92 -33.53 15.57 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.459 -1.246 . . . . 1.0 107.989 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.55 53.27 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.168 -0.613 . . . . 1.0 112.478 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.67 11.48 39.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.622 0.576 . . . . 1.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -120.66 143.06 48.9 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.22 -1.4 . . . . 1.0 107.22 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.633 0 O-C-N 118.215 -2.803 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.707 0 N-CA-C 105.203 -3.159 . . . . 1.0 105.203 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.5 pt -110.86 75.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 119.202 1.501 . . . . 1.0 112.013 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.84 -102.5 1.81 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 105.245 -3.142 . . . . 1.0 105.245 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -33.16 -44.83 0.13 Allowed 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 122.311 1.053 . . . . 1.0 112.588 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.57 -27.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.837 -1.983 . . . . 1.0 114.619 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.51 -7.83 54.11 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -100.2 -26.14 14.03 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 t -60.74 -34.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 122.865 1.317 . . . . 1.0 108.625 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 2.5 mt -71.52 -4.34 26.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.68 -1.6 . . . . 1.0 109.061 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -2.84 31.12 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -117.12 -45.59 2.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.01 -0.737 . . . . 1.0 109.01 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.32 -118.99 2.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.355 -2.298 . . . . 1.0 107.355 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.49 65.13 0.15 Allowed Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 103.3 -2.852 . . . . 1.0 103.3 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.593 ' O ' HD11 ' A' ' 17' ' ' ILE 2.524 59.4 Cg_endo 51.33 -78.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 1 C-N-CA 126.264 4.643 . . . . 1.0 112.71 -178.28 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.23 -21.8 14.82 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.452 -0.899 . . . . 1.0 113.338 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -40.61 -43.28 1.87 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.979 1.844 . . . . 1.0 115.979 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.701 HD12 ' H ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -58.6 -37.55 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.701 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.7 m -91.3 6.01 46.96 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.117 -1.033 . . . . 1.0 109.144 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.08 -69.08 0.79 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -89.86 -38.93 11.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 118.331 -1.347 . . . . 1.0 111.095 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -26.59 65.55 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 117.11 -1.836 . . . . 1.0 108.684 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' NH1' ' O ' ' A' ' 18' ' ' SER . 4.3 ttp180 -67.83 -55.78 11.64 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -52.27 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.679 -1.601 . . . . 1.0 108.078 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -20.81 1.86 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.565 1.691 . . . . 1.0 115.565 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.56 3.62 42.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.975 0.797 . . . . 1.0 113.059 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -121.02 177.38 5.14 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.155 0.979 . . . . 1.0 110.482 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.473 0 O-C-N 119.247 -2.158 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.675 0 N-CA-C 105.688 -2.965 . . . . 1.0 105.688 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.02 -125.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-N 118.243 1.022 . . . . 1.0 110.223 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.4 -70.95 2.56 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.445 -1.862 . . . . 1.0 108.445 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.2 3.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.77 -1.215 . . . . 1.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 5' ' ' VAL . 2.1 t -35.53 -34.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 114.872 1.434 . . . . 1.0 114.872 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -86.55 -35.34 19.57 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.028 -1.469 . . . . 1.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -52.61 -41.67 63.88 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 123.774 1.75 . . . . 1.0 106.557 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' CD ' ' A' ' 14' ' ' PRO . 95.9 t -50.42 -43.54 22.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 111.596 -2.547 . . . . 1.0 108.458 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.61 8.52 33.78 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.031 -1.441 . . . . 1.0 114.7 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -30.15 6.45 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-O 121.868 0.842 . . . . 1.0 108.938 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -93.58 -13.03 28.19 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.09 -85.6 0.21 Allowed Glycine 0 N--CA 1.494 2.517 0 O-C-N 124.699 1.249 . . . . 1.0 111.557 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.05 69.43 0.13 Allowed Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 105.736 -1.95 . . . . 1.0 105.736 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.447 ' CD ' ' HA ' ' A' ' 8' ' ' VAL 2.525 73.1 Cg_endo 42.09 -76.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 1 C-N-CA 126.645 4.897 . . . . 1.0 114.002 -172.404 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.96 -14.48 17.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.265 1.58 . . . . 1.0 115.265 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -41.4 -43.24 2.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.736 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -55.23 -33.01 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.568 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -100.29 5.57 44.54 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.44 0.638 . . . . 1.0 109.85 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.98 -64.21 1.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -48.02 14.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 118.395 -1.322 . . . . 1.0 109.25 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -62.78 -9.82 10.78 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 117.235 -1.786 . . . . 1.0 110.352 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.96 -65.26 1.03 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -58.61 -31.13 67.79 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.347 -1.341 . . . . 1.0 111.137 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.82 -15.54 63.13 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.097 -1.441 . . . . 1.0 110.049 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -101.19 -41.6 6.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.636 0.731 . . . . 1.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -114.41 71.8 0.77 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.823 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.599 0 O-C-N 118.779 -2.45 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 N-CA-C 105.795 -2.922 . . . . 1.0 105.795 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp -111.01 -10.83 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 CA-C-N 119.285 1.543 . . . . 1.0 113.029 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.652 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -32.77 -52.17 0.47 Allowed Glycine 0 N--CA 1.503 3.122 0 N-CA-C 116.063 1.185 . . . . 1.0 116.063 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.32 4.67 44.2 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.001 -0.679 . . . . 1.0 112.319 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 26.1 t -92.02 -55.49 6.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 104.137 -2.542 . . . . 1.0 104.137 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 2' ' ' ILE . 56.7 mt -37.64 -60.9 0.66 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.833 0.708 . . . . 1.0 111.09 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -45.07 -49.18 11.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.046 -1.434 . . . . 1.0 110.738 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 5' ' ' VAL . 96.3 t -52.34 -49.71 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.939 0.876 . . . . 1.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 11.8 mt -63.4 -12.15 28.43 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 114.127 -1.397 . . . . 1.0 110.758 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.45 12.17 33.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.992 -1.485 . . . . 1.0 106.992 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -63.1 1.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 103.307 -2.849 . . . . 1.0 103.307 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.55 -131.99 2.01 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 105.205 -3.158 . . . . 1.0 105.205 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.6 mt -158.88 55.88 0.87 Allowed Pre-proline 0 N--CA 1.498 1.954 0 CA-C-N 111.795 -2.202 . . . . 1.0 107.768 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.642 ' O ' HD11 ' A' ' 17' ' ' ILE 2.529 59.1 Cg_endo 52.11 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 1 C-N-CA 125.789 4.326 . . . . 1.0 112.947 177.879 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 -15.12 17.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.07 1.137 . . . . 1.0 114.07 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -47.51 -47.27 27.78 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 122.208 1.004 . . . . 1.0 113.246 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.766 HD12 ' H ' ' A' ' 18' ' ' SER . 1.1 pp -56.11 -30.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 113.46 -1.7 . . . . 1.0 109.183 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.766 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.8 m -101.0 8.78 42.84 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.629 -0.828 . . . . 1.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -70.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -40.68 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 117.412 -1.715 . . . . 1.0 110.317 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -12.3 59.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 117.012 -1.875 . . . . 1.0 109.525 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 15.0 ttt180 -86.38 -55.81 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 101.83 -3.396 . . . . 1.0 101.83 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -46.26 -55.17 7.58 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.256 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -12.84 5.38 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.786 1.402 . . . . 1.0 114.786 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -101.54 6.39 42.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.476 0.485 . . . . 1.0 111.101 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -118.66 -37.85 3.21 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.362 1.077 . . . . 1.0 110.359 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.581 0 O-C-N 118.299 -2.751 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.791 0 N-CA-C 105.607 -2.997 . . . . 1.0 105.607 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.631 HD12 ' H ' ' A' ' 3' ' ' GLY . 1.3 pp -107.53 -28.91 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.464 0 CA-C-N 118.803 1.302 . . . . 1.0 113.145 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.631 ' H ' HD12 ' A' ' 2' ' ' ILE . . . -27.12 -36.89 0.01 OUTLIER Glycine 0 N--CA 1.506 3.354 0 N-CA-C 117.292 1.677 . . . . 1.0 117.292 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.05 -49.59 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.116 -1.439 . . . . 1.0 107.116 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 5' ' ' VAL . 14.0 t -40.13 -54.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 124.535 1.147 . . . . 1.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.6 mt -46.01 -50.83 14.53 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 122.345 1.069 . . . . 1.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -45.51 -47.14 14.22 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 112.869 -1.968 . . . . 1.0 110.171 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 t -54.38 -47.64 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 113.312 -1.767 . . . . 1.0 109.287 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.83 -5.12 19.05 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.35 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 8.75 34.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.225 -2.139 . . . . 1.0 105.225 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.83 -64.37 1.22 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.93 -126.24 2.37 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 106.434 -2.666 . . . . 1.0 106.434 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -171.09 60.53 0.32 Allowed Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 122.657 1.218 . . . . 1.0 108.405 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.582 ' O ' HD11 ' A' ' 17' ' ' ILE 2.522 95.9 Cg_endo 41.78 -82.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 1 C-N-CA 126.607 4.871 . . . . 1.0 114.006 -173.707 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.56 -12.8 17.5 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -47.67 -48.41 29.09 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.405 -1.318 . . . . 1.0 113.05 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -58.86 -42.24 85.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.5 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -71.66 -6.24 39.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.767 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.105 -0.952 . . . . 1.0 108.877 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -90.22 -36.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.693 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.25 -16.55 61.4 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.028 -1.869 . . . . 1.0 108.51 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 -24.35 20.35 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.466 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -91.1 -35.16 14.75 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.487 -0.885 . . . . 1.0 109.065 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -13.01 16.53 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.006 0.431 . . . . 1.0 111.805 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -100.98 8.08 43.21 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.848 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.702 HE21 ' N ' ' A' ' 27' ' ' NH2 . 0.0 OUTLIER -120.93 178.35 4.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.517 0.675 . . . . 1.0 109.498 -179.77 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . 0.702 ' N ' HE21 ' A' ' 26' ' ' GLN . . . . . . . . 0 C--N 1.301 -1.528 0 O-C-N 118.975 -2.328 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.783 0 N-CA-C 106.33 -2.708 . . . . 1.0 106.33 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.647 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -108.41 -34.47 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-N 118.32 1.06 . . . . 1.0 112.653 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.89 -56.02 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.817 1.887 . . . . 1.0 117.817 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.84 -32.59 11.27 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.932 0.396 . . . . 1.0 111.095 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 5' ' ' VAL . 3.4 t -51.09 -49.07 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.8 mt -54.8 -19.2 5.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 113.596 -1.638 . . . . 1.0 112.661 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -96.67 -28.06 14.5 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.7 t -52.54 -50.03 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.5 6.16 0.23 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.947 -1.933 . . . . 1.0 113.409 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -102.13 -9.04 20.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.491 -1.3 . . . . 1.0 107.491 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m -115.52 -60.91 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.557 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.5 -113.55 0.76 Allowed Glycine 0 N--CA 1.503 3.148 0 C-N-CA 119.394 -1.384 . . . . 1.0 109.795 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -178.42 60.91 0.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 104.465 -2.42 . . . . 1.0 104.465 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.518 55.0 Cg_endo 53.87 -75.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 1 C-N-CA 125.744 4.296 . . . . 1.0 114.474 176.608 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.15 -21.97 14.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 115.367 1.618 . . . . 1.0 115.367 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -38.85 -40.29 0.62 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.448 2.018 . . . . 1.0 116.448 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.852 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -51.01 -39.5 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 113.164 -1.834 . . . . 1.0 111.673 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -101.08 9.89 41.59 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 1.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -66.73 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.886 -1.506 . . . . 1.0 108.783 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -35.61 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.189 -0.604 . . . . 1.0 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 10.5 mttt -76.73 -4.17 41.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.768 -1.573 . . . . 1.0 107.828 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -90.4 -76.59 0.43 Allowed 'General case' 0 C--N 1.306 -1.309 1 N-CA-C 95.734 -5.654 . . . . 1.0 95.734 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -37.33 -62.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 114.875 1.435 . . . . 1.0 114.875 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -22.05 32.79 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.38 -50.8 3.5 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -112.59 -2.59 14.54 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 113.48 0.918 . . . . 1.0 113.48 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.783 0 O-C-N 117.735 -3.103 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.638 HD12 HD11 ' A' ' 6' ' ' LEU . 23.2 pt . . . . . 0 N--CA 1.505 2.28 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -29.56 -41.96 0.04 OUTLIER Glycine 0 N--CA 1.51 3.61 0 CA-C-O 121.807 0.67 . . . . 1.0 114.428 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.711 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -93.36 -40.66 10.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -50.61 -37.48 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 123.215 0.322 . . . . 1.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 2' ' ' ILE . 15.9 mt -86.32 -5.32 59.2 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.935 -0.706 . . . . 1.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -100.38 -6.03 26.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.28 0.987 . . . . 1.0 109.692 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 4' ' ' ALA . 98.1 t -87.79 -41.34 14.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.847 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.16 22.11 3.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.708 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -20.9 8.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 115.524 1.676 . . . . 1.0 115.524 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -121.24 -76.65 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.02 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -121.3 -96.35 1.45 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 106.947 -2.461 . . . . 1.0 106.947 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.41 70.95 0.14 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 104.428 -2.434 . . . . 1.0 104.428 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HG2' HG22 ' A' ' 8' ' ' VAL 2.531 18.3 Cg_endo 59.31 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.861 3.04 . . . . 1.0 111.813 176.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.64 -15.19 17.12 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.61 1.337 . . . . 1.0 114.61 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.52 -39.68 0.49 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.284 1.587 . . . . 1.0 115.284 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.799 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -51.4 -35.77 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.116 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.416 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.34 5.77 44.48 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.484 0.659 . . . . 1.0 109.769 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -63.11 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.581 -1.19 . . . . 1.0 110.038 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.16 -44.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.268 -0.878 . . . . 1.0 109.946 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -28.32 69.14 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 116.923 -1.911 . . . . 1.0 108.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.416 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 2.9 ttt180 -73.86 -28.55 61.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.701 -1.599 . . . . 1.0 108.265 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.03 -22.9 20.54 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.273 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -36.4 10.85 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.721 0.637 . . . . 1.0 112.721 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -100.18 66.7 1.33 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-N 113.294 -1.776 . . . . 1.0 107.071 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 4' ' ' ALA . 7.9 pt . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.25 -68.66 0.0 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 116.125 1.21 . . . . 1.0 116.125 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 2' ' ' ILE . . . -97.7 -26.78 14.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.82 -19.75 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.75 -11.86 38.29 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.352 -0.84 . . . . 1.0 110.731 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.29 -2.66 33.13 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.747 0.784 . . . . 1.0 110.006 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.4 -49.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.427 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.05 19.07 5.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.538 1.31 . . . . 1.0 114.538 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -16.71 14.34 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.172 -1.376 . . . . 1.0 109.912 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 m -115.9 -61.83 1.68 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.08 -120.81 1.71 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 106.399 -2.681 . . . . 1.0 106.399 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -156.26 63.4 3.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 113.269 -1.465 . . . . 1.0 107.601 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.446 ' O ' HD11 ' A' ' 17' ' ' ILE 2.545 1.0 OUTLIER 61.26 -100.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 123.03 2.487 . . . . 1.0 108.056 175.51 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.57 -8.85 22.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -49.96 -42.67 49.22 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 119.481 -0.888 . . . . 1.0 112.306 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 18' ' ' SER . 1.3 pp -59.03 -26.12 31.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 113.628 -1.624 . . . . 1.0 109.835 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.645 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -100.98 3.62 41.74 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.042 0.925 . . . . 1.0 109.95 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.59 -61.44 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.353 -0.839 . . . . 1.0 111.155 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -43.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.466 -1.294 . . . . 1.0 110.078 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -32.66 74.21 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.919 -1.513 . . . . 1.0 107.622 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -16.85 60.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 124.452 1.095 . . . . 1.0 110.213 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -41.17 11.39 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -47.17 52.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.245 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -84.83 68.06 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-N 113.728 -1.578 . . . . 1.0 108.305 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.28 -71.77 0.21 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.92 -46.4 7.86 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.982 -1.087 . . . . 1.0 108.313 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 5' ' ' VAL . 5.3 t -29.86 -33.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.972 1.42 . . . . 1.0 114.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.95 -49.68 17.06 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.526 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -45.12 -43.3 9.63 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.528 1.156 . . . . 1.0 108.689 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 8' ' ' VAL . 17.6 t -46.37 -56.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.675 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.15 6.44 1.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.504 -1.68 . . . . 1.0 113.564 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.34 -2.14 18.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.909 -1.886 . . . . 1.0 105.909 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.2 m -120.08 -61.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.679 -1.971 . . . . 1.0 105.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.73 -122.99 0.9 Allowed Glycine 0 N--CA 1.481 1.66 0 N-CA-C 107.908 -2.077 . . . . 1.0 107.908 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 13' ' ' LEU . 2.1 pt? -150.32 32.88 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 111.838 -2.181 . . . . 1.0 109.66 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.536 41.9 Cg_exo 94.77 175.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.758 2.972 . . . . 1.0 109.208 -167.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -26.74 -25.3 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 118.648 2.833 . . . . 1.0 118.648 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 14' ' ' PRO . 2.9 mm? -43.26 -38.77 2.72 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.664 0.745 . . . . 1.0 112.405 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -30.69 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 114.299 -1.319 . . . . 1.0 111.79 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.484 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 3.65 42.14 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.213 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -78.4 0.53 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.164 -1.791 . . . . 1.0 106.164 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.74 -36.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 117.973 -1.491 . . . . 1.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -74.86 -9.53 58.63 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 116.923 -1.911 . . . . 1.0 109.94 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.484 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 11.2 ttm180 -90.2 -50.66 5.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 103.694 -2.706 . . . . 1.0 103.694 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -41.81 95.2 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.576 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.42 -28.85 8.92 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.788 -1.165 . . . . 1.0 113.204 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -101.33 -29.63 11.95 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 119.799 -0.76 . . . . 1.0 111.075 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 -179.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 6' ' ' LEU . 2.7 pt . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 113.686 0.995 . . . . 1.0 113.686 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.23 -65.59 0.01 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 116.148 1.219 . . . . 1.0 116.148 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.75 -29.85 13.13 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.963 -0.695 . . . . 1.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 5' ' ' VAL . 2.1 t -53.58 -26.08 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.96 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 2' ' ' ILE . 73.9 mt -90.09 -14.29 34.04 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.94 1.84 40.19 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.303 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -90.75 -47.63 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -87.84 19.36 3.55 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.515 -1.22 . . . . 1.0 112.709 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 -18.17 19.5 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.064 -1.425 . . . . 1.0 109.23 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -122.95 -61.88 1.4 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.76 -118.42 1.48 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 61.01 4.47 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 17' ' ' ILE 2.549 5.8 Cg_endo 62.88 -99.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 123.325 2.683 . . . . 1.0 108.975 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.67 -10.07 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.351 1.241 . . . . 1.0 114.351 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.81 -44.36 19.21 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.59 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -61.79 -24.92 35.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.684 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.515 ' H ' HD12 ' A' ' 17' ' ' ILE . 50.9 m -100.87 4.99 43.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -61.1 1.42 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.842 -1.17 . . . . 1.0 107.842 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -49.94 13.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.023 -1.071 . . . . 1.0 110.23 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -9.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.866 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -90.79 -23.7 20.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 105.874 -1.898 . . . . 1.0 105.874 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.15 -58.61 2.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.97 1.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 115.595 1.702 . . . . 1.0 115.595 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.613 -1.625 . . . . 1.0 106.613 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-N 113.799 -1.546 . . . . 1.0 107.817 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.755 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp . . . . . 0 N--CA 1.51 2.569 0 N-CA-C 113.138 0.792 . . . . 1.0 113.138 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.755 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -15.26 -53.18 0.01 OUTLIER Glycine 0 N--CA 1.51 3.575 0 N-CA-C 117.479 1.751 . . . . 1.0 117.479 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.11 -30.03 12.17 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.883 -0.658 . . . . 1.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 2' ' ' ILE . 6.1 t -54.56 -42.27 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 2' ' ' ILE . 43.7 mt -61.97 -16.99 55.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.459 -1.246 . . . . 1.0 111.451 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.08 -3.21 29.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.424 1.078 . . . . 1.0 110.51 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 4' ' ' ALA . 44.0 t -90.35 -54.62 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -79.12 19.09 0.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.587 -1.188 . . . . 1.0 113.82 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -23.75 12.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.188 -1.369 . . . . 1.0 107.456 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.404 HG23 ' HD3' ' A' ' 14' ' ' PRO . 2.5 t -112.31 -29.31 7.58 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.801 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -101.51 0.2 Allowed Glycine 0 N--CA 1.483 1.819 0 CA-C-N 114.383 -1.28 . . . . 1.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.15 66.23 1.6 Allowed Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.774 ' O ' HD11 ' A' ' 17' ' ' ILE 2.535 25.5 Cg_endo 58.16 -85.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.12 3.213 . . . . 1.0 110.95 173.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.45 -15.26 17.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -46.55 -42.74 16.32 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.574 1.694 . . . . 1.0 115.574 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.774 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.9 -23.39 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 114.587 -1.188 . . . . 1.0 108.984 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -101.38 1.32 38.32 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.338 -0.846 . . . . 1.0 109.111 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -70.98 0.73 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -30.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.481 -1.288 . . . . 1.0 112.494 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 16.0 mtpt -80.45 -27.17 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 116.798 -1.961 . . . . 1.0 107.627 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -30.33 64.66 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -33.48 16.22 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.102 -1.039 . . . . 1.0 108.569 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -60.82 -7.38 2.3 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.746 -0.781 . . . . 1.0 112.603 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -100.25 -9.79 22.02 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.673 -1.232 . . . . 1.0 107.673 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 179.898 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 N--CA 1.506 2.375 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -7.16 -68.76 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 N-CA-C 116.395 1.318 . . . . 1.0 116.395 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.75 -21.99 15.02 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 120.896 0.379 . . . . 1.0 110.702 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.41 -29.58 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.711 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.6 mt -89.46 -6.91 56.06 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.4 -0.92 . . . . 1.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -93.99 -36.9 11.94 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 4' ' ' ALA . 78.6 t -49.32 -36.23 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.99 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.72 17.64 7.4 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.774 -1.557 . . . . 1.0 113.508 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -108.66 -13.54 14.78 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.302 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -63.09 1.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.678 -0.809 . . . . 1.0 109.042 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.44 -97.47 0.27 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 108.966 -1.654 . . . . 1.0 108.966 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.52 65.33 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 104.687 -2.338 . . . . 1.0 104.687 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.538 11.5 Cg_endo 60.19 -93.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.334 2.689 . . . . 1.0 110.346 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -13.1 18.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -36.79 -42.27 0.37 Allowed 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 115.948 1.832 . . . . 1.0 115.948 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.747 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -51.77 -37.13 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.61 -1.177 . . . . 1.0 112.046 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -97.29 7.17 47.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.727 0.775 . . . . 1.0 109.866 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -67.28 0.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.985 -1.461 . . . . 1.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -41.66 13.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 118.989 -1.085 . . . . 1.0 110.165 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -69.97 -16.15 63.15 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.299 -1.76 . . . . 1.0 109.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 4.3 ttt180 -90.54 -23.51 20.88 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.546 -0.862 . . . . 1.0 108.892 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -51.61 5.22 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.711 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -47.88 -9.94 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 114.684 1.364 . . . . 1.0 114.684 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.22 -23.36 14.84 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.926 0.766 . . . . 1.0 112.178 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 . . . . . 0 N--CA 1.504 2.261 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 112.713 0.634 . . . . 1.0 112.713 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -5.38 -71.64 0.01 OUTLIER Glycine 0 N--CA 1.507 3.367 0 N-CA-C 117.221 1.648 . . . . 1.0 117.221 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.2 -17.31 17.43 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 119.544 -0.862 . . . . 1.0 111.414 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -55.99 -48.43 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.631 -2.359 . . . . 1.0 104.631 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 mt -55.99 -17.71 7.46 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 114.201 -1.363 . . . . 1.0 112.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -100.05 -25.53 14.27 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.783 -0.767 . . . . 1.0 109.059 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' A' ' 14' ' ' PRO . 4.1 t -58.52 -28.8 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.34 13.89 14.24 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.922 -1.035 . . . . 1.0 111.358 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -101.12 -3.16 29.71 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.657 -0.817 . . . . 1.0 108.801 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -78.97 0.6 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.524 -2.028 . . . . 1.0 105.524 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.31 -85.46 0.07 OUTLIER Glycine 0 N--CA 1.491 2.352 1 N-CA-C 102.237 -4.345 . . . . 1.0 102.237 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 79.86 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 104.441 -2.429 . . . . 1.0 104.441 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.565 ' HD2' HG13 ' A' ' 8' ' ' VAL 2.544 9.4 Cg_endo 64.07 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.745 2.297 . . . . 1.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.62 -4.7 27.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 114.521 1.304 . . . . 1.0 114.521 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.32 -24.7 1.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.633 1.716 . . . . 1.0 115.633 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -65.53 -32.53 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -100.6 9.84 41.97 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.999 0.904 . . . . 1.0 108.909 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -101.37 -69.62 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 113.93 -1.486 . . . . 1.0 108.7 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.482 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -90.52 -38.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 118.559 -1.256 . . . . 1.0 109.609 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -12.49 61.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.495 -1.682 . . . . 1.0 108.76 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -90.02 -60.38 1.95 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -57.92 -33.22 68.55 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.447 -0.901 . . . . 1.0 112.976 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 3.6 ttp180 -71.58 -11.79 61.03 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 116.207 -2.197 . . . . 1.0 110.693 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -101.48 -45.16 5.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.621 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 3' ' ' GLY . 1.7 pp . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 113.071 0.767 . . . . 1.0 113.071 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.673 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -6.5 -72.7 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.554 1.782 . . . . 1.0 117.554 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.89 -12.12 20.11 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.823 -0.751 . . . . 1.0 110.58 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -61.0 -41.69 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 103.31 -2.848 . . . . 1.0 103.31 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.41 -16.28 22.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 113.707 -1.588 . . . . 1.0 110.797 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -100.64 -2.11 33.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 123.664 0.602 . . . . 1.0 110.506 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.576 HG13 ' HG2' ' A' ' 14' ' ' PRO . 11.5 t -90.4 -46.71 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.04 0.448 . . . . 1.0 110.612 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.519 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.44 19.98 4.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.399 1.095 . . . . 1.0 113.251 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 -17.41 15.17 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 113.844 -1.526 . . . . 1.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.84 -64.64 1.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 104.384 -2.45 . . . . 1.0 104.384 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.53 -122.27 1.57 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 1.0 104.426 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mt -152.64 67.27 6.59 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 105.812 -1.922 . . . . 1.0 105.812 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.689 ' O ' HD11 ' A' ' 17' ' ' ILE 2.533 18.5 Cg_endo 56.84 -81.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.934 3.09 . . . . 1.0 112.3 173.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.18 -14.33 17.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -46.23 -43.6 15.55 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.325 1.232 . . . . 1.0 114.325 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.689 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -62.36 -24.28 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.511 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -100.33 3.19 43.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 -69.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.404 0.621 . . . . 1.0 109.654 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -35.08 8.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 118.586 -0.721 . . . . 1.0 111.142 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -24.03 63.91 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 116.134 -2.227 . . . . 1.0 105.052 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -61.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -36.21 22.19 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.237 1.018 . . . . 1.0 110.738 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.83 -21.33 66.03 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.114 -0.948 . . . . 1.0 112.762 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -101.62 -45.37 5.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.551 1.157 . . . . 1.0 110.248 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-N 114.789 -1.096 . . . . 1.0 110.012 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.535 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -9.88 -58.75 0.01 OUTLIER Glycine 0 N--CA 1.508 3.467 0 N-CA-C 117.713 1.845 . . . . 1.0 117.713 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.1 -27.5 13.51 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.577 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 2' ' ' ILE . 9.5 t -54.49 -44.77 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.15 -17.04 23.39 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.996 -1.456 . . . . 1.0 111.822 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -100.24 -6.04 26.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.019 0.824 . . . . 1.0 110.022 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 10' ' ' THR . 34.4 t -90.61 -51.12 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.436 HD23 HG12 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -71.92 11.63 0.51 Allowed 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 114.322 -1.308 . . . . 1.0 112.611 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -105.13 -12.4 16.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.216 -1.402 . . . . 1.0 107.216 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 -31.96 4.23 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.95 -111.21 0.47 Allowed Glycine 0 N--CA 1.481 1.689 1 N-CA-C 101.822 -4.511 . . . . 1.0 101.822 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -149.64 66.82 8.45 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 104.456 -2.424 . . . . 1.0 104.456 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.534 12.0 Cg_endo 61.56 -83.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.848 3.032 . . . . 1.0 111.577 169.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.21 -18.94 16.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.28 -37.41 16.23 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.547 -1.261 . . . . 1.0 114.098 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.733 HD12 ' H ' ' A' ' 18' ' ' SER . 1.1 pp -57.34 -30.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.513 0.673 . . . . 1.0 109.357 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.733 ' H ' HD12 ' A' ' 17' ' ' ILE . 2.7 m -100.25 10.32 41.42 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.499 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -102.77 -64.3 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.139 -1.392 . . . . 1.0 108.435 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.05 -39.54 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 118.334 -1.347 . . . . 1.0 111.608 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -72.48 -27.62 62.39 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 116.511 -2.076 . . . . 1.0 108.83 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -61.12 -36.51 79.93 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.403 -1.319 . . . . 1.0 107.574 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -35.61 14.6 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.797 -1.161 . . . . 1.0 110.587 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -21.61 61.91 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 118.778 -1.169 . . . . 1.0 110.574 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -100.68 2.57 41.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.346 1.029 . . . . 1.0 110.648 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 107.228 -1.397 . . . . 1.0 107.228 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.9 pt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 122.202 1.001 . . . . 1.0 109.632 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.12 -34.93 4.09 Favored Glycine 0 N--CA 1.502 3.093 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.81 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.09 -51.38 3.69 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 104.625 -2.361 . . . . 1.0 104.625 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 5' ' ' VAL . 2.8 t -28.28 -30.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 126.126 2.141 . . . . 1.0 114.258 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' ALA . 20.3 mt -90.49 -56.0 3.37 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.605 -0.838 . . . . 1.0 109.179 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -46.41 -41.89 14.35 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 124.074 1.893 . . . . 1.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 4' ' ' ALA . 71.9 t -46.9 -45.65 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 111.049 -2.796 . . . . 1.0 110.235 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.36 16.52 9.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.333 -1.303 . . . . 1.0 113.481 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -45.3 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.939 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -84.31 -41.44 16.81 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.16 -1.416 . . . . 1.0 109.844 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.87 -114.95 0.49 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.999 -1.64 . . . . 1.0 108.999 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -169.72 57.78 0.31 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 17' ' ' ILE 2.548 18.6 Cg_endo 59.08 -102.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 124.616 3.544 . . . . 1.0 108.496 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -7.7 24.13 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.794 1.035 . . . . 1.0 113.794 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.22 -42.75 41.38 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 117.949 -1.5 . . . . 1.0 112.545 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.865 HD12 ' H ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.91 -40.93 88.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.745 -1.182 . . . . 1.0 108.504 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.865 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -71.1 -7.29 45.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -74.82 0.6 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.684 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -30.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 119.039 -1.064 . . . . 1.0 112.86 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -79.22 -9.47 59.58 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 116.865 -1.934 . . . . 1.0 108.138 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -90.67 -62.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.431 1 N-CA-C 98.926 -4.472 . . . . 1.0 98.926 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -42.48 -63.8 0.71 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.376 -1.284 . . . . 1.0 112.78 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -18.82 0.1 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.519 2.044 . . . . 1.0 116.519 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -101.24 14.8 30.82 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.764 0.792 . . . . 1.0 111.709 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 N--CA 1.49 1.528 0 CA-C-N 113.866 -1.515 . . . . 1.0 107.998 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 3' ' ' GLY . 1.2 pp . . . . . 0 N--CA 1.506 2.353 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.511 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -11.93 -60.98 0.01 OUTLIER Glycine 0 N--CA 1.504 3.2 0 N-CA-C 117.712 1.845 . . . . 1.0 117.712 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.32 -43.7 8.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -35.6 -55.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.795 1.31 . . . . 1.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.499 ' CD1' HD13 ' A' ' 2' ' ' ILE . 26.7 mt -49.29 -38.97 29.18 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' NZ ' HG21 ' A' ' 10' ' ' THR . 0.7 OUTLIER -68.2 -35.42 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.767 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.459 ' CG1' ' HG3' ' A' ' 14' ' ' PRO . 1.4 t -61.08 -32.8 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.385 1.088 . . . . 1.0 109.077 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mt -72.82 -2.14 19.41 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.576 -1.193 . . . . 1.0 108.787 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.516 HG21 ' NZ ' ' A' ' 7' ' ' LYS . 3.7 m -98.98 -10.21 22.99 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.449 -1.685 . . . . 1.0 106.449 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -105.23 -45.56 4.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.406 -1.701 . . . . 1.0 106.406 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.39 -133.44 2.91 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 106.094 -2.802 . . . . 1.0 106.094 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.13 68.19 7.22 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 112.39 -1.905 . . . . 1.0 107.39 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.718 ' O ' HD11 ' A' ' 17' ' ' ILE 2.527 47.7 Cg_endo 54.15 -83.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 125.209 3.939 . . . . 1.0 112.824 171.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.42 -17.7 16.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.28 -46.26 17.83 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -58.9 -26.06 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.078 0.942 . . . . 1.0 109.466 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.577 ' H ' HD12 ' A' ' 17' ' ' ILE . 74.0 m -101.26 5.78 42.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.091 -0.959 . . . . 1.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.58 -67.57 0.86 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 123.44 0.462 . . . . 1.0 109.935 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.91 -34.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 118.405 -1.318 . . . . 1.0 111.347 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 5.6 mtpt -69.35 -16.76 63.6 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 116.717 -1.993 . . . . 1.0 107.163 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -91.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.369 -1.715 . . . . 1.0 106.369 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -47.79 -40.09 19.95 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.1 -0.954 . . . . 1.0 108.957 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.73 39.88 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.412 -0.915 . . . . 1.0 109.767 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 8.6 pt20 -100.31 -26.14 14.0 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 121.0 0.429 . . . . 1.0 110.993 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.142 0 CA-C-O 122.321 1.058 . . . . 1.0 113.185 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt . . . . . 0 N--CA 1.505 2.294 0 N-CA-C 112.366 0.506 . . . . 1.0 112.366 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -15.64 -60.62 0.01 OUTLIER Glycine 0 N--CA 1.506 3.319 0 N-CA-C 117.094 1.598 . . . . 1.0 117.094 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.76 -24.82 20.26 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.284 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 2' ' ' ILE . 36.6 t -58.93 -48.39 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.8 mt -38.1 -59.31 0.87 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.409 -1.269 . . . . 1.0 111.219 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -42.48 -53.16 4.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.207 -1.815 . . . . 1.0 109.825 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 14' ' ' PRO . 10.7 t -44.92 -57.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.114 -1.403 . . . . 1.0 109.146 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.67 -19.22 65.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.215 -2.266 . . . . 1.0 111.864 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -0.21 54.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 118.61 -1.236 . . . . 1.0 107.827 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -107.08 -61.92 1.48 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.397 -2.446 . . . . 1.0 104.397 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -127.7 1.77 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 106.366 -2.693 . . . . 1.0 106.366 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 4.8 mt -159.45 58.89 1.26 Allowed Pre-proline 0 N--CA 1.497 1.896 0 CA-C-N 112.783 -1.708 . . . . 1.0 107.707 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.618 ' O ' HD11 ' A' ' 17' ' ' ILE 2.537 38.9 Cg_endo 55.94 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 124.825 3.684 . . . . 1.0 111.081 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.68 -12.38 19.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.469 0.914 . . . . 1.0 113.469 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -46.22 -45.14 16.78 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.751 -1.179 . . . . 1.0 113.177 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.712 HD12 ' H ' ' A' ' 18' ' ' SER . 1.3 pp -56.81 -32.3 38.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.016 -1.902 . . . . 1.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.712 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -100.93 8.81 42.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.246 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.93 -70.67 0.73 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 -39.93 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 117.539 -1.664 . . . . 1.0 109.811 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -23.15 67.25 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 117.71 -1.596 . . . . 1.0 108.795 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -82.66 -14.6 54.38 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.967 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -43.93 9.9 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.139 -2.171 . . . . 1.0 105.139 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -22.05 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.792 -1.549 . . . . 1.0 113.111 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.43 6.98 44.49 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.334 1.021 . . . . 1.0 112.69 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 122.3 1.048 . . . . 1.0 108.735 179.902 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 121.433 0.635 . . . . 1.0 111.866 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.53 -27.91 6.58 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.671 -1.252 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.92 -47.08 5.15 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.785 -1.931 . . . . 1.0 105.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 5' ' ' VAL . 17.0 t -36.48 -56.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 115.052 -0.976 . . . . 1.0 111.071 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.0 mt -51.53 -33.32 31.43 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.791 -1.55 . . . . 1.0 113.187 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' NZ ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.95 -31.9 66.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.538 -1.21 . . . . 1.0 111.908 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 t -64.23 -38.22 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 9' ' ' LEU . 1.3 mt -62.18 -24.19 67.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.5 -1.227 . . . . 1.0 107.933 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.94 -11.89 59.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.035 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 -12.67 18.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' HG13 ' A' ' 17' ' ' ILE . . . 141.64 123.22 1.88 Allowed Glycine 0 N--CA 1.478 1.486 0 N-CA-C 106.713 -2.555 . . . . 1.0 106.713 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.51 100.86 0.23 Allowed Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 121.51 0.671 . . . . 1.0 111.148 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.514 10.4 Cg_endo 31.89 -84.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 1 C-N-CA 127.118 5.212 . . . . 1.0 115.611 -163.062 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -7.84 22.75 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.95 1.833 . . . . 1.0 115.95 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.6 -41.22 0.66 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.577 1.325 . . . . 1.0 114.577 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.748 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -50.31 -37.79 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.139 -1.392 . . . . 1.0 111.253 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.49 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 6.81 43.87 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.111 -0.635 . . . . 1.0 109.329 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.411 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.75 -64.09 1.08 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -44.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.053 -1.459 . . . . 1.0 110.955 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 10.8 mtpt -61.68 -24.55 66.83 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.473 1.108 . . . . 1.0 109.044 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -90.91 -14.85 30.85 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.87 -0.732 . . . . 1.0 112.12 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -91.27 -26.31 19.05 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.664 -1.214 . . . . 1.0 109.08 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.13 -27.34 13.29 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.489 -0.884 . . . . 1.0 110.086 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.498 1.972 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.727 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 6' ' ' LEU . 1.7 pp . . . . . 0 N--CA 1.506 2.334 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.593 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -6.62 -78.49 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.21 -5.64 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.263 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 23.6 t -63.19 -44.6 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 103.962 -2.607 . . . . 1.0 103.962 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 2' ' ' ILE . 15.5 mt -43.32 -47.71 6.73 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 123.028 1.394 . . . . 1.0 108.369 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 1.3 tptp -50.6 -47.38 58.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 112.365 -2.198 . . . . 1.0 110.699 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.566 HG13 ' CG ' ' A' ' 14' ' ' PRO . 51.0 t -53.99 -34.85 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.257 -1.338 . . . . 1.0 111.067 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.38 6.31 43.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 112.623 -2.08 . . . . 1.0 111.736 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -109.17 -3.7 17.09 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -118.62 -59.36 1.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.9 -114.61 1.18 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.335 -1.906 . . . . 1.0 108.335 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.4 mt 179.44 61.25 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 103.153 -2.906 . . . . 1.0 103.153 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.756 ' O ' HD11 ' A' ' 17' ' ' ILE 2.52 73.4 Cg_endo 50.92 -73.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 1 C-N-CA 125.483 4.122 . . . . 1.0 113.985 -178.643 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -101.87 -22.72 14.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.861 1.06 . . . . 1.0 113.861 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -45.38 -46.31 13.11 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.657 1.725 . . . . 1.0 115.657 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.756 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -62.75 -25.31 37.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.831 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 17' ' ' ILE . 68.6 m -101.53 3.12 39.83 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.895 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -71.33 0.71 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.98 -37.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 117.682 -1.607 . . . . 1.0 111.622 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.9 mtpt -71.77 -4.7 29.21 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 115.43 -2.508 . . . . 1.0 109.224 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -52.32 4.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -27.57 66.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 114.223 -1.353 . . . . 1.0 111.171 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -7.32 56.15 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.862 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -101.04 -48.84 4.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.727 1.267 . . . . 1.0 107.739 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 122.53 1.157 . . . . 1.0 110.611 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.4 pt . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 119.898 -0.096 . . . . 1.0 110.951 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -38.91 -28.7 0.07 OUTLIER Glycine 0 N--CA 1.508 3.474 0 O-C-N 123.914 0.759 . . . . 1.0 112.908 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -99.69 -52.15 3.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.1 t -49.48 -24.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 124.006 0.816 . . . . 1.0 111.851 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.62 -39.97 15.61 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -47.98 -45.08 31.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.96 1.362 . . . . 1.0 109.847 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 4' ' ' ALA . 1.6 t -54.15 -36.46 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 113.586 -1.643 . . . . 1.0 110.633 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -90.87 13.88 15.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 113.824 -1.534 . . . . 1.0 111.612 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -11.48 19.12 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.548 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -113.39 -68.11 0.95 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.537 -2.394 . . . . 1.0 104.537 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.33 -120.14 1.62 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.309 -2.317 . . . . 1.0 107.309 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -160.74 60.71 1.36 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 107.343 -1.354 . . . . 1.0 107.343 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.523 15.9 Cg_endo 52.95 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.24 3.294 . . . . 1.0 112.658 174.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -102.39 -18.61 15.31 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -50.43 -46.24 56.36 Favored 'General case' 0 N--CA 1.515 2.799 0 CA-C-O 123.657 1.694 . . . . 1.0 113.405 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.827 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -60.77 -24.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.871 -2.422 . . . . 1.0 107.143 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.424 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.64 3.4 42.47 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.347 -1.297 . . . . 1.0 109.066 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -63.21 1.17 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.678 0.751 . . . . 1.0 109.469 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.68 -43.91 15.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 118.827 -1.149 . . . . 1.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.91 -19.43 65.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 117.513 -1.675 . . . . 1.0 108.439 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 20.6 ttt180 -84.29 -19.92 32.98 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.92 -33.53 15.57 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.459 -1.246 . . . . 1.0 107.989 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.55 53.27 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.168 -0.613 . . . . 1.0 112.478 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.67 11.48 39.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.622 0.576 . . . . 1.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 107.22 -1.4 . . . . 1.0 107.22 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.857 0.837 . . . . 1.0 112.013 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.84 -102.5 1.81 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 105.245 -3.142 . . . . 1.0 105.245 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -33.16 -44.83 0.13 Allowed 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 122.311 1.053 . . . . 1.0 112.588 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.57 -27.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.837 -1.983 . . . . 1.0 114.619 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.51 -7.83 54.11 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -100.2 -26.14 14.03 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 t -60.74 -34.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 122.865 1.317 . . . . 1.0 108.625 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 2.5 mt -71.52 -4.34 26.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.68 -1.6 . . . . 1.0 109.061 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -2.84 31.12 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -117.12 -45.59 2.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.01 -0.737 . . . . 1.0 109.01 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.32 -118.99 2.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.355 -2.298 . . . . 1.0 107.355 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.49 65.13 0.15 Allowed Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 103.3 -2.852 . . . . 1.0 103.3 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.593 ' O ' HD11 ' A' ' 17' ' ' ILE 2.524 59.4 Cg_endo 51.33 -78.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 1 C-N-CA 126.264 4.643 . . . . 1.0 112.71 -178.28 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.23 -21.8 14.82 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.452 -0.899 . . . . 1.0 113.338 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -40.61 -43.28 1.87 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.979 1.844 . . . . 1.0 115.979 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.701 HD12 ' H ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -58.6 -37.55 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.701 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.7 m -91.3 6.01 46.96 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.117 -1.033 . . . . 1.0 109.144 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.08 -69.08 0.79 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -89.86 -38.93 11.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 118.331 -1.347 . . . . 1.0 111.095 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -26.59 65.55 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 117.11 -1.836 . . . . 1.0 108.684 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' NH1' ' O ' ' A' ' 18' ' ' SER . 4.3 ttp180 -67.83 -55.78 11.64 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -52.27 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.679 -1.601 . . . . 1.0 108.078 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -20.81 1.86 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.565 1.691 . . . . 1.0 115.565 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.56 3.62 42.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.975 0.797 . . . . 1.0 113.059 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 122.155 0.979 . . . . 1.0 110.482 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 N--CA 1.499 1.995 0 N-CA-C 110.223 -0.288 . . . . 1.0 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.4 -70.95 2.56 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.445 -1.862 . . . . 1.0 108.445 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.2 3.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.77 -1.215 . . . . 1.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 5' ' ' VAL . 2.1 t -35.53 -34.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 114.872 1.434 . . . . 1.0 114.872 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -86.55 -35.34 19.57 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.028 -1.469 . . . . 1.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -52.61 -41.67 63.88 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 123.774 1.75 . . . . 1.0 106.557 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' CD ' ' A' ' 14' ' ' PRO . 95.9 t -50.42 -43.54 22.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 111.596 -2.547 . . . . 1.0 108.458 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.61 8.52 33.78 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.031 -1.441 . . . . 1.0 114.7 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -30.15 6.45 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-O 121.868 0.842 . . . . 1.0 108.938 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -93.58 -13.03 28.19 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.09 -85.6 0.21 Allowed Glycine 0 N--CA 1.494 2.517 0 O-C-N 124.699 1.249 . . . . 1.0 111.557 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.05 69.43 0.13 Allowed Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 105.736 -1.95 . . . . 1.0 105.736 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.447 ' CD ' ' HA ' ' A' ' 8' ' ' VAL 2.525 73.1 Cg_endo 42.09 -76.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 1 C-N-CA 126.645 4.897 . . . . 1.0 114.002 -172.404 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.96 -14.48 17.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.265 1.58 . . . . 1.0 115.265 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -41.4 -43.24 2.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.736 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -55.23 -33.01 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.568 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -100.29 5.57 44.54 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.44 0.638 . . . . 1.0 109.85 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.98 -64.21 1.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -48.02 14.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 118.395 -1.322 . . . . 1.0 109.25 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -62.78 -9.82 10.78 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 117.235 -1.786 . . . . 1.0 110.352 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.96 -65.26 1.03 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -58.61 -31.13 67.79 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.347 -1.341 . . . . 1.0 111.137 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.82 -15.54 63.13 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.097 -1.441 . . . . 1.0 110.049 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -101.19 -41.6 6.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.636 0.731 . . . . 1.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 . . . . . 0 N--CA 1.495 1.795 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.823 -179.444 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp . . . . . 0 N--CA 1.506 2.326 0 N-CA-C 113.029 0.751 . . . . 1.0 113.029 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.652 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -32.77 -52.17 0.47 Allowed Glycine 0 N--CA 1.503 3.122 0 N-CA-C 116.063 1.185 . . . . 1.0 116.063 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.32 4.67 44.2 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.001 -0.679 . . . . 1.0 112.319 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 26.1 t -92.02 -55.49 6.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 104.137 -2.542 . . . . 1.0 104.137 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 2' ' ' ILE . 56.7 mt -37.64 -60.9 0.66 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.833 0.708 . . . . 1.0 111.09 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -45.07 -49.18 11.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.046 -1.434 . . . . 1.0 110.738 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 5' ' ' VAL . 96.3 t -52.34 -49.71 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.939 0.876 . . . . 1.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 11.8 mt -63.4 -12.15 28.43 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 114.127 -1.397 . . . . 1.0 110.758 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.45 12.17 33.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.992 -1.485 . . . . 1.0 106.992 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -63.1 1.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 103.307 -2.849 . . . . 1.0 103.307 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.55 -131.99 2.01 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 105.205 -3.158 . . . . 1.0 105.205 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.6 mt -158.88 55.88 0.87 Allowed Pre-proline 0 N--CA 1.498 1.954 0 CA-C-N 111.795 -2.202 . . . . 1.0 107.768 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.642 ' O ' HD11 ' A' ' 17' ' ' ILE 2.529 59.1 Cg_endo 52.11 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 1 C-N-CA 125.789 4.326 . . . . 1.0 112.947 177.879 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 -15.12 17.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.07 1.137 . . . . 1.0 114.07 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -47.51 -47.27 27.78 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 122.208 1.004 . . . . 1.0 113.246 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.766 HD12 ' H ' ' A' ' 18' ' ' SER . 1.1 pp -56.11 -30.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 113.46 -1.7 . . . . 1.0 109.183 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.766 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.8 m -101.0 8.78 42.84 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.629 -0.828 . . . . 1.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -70.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -40.68 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 117.412 -1.715 . . . . 1.0 110.317 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -12.3 59.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 117.012 -1.875 . . . . 1.0 109.525 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 15.0 ttt180 -86.38 -55.81 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 101.83 -3.396 . . . . 1.0 101.83 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -46.26 -55.17 7.58 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.256 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -12.84 5.38 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.786 1.402 . . . . 1.0 114.786 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -101.54 6.39 42.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.476 0.485 . . . . 1.0 111.101 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 122.362 1.077 . . . . 1.0 110.359 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.631 HD12 ' H ' ' A' ' 3' ' ' GLY . 1.3 pp . . . . . 0 N--CA 1.508 2.464 0 N-CA-C 113.145 0.795 . . . . 1.0 113.145 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.631 ' H ' HD12 ' A' ' 2' ' ' ILE . . . -27.12 -36.89 0.01 OUTLIER Glycine 0 N--CA 1.506 3.354 0 N-CA-C 117.292 1.677 . . . . 1.0 117.292 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.05 -49.59 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.116 -1.439 . . . . 1.0 107.116 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 5' ' ' VAL . 14.0 t -40.13 -54.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 124.535 1.147 . . . . 1.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.6 mt -46.01 -50.83 14.53 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 122.345 1.069 . . . . 1.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -45.51 -47.14 14.22 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 112.869 -1.968 . . . . 1.0 110.171 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 t -54.38 -47.64 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 113.312 -1.767 . . . . 1.0 109.287 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.83 -5.12 19.05 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.35 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 8.75 34.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.225 -2.139 . . . . 1.0 105.225 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.83 -64.37 1.22 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.93 -126.24 2.37 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 106.434 -2.666 . . . . 1.0 106.434 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -171.09 60.53 0.32 Allowed Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 122.657 1.218 . . . . 1.0 108.405 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.582 ' O ' HD11 ' A' ' 17' ' ' ILE 2.522 95.9 Cg_endo 41.78 -82.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 1 C-N-CA 126.607 4.871 . . . . 1.0 114.006 -173.707 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.56 -12.8 17.5 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -47.67 -48.41 29.09 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.405 -1.318 . . . . 1.0 113.05 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -58.86 -42.24 85.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.5 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -71.66 -6.24 39.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.767 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.105 -0.952 . . . . 1.0 108.877 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -90.22 -36.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.693 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.25 -16.55 61.4 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.028 -1.869 . . . . 1.0 108.51 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 -24.35 20.35 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.466 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -91.1 -35.16 14.75 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.487 -0.885 . . . . 1.0 109.065 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -13.01 16.53 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.006 0.431 . . . . 1.0 111.805 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -100.98 8.08 43.21 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.848 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.517 0.675 . . . . 1.0 109.498 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.509 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.205 0 N-CA-C 112.653 0.612 . . . . 1.0 112.653 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.89 -56.02 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.817 1.887 . . . . 1.0 117.817 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.84 -32.59 11.27 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.932 0.396 . . . . 1.0 111.095 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 5' ' ' VAL . 3.4 t -51.09 -49.07 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.8 mt -54.8 -19.2 5.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 113.596 -1.638 . . . . 1.0 112.661 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -96.67 -28.06 14.5 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.7 t -52.54 -50.03 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.5 6.16 0.23 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.947 -1.933 . . . . 1.0 113.409 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -102.13 -9.04 20.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.491 -1.3 . . . . 1.0 107.491 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m -115.52 -60.91 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.557 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.5 -113.55 0.76 Allowed Glycine 0 N--CA 1.503 3.148 0 C-N-CA 119.394 -1.384 . . . . 1.0 109.795 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -178.42 60.91 0.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 104.465 -2.42 . . . . 1.0 104.465 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.518 55.0 Cg_endo 53.87 -75.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 1 C-N-CA 125.744 4.296 . . . . 1.0 114.474 176.608 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.15 -21.97 14.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 115.367 1.618 . . . . 1.0 115.367 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -38.85 -40.29 0.62 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.448 2.018 . . . . 1.0 116.448 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.852 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -51.01 -39.5 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 113.164 -1.834 . . . . 1.0 111.673 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -101.08 9.89 41.59 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 1.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -66.73 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.886 -1.506 . . . . 1.0 108.783 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -35.61 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.189 -0.604 . . . . 1.0 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 10.5 mttt -76.73 -4.17 41.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.768 -1.573 . . . . 1.0 107.828 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -90.4 -76.59 0.43 Allowed 'General case' 0 C--N 1.306 -1.309 1 N-CA-C 95.734 -5.654 . . . . 1.0 95.734 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -37.33 -62.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 114.875 1.435 . . . . 1.0 114.875 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -22.05 32.79 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.38 -50.8 3.5 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 N--CA 1.503 2.195 0 N-CA-C 113.48 0.918 . . . . 1.0 113.48 -179.694 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.746 0 N-CA-C 106.009 -2.836 . . . . 1.0 106.009 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.638 HD12 HD11 ' A' ' 6' ' ' LEU . 23.2 pt -110.88 -15.65 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-N 118.866 1.333 . . . . 1.0 114.379 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -29.56 -41.96 0.04 OUTLIER Glycine 0 N--CA 1.51 3.61 0 CA-C-O 121.807 0.67 . . . . 1.0 114.428 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.711 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -93.36 -40.66 10.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -50.61 -37.48 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 123.215 0.322 . . . . 1.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 2' ' ' ILE . 15.9 mt -86.32 -5.32 59.2 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.935 -0.706 . . . . 1.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -100.38 -6.03 26.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.28 0.987 . . . . 1.0 109.692 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 4' ' ' ALA . 98.1 t -87.79 -41.34 14.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.847 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.16 22.11 3.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.708 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -20.9 8.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 115.524 1.676 . . . . 1.0 115.524 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -121.24 -76.65 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.02 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -121.3 -96.35 1.45 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 106.947 -2.461 . . . . 1.0 106.947 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.41 70.95 0.14 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 104.428 -2.434 . . . . 1.0 104.428 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HG2' HG22 ' A' ' 8' ' ' VAL 2.531 18.3 Cg_endo 59.31 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.861 3.04 . . . . 1.0 111.813 176.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.64 -15.19 17.12 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.61 1.337 . . . . 1.0 114.61 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.52 -39.68 0.49 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.284 1.587 . . . . 1.0 115.284 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.799 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -51.4 -35.77 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.116 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.416 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.34 5.77 44.48 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.484 0.659 . . . . 1.0 109.769 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -63.11 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.581 -1.19 . . . . 1.0 110.038 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.16 -44.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.268 -0.878 . . . . 1.0 109.946 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -28.32 69.14 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 116.923 -1.911 . . . . 1.0 108.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 2.9 ttt180 -73.86 -28.55 61.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.701 -1.599 . . . . 1.0 108.265 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.03 -22.9 20.54 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.812 -0.631 . . . . 1.0 112.273 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -36.4 10.85 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.721 0.637 . . . . 1.0 112.721 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -100.18 66.7 1.33 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.57 42.74 2.92 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.294 -1.776 . . . . 1.0 107.071 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.662 0 O-C-N 118.595 -2.565 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 N-CA-C 105.819 -2.912 . . . . 1.0 105.819 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 4' ' ' ALA . 7.9 pt -120.38 -119.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 118.42 1.11 . . . . 1.0 108.994 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.25 -68.66 0.0 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 116.125 1.21 . . . . 1.0 116.125 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 2' ' ' ILE . . . -97.7 -26.78 14.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.82 -19.75 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.75 -11.86 38.29 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.352 -0.84 . . . . 1.0 110.731 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.29 -2.66 33.13 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.747 0.784 . . . . 1.0 110.006 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.4 -49.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.427 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.05 19.07 5.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.538 1.31 . . . . 1.0 114.538 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -16.71 14.34 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.172 -1.376 . . . . 1.0 109.912 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 m -115.9 -61.83 1.68 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.08 -120.81 1.71 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 106.399 -2.681 . . . . 1.0 106.399 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -156.26 63.4 3.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 113.269 -1.465 . . . . 1.0 107.601 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.446 ' O ' HD11 ' A' ' 17' ' ' ILE 2.545 1.0 OUTLIER 61.26 -100.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 123.03 2.487 . . . . 1.0 108.056 175.51 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.57 -8.85 22.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -49.96 -42.67 49.22 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 119.481 -0.888 . . . . 1.0 112.306 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 18' ' ' SER . 1.3 pp -59.03 -26.12 31.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 113.628 -1.624 . . . . 1.0 109.835 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.645 ' N ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -100.98 3.62 41.74 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.042 0.925 . . . . 1.0 109.95 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.59 -61.44 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.353 -0.839 . . . . 1.0 111.155 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -43.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.466 -1.294 . . . . 1.0 110.078 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -32.66 74.21 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.919 -1.513 . . . . 1.0 107.622 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -16.85 60.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 124.452 1.095 . . . . 1.0 110.213 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -41.17 11.39 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -47.17 52.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.245 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -84.83 68.06 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -120.46 -116.23 0.32 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.728 -1.578 . . . . 1.0 108.305 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.592 0 O-C-N 117.676 -3.14 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 N-CA-C 106.961 -2.456 . . . . 1.0 106.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.54 -154.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.28 -71.77 0.21 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.92 -46.4 7.86 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.982 -1.087 . . . . 1.0 108.313 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 5' ' ' VAL . 5.3 t -29.86 -33.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.972 1.42 . . . . 1.0 114.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.95 -49.68 17.06 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.526 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -45.12 -43.3 9.63 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.528 1.156 . . . . 1.0 108.689 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 8' ' ' VAL . 17.6 t -46.37 -56.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.675 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.15 6.44 1.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.504 -1.68 . . . . 1.0 113.564 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.34 -2.14 18.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.909 -1.886 . . . . 1.0 105.909 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.2 m -120.08 -61.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 105.679 -1.971 . . . . 1.0 105.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.73 -122.99 0.9 Allowed Glycine 0 N--CA 1.481 1.66 0 N-CA-C 107.908 -2.077 . . . . 1.0 107.908 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 13' ' ' LEU . 2.1 pt? -150.32 32.88 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 111.838 -2.181 . . . . 1.0 109.66 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.536 41.9 Cg_exo 94.77 175.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.758 2.972 . . . . 1.0 109.208 -167.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -26.74 -25.3 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 118.648 2.833 . . . . 1.0 118.648 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 14' ' ' PRO . 2.9 mm? -43.26 -38.77 2.72 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.664 0.745 . . . . 1.0 112.405 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -30.69 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 114.299 -1.319 . . . . 1.0 111.79 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.484 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 3.65 42.14 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.213 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -78.4 0.53 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.164 -1.791 . . . . 1.0 106.164 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.74 -36.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 117.973 -1.491 . . . . 1.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -74.86 -9.53 58.63 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 116.923 -1.911 . . . . 1.0 109.94 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 11.2 ttm180 -90.2 -50.66 5.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 103.694 -2.706 . . . . 1.0 103.694 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -41.81 95.2 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.576 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.42 -28.85 8.92 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.788 -1.165 . . . . 1.0 113.204 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -101.33 -29.63 11.95 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 119.799 -0.76 . . . . 1.0 111.075 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -115.46 93.84 4.45 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.61 0 O-C-N 119.067 -2.271 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.44 0 N-CA-C 105.747 -2.941 . . . . 1.0 105.747 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 6' ' ' LEU . 2.7 pt -121.39 -24.45 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 113.686 0.995 . . . . 1.0 113.686 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.23 -65.59 0.01 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 116.148 1.219 . . . . 1.0 116.148 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.75 -29.85 13.13 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.963 -0.695 . . . . 1.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 5' ' ' VAL . 2.1 t -53.58 -26.08 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.96 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 2' ' ' ILE . 73.9 mt -90.09 -14.29 34.04 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.94 1.84 40.19 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.303 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -90.75 -47.63 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -87.84 19.36 3.55 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.515 -1.22 . . . . 1.0 112.709 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 -18.17 19.5 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.064 -1.425 . . . . 1.0 109.23 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -122.95 -61.88 1.4 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.76 -118.42 1.48 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 61.01 4.47 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 17' ' ' ILE 2.549 5.8 Cg_endo 62.88 -99.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 123.325 2.683 . . . . 1.0 108.975 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.67 -10.07 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.351 1.241 . . . . 1.0 114.351 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.81 -44.36 19.21 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.59 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -61.79 -24.92 35.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.684 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.515 ' H ' HD12 ' A' ' 17' ' ' ILE . 50.9 m -100.87 4.99 43.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -61.1 1.42 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.842 -1.17 . . . . 1.0 107.842 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -49.94 13.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.023 -1.071 . . . . 1.0 110.23 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -9.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.866 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -90.79 -23.7 20.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 105.874 -1.898 . . . . 1.0 105.874 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.15 -58.61 2.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.97 1.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 115.595 1.702 . . . . 1.0 115.595 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.613 -1.625 . . . . 1.0 106.613 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.53 -116.15 0.26 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 113.799 -1.546 . . . . 1.0 107.817 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.54 0 O-C-N 117.664 -3.147 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.713 0 N-CA-C 106.077 -2.809 . . . . 1.0 106.077 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.755 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp -109.03 -27.12 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 CA-C-N 119.222 1.511 . . . . 1.0 113.138 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.755 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -15.26 -53.18 0.01 OUTLIER Glycine 0 N--CA 1.51 3.575 0 N-CA-C 117.479 1.751 . . . . 1.0 117.479 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.11 -30.03 12.17 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.883 -0.658 . . . . 1.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 2' ' ' ILE . 6.1 t -54.56 -42.27 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 2' ' ' ILE . 43.7 mt -61.97 -16.99 55.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.459 -1.246 . . . . 1.0 111.451 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.08 -3.21 29.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.424 1.078 . . . . 1.0 110.51 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 4' ' ' ALA . 44.0 t -90.35 -54.62 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -79.12 19.09 0.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.587 -1.188 . . . . 1.0 113.82 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -23.75 12.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.188 -1.369 . . . . 1.0 107.456 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.404 HG23 ' HD3' ' A' ' 14' ' ' PRO . 2.5 t -112.31 -29.31 7.58 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.801 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -101.51 0.2 Allowed Glycine 0 N--CA 1.483 1.819 0 CA-C-N 114.383 -1.28 . . . . 1.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.15 66.23 1.6 Allowed Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.774 ' O ' HD11 ' A' ' 17' ' ' ILE 2.535 25.5 Cg_endo 58.16 -85.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.12 3.213 . . . . 1.0 110.95 173.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.45 -15.26 17.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -46.55 -42.74 16.32 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.574 1.694 . . . . 1.0 115.574 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.774 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.9 -23.39 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 114.587 -1.188 . . . . 1.0 108.984 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -101.38 1.32 38.32 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.338 -0.846 . . . . 1.0 109.111 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -70.98 0.73 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -30.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.481 -1.288 . . . . 1.0 112.494 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 16.0 mtpt -80.45 -27.17 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 116.798 -1.961 . . . . 1.0 107.627 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -30.33 64.66 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -33.48 16.22 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.102 -1.039 . . . . 1.0 108.569 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -60.82 -7.38 2.3 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.746 -0.781 . . . . 1.0 112.603 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -100.25 -9.79 22.02 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.673 -1.232 . . . . 1.0 107.673 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -120.25 98.96 6.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 118.142 -2.849 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.681 0 N-CA-C 106.315 -2.714 . . . . 1.0 106.315 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 pt -112.3 -28.1 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 CA-C-N 118.447 1.123 . . . . 1.0 113.802 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -7.16 -68.76 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 N-CA-C 116.395 1.318 . . . . 1.0 116.395 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.75 -21.99 15.02 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 120.896 0.379 . . . . 1.0 110.702 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.41 -29.58 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.711 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.6 mt -89.46 -6.91 56.06 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.4 -0.92 . . . . 1.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -93.99 -36.9 11.94 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 4' ' ' ALA . 78.6 t -49.32 -36.23 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.99 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.72 17.64 7.4 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.774 -1.557 . . . . 1.0 113.508 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -108.66 -13.54 14.78 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.302 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -63.09 1.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.678 -0.809 . . . . 1.0 109.042 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.44 -97.47 0.27 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 108.966 -1.654 . . . . 1.0 108.966 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.52 65.33 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 104.687 -2.338 . . . . 1.0 104.687 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.538 11.5 Cg_endo 60.19 -93.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.334 2.689 . . . . 1.0 110.346 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -13.1 18.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -36.79 -42.27 0.37 Allowed 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 115.948 1.832 . . . . 1.0 115.948 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.747 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -51.77 -37.13 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.61 -1.177 . . . . 1.0 112.046 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -97.29 7.17 47.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.727 0.775 . . . . 1.0 109.866 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -67.28 0.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.985 -1.461 . . . . 1.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -41.66 13.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 118.989 -1.085 . . . . 1.0 110.165 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -69.97 -16.15 63.15 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.299 -1.76 . . . . 1.0 109.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 4.3 ttt180 -90.54 -23.51 20.88 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.546 -0.862 . . . . 1.0 108.892 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -51.61 5.22 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.711 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -47.88 -9.94 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 114.684 1.364 . . . . 1.0 114.684 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.22 -23.36 14.84 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.926 0.766 . . . . 1.0 112.178 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 23.11 49.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.542 0 O-C-N 117.724 -3.11 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.619 0 N-CA-C 105.816 -2.913 . . . . 1.0 105.816 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -110.66 -29.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 118.366 1.083 . . . . 1.0 112.713 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -5.38 -71.64 0.01 OUTLIER Glycine 0 N--CA 1.507 3.367 0 N-CA-C 117.221 1.648 . . . . 1.0 117.221 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.2 -17.31 17.43 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 119.544 -0.862 . . . . 1.0 111.414 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -55.99 -48.43 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.631 -2.359 . . . . 1.0 104.631 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 mt -55.99 -17.71 7.46 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 114.201 -1.363 . . . . 1.0 112.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -100.05 -25.53 14.27 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.783 -0.767 . . . . 1.0 109.059 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' A' ' 14' ' ' PRO . 4.1 t -58.52 -28.8 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.34 13.89 14.24 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.922 -1.035 . . . . 1.0 111.358 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -101.12 -3.16 29.71 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.657 -0.817 . . . . 1.0 108.801 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -78.97 0.6 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.524 -2.028 . . . . 1.0 105.524 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.31 -85.46 0.07 OUTLIER Glycine 0 N--CA 1.491 2.352 1 N-CA-C 102.237 -4.345 . . . . 1.0 102.237 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 79.86 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 104.441 -2.429 . . . . 1.0 104.441 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.565 ' HD2' HG13 ' A' ' 8' ' ' VAL 2.544 9.4 Cg_endo 64.07 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.745 2.297 . . . . 1.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.62 -4.7 27.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 114.521 1.304 . . . . 1.0 114.521 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.32 -24.7 1.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.633 1.716 . . . . 1.0 115.633 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -65.53 -32.53 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -100.6 9.84 41.97 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.999 0.904 . . . . 1.0 108.909 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -101.37 -69.62 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 113.93 -1.486 . . . . 1.0 108.7 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.482 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -90.52 -38.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 118.559 -1.256 . . . . 1.0 109.609 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -12.49 61.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.495 -1.682 . . . . 1.0 108.76 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -90.02 -60.38 1.95 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -57.92 -33.22 68.55 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.447 -0.901 . . . . 1.0 112.976 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 3.6 ttp180 -71.58 -11.79 61.03 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 116.207 -2.197 . . . . 1.0 110.693 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -101.48 -45.16 5.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -115.11 98.17 6.64 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.621 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.766 0 O-C-N 118.888 -2.383 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.786 0 N-CA-C 105.915 -2.874 . . . . 1.0 105.915 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 3' ' ' GLY . 1.7 pp -111.35 -21.58 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 118.964 1.382 . . . . 1.0 113.071 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.673 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -6.5 -72.7 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.554 1.782 . . . . 1.0 117.554 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.89 -12.12 20.11 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.823 -0.751 . . . . 1.0 110.58 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -61.0 -41.69 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 103.31 -2.848 . . . . 1.0 103.31 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.41 -16.28 22.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 113.707 -1.588 . . . . 1.0 110.797 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -100.64 -2.11 33.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 123.664 0.602 . . . . 1.0 110.506 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.576 HG13 ' HG2' ' A' ' 14' ' ' PRO . 11.5 t -90.4 -46.71 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.04 0.448 . . . . 1.0 110.612 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.519 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.44 19.98 4.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.399 1.095 . . . . 1.0 113.251 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 -17.41 15.17 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 113.844 -1.526 . . . . 1.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.84 -64.64 1.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 104.384 -2.45 . . . . 1.0 104.384 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.53 -122.27 1.57 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 1.0 104.426 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mt -152.64 67.27 6.59 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 105.812 -1.922 . . . . 1.0 105.812 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.689 ' O ' HD11 ' A' ' 17' ' ' ILE 2.533 18.5 Cg_endo 56.84 -81.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.934 3.09 . . . . 1.0 112.3 173.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.18 -14.33 17.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -46.23 -43.6 15.55 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.325 1.232 . . . . 1.0 114.325 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.689 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -62.36 -24.28 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.511 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -100.33 3.19 43.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 -69.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.404 0.621 . . . . 1.0 109.654 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -35.08 8.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 118.586 -0.721 . . . . 1.0 111.142 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -24.03 63.91 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 116.134 -2.227 . . . . 1.0 105.052 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -61.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -36.21 22.19 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.237 1.018 . . . . 1.0 110.738 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.83 -21.33 66.03 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.114 -0.948 . . . . 1.0 112.762 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -101.62 -45.37 5.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.551 1.157 . . . . 1.0 110.248 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.48 128.67 44.81 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.789 -1.096 . . . . 1.0 110.012 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.735 0 O-C-N 118.334 -2.729 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.503 0 N-CA-C 106.028 -2.829 . . . . 1.0 106.028 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.777 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -113.36 -36.56 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 118.613 1.207 . . . . 1.0 112.652 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -9.88 -58.75 0.01 OUTLIER Glycine 0 N--CA 1.508 3.467 0 N-CA-C 117.713 1.845 . . . . 1.0 117.713 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.1 -27.5 13.51 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.577 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 2' ' ' ILE . 9.5 t -54.49 -44.77 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.15 -17.04 23.39 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.996 -1.456 . . . . 1.0 111.822 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -100.24 -6.04 26.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.019 0.824 . . . . 1.0 110.022 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 10' ' ' THR . 34.4 t -90.61 -51.12 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.436 HD23 HG12 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -71.92 11.63 0.51 Allowed 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 114.322 -1.308 . . . . 1.0 112.611 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -105.13 -12.4 16.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.216 -1.402 . . . . 1.0 107.216 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 -31.96 4.23 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.95 -111.21 0.47 Allowed Glycine 0 N--CA 1.481 1.689 1 N-CA-C 101.822 -4.511 . . . . 1.0 101.822 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -149.64 66.82 8.45 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 104.456 -2.424 . . . . 1.0 104.456 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.534 12.0 Cg_endo 61.56 -83.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.848 3.032 . . . . 1.0 111.577 169.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.21 -18.94 16.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -48.28 -37.41 16.23 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.547 -1.261 . . . . 1.0 114.098 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.733 HD12 ' H ' ' A' ' 18' ' ' SER . 1.1 pp -57.34 -30.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.513 0.673 . . . . 1.0 109.357 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.733 ' H ' HD12 ' A' ' 17' ' ' ILE . 2.7 m -100.25 10.32 41.42 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.499 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -102.77 -64.3 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.139 -1.392 . . . . 1.0 108.435 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.05 -39.54 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 118.334 -1.347 . . . . 1.0 111.608 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -72.48 -27.62 62.39 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 116.511 -2.076 . . . . 1.0 108.83 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -61.12 -36.51 79.93 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.403 -1.319 . . . . 1.0 107.574 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -35.61 14.6 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.797 -1.161 . . . . 1.0 110.587 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -21.61 61.91 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 118.778 -1.169 . . . . 1.0 110.574 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -100.68 2.57 41.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.346 1.029 . . . . 1.0 110.648 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -116.15 29.61 7.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.228 -1.397 . . . . 1.0 107.228 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.694 0 O-C-N 119.28 -2.138 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.56 0 N-CA-C 106.639 -2.584 . . . . 1.0 106.639 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.9 pt -81.67 70.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.202 1.001 . . . . 1.0 109.632 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.12 -34.93 4.09 Favored Glycine 0 N--CA 1.502 3.093 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.81 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -100.09 -51.38 3.69 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 104.625 -2.361 . . . . 1.0 104.625 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 5' ' ' VAL . 2.8 t -28.28 -30.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 126.126 2.141 . . . . 1.0 114.258 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' ALA . 20.3 mt -90.49 -56.0 3.37 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.605 -0.838 . . . . 1.0 109.179 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -46.41 -41.89 14.35 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 124.074 1.893 . . . . 1.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 4' ' ' ALA . 71.9 t -46.9 -45.65 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 111.049 -2.796 . . . . 1.0 110.235 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.36 16.52 9.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.333 -1.303 . . . . 1.0 113.481 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -45.3 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.939 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -84.31 -41.44 16.81 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.16 -1.416 . . . . 1.0 109.844 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.87 -114.95 0.49 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.999 -1.64 . . . . 1.0 108.999 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -169.72 57.78 0.31 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 17' ' ' ILE 2.548 18.6 Cg_endo 59.08 -102.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 124.616 3.544 . . . . 1.0 108.496 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -7.7 24.13 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.794 1.035 . . . . 1.0 113.794 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.22 -42.75 41.38 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 117.949 -1.5 . . . . 1.0 112.545 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.865 HD12 ' H ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.91 -40.93 88.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.745 -1.182 . . . . 1.0 108.504 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.865 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -71.1 -7.29 45.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -74.82 0.6 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.684 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -30.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 119.039 -1.064 . . . . 1.0 112.86 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -79.22 -9.47 59.58 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 116.865 -1.934 . . . . 1.0 108.138 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -90.67 -62.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.431 1 N-CA-C 98.926 -4.472 . . . . 1.0 98.926 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -42.48 -63.8 0.71 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.376 -1.284 . . . . 1.0 112.78 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -18.82 0.1 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.519 2.044 . . . . 1.0 116.519 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -101.24 14.8 30.82 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.764 0.792 . . . . 1.0 111.709 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -118.22 133.22 56.09 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.866 -1.515 . . . . 1.0 107.998 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.62 0 O-C-N 118.212 -2.805 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.825 0 N-CA-C 106.211 -2.756 . . . . 1.0 106.211 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 3' ' ' GLY . 1.2 pp -115.16 -5.61 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-N 118.424 1.112 . . . . 1.0 113.124 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.511 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -11.93 -60.98 0.01 OUTLIER Glycine 0 N--CA 1.504 3.2 0 N-CA-C 117.712 1.845 . . . . 1.0 117.712 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.32 -43.7 8.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -35.6 -55.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.795 1.31 . . . . 1.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.499 ' CD1' HD13 ' A' ' 2' ' ' ILE . 26.7 mt -49.29 -38.97 29.18 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' NZ ' HG21 ' A' ' 10' ' ' THR . 0.7 OUTLIER -68.2 -35.42 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.767 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.459 ' CG1' ' HG3' ' A' ' 14' ' ' PRO . 1.4 t -61.08 -32.8 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.385 1.088 . . . . 1.0 109.077 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mt -72.82 -2.14 19.41 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.576 -1.193 . . . . 1.0 108.787 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.516 HG21 ' NZ ' ' A' ' 7' ' ' LYS . 3.7 m -98.98 -10.21 22.99 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.449 -1.685 . . . . 1.0 106.449 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -105.23 -45.56 4.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.406 -1.701 . . . . 1.0 106.406 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.39 -133.44 2.91 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 106.094 -2.802 . . . . 1.0 106.094 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.13 68.19 7.22 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 112.39 -1.905 . . . . 1.0 107.39 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.718 ' O ' HD11 ' A' ' 17' ' ' ILE 2.527 47.7 Cg_endo 54.15 -83.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 125.209 3.939 . . . . 1.0 112.824 171.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.42 -17.7 16.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -46.28 -46.26 17.83 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -58.9 -26.06 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.078 0.942 . . . . 1.0 109.466 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.577 ' H ' HD12 ' A' ' 17' ' ' ILE . 74.0 m -101.26 5.78 42.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.091 -0.959 . . . . 1.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.58 -67.57 0.86 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 123.44 0.462 . . . . 1.0 109.935 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.91 -34.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 118.405 -1.318 . . . . 1.0 111.347 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 5.6 mtpt -69.35 -16.76 63.6 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 116.717 -1.993 . . . . 1.0 107.163 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -91.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.369 -1.715 . . . . 1.0 106.369 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -47.79 -40.09 19.95 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.1 -0.954 . . . . 1.0 108.957 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.73 39.88 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.412 -0.915 . . . . 1.0 109.767 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 8.6 pt20 -100.31 -26.14 14.0 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 121.0 0.429 . . . . 1.0 110.993 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.72 6.4 31.83 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.321 1.058 . . . . 1.0 113.185 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.674 0 O-C-N 118.651 -2.531 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.645 0 N-CA-C 106.067 -2.813 . . . . 1.0 106.067 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt -112.67 -42.3 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 CA-C-N 118.463 1.132 . . . . 1.0 112.366 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -15.64 -60.62 0.01 OUTLIER Glycine 0 N--CA 1.506 3.319 0 N-CA-C 117.094 1.598 . . . . 1.0 117.094 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.76 -24.82 20.26 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.284 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 2' ' ' ILE . 36.6 t -58.93 -48.39 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.8 mt -38.1 -59.31 0.87 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.409 -1.269 . . . . 1.0 111.219 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -42.48 -53.16 4.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.207 -1.815 . . . . 1.0 109.825 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 14' ' ' PRO . 10.7 t -44.92 -57.19 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.114 -1.403 . . . . 1.0 109.146 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.67 -19.22 65.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.215 -2.266 . . . . 1.0 111.864 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -0.21 54.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 118.61 -1.236 . . . . 1.0 107.827 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -107.08 -61.92 1.48 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.397 -2.446 . . . . 1.0 104.397 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -127.7 1.77 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 106.366 -2.693 . . . . 1.0 106.366 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 4.8 mt -159.45 58.89 1.26 Allowed Pre-proline 0 N--CA 1.497 1.896 0 CA-C-N 112.783 -1.708 . . . . 1.0 107.707 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.618 ' O ' HD11 ' A' ' 17' ' ' ILE 2.537 38.9 Cg_endo 55.94 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 124.825 3.684 . . . . 1.0 111.081 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.68 -12.38 19.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.469 0.914 . . . . 1.0 113.469 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -46.22 -45.14 16.78 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.751 -1.179 . . . . 1.0 113.177 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.712 HD12 ' H ' ' A' ' 18' ' ' SER . 1.3 pp -56.81 -32.3 38.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.016 -1.902 . . . . 1.0 110.202 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.712 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -100.93 8.81 42.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.246 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.93 -70.67 0.73 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 -39.93 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 117.539 -1.664 . . . . 1.0 109.811 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -23.15 67.25 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 117.71 -1.596 . . . . 1.0 108.795 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -82.66 -14.6 54.38 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.967 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -43.93 9.9 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.139 -2.171 . . . . 1.0 105.139 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -22.05 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.792 -1.549 . . . . 1.0 113.111 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.43 6.98 44.49 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.334 1.021 . . . . 1.0 112.69 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -112.79 -35.72 5.39 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.3 1.048 . . . . 1.0 108.735 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 118.873 -2.392 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.625 0 N-CA-C 105.564 -3.015 . . . . 1.0 105.564 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 pt -112.95 52.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 118.856 1.328 . . . . 1.0 111.866 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.53 -27.91 6.58 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.671 -1.252 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.92 -47.08 5.15 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.785 -1.931 . . . . 1.0 105.785 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 5' ' ' VAL . 17.0 t -36.48 -56.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 115.052 -0.976 . . . . 1.0 111.071 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.0 mt -51.53 -33.32 31.43 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.791 -1.55 . . . . 1.0 113.187 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' NZ ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.95 -31.9 66.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.538 -1.21 . . . . 1.0 111.908 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 t -64.23 -38.22 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 9' ' ' LEU . 1.3 mt -62.18 -24.19 67.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.5 -1.227 . . . . 1.0 107.933 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.94 -11.89 59.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.035 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 -12.67 18.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' HG13 ' A' ' 17' ' ' ILE . . . 141.64 123.22 1.88 Allowed Glycine 0 N--CA 1.478 1.486 0 N-CA-C 106.713 -2.555 . . . . 1.0 106.713 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.51 100.86 0.23 Allowed Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 121.51 0.671 . . . . 1.0 111.148 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . 2.514 10.4 Cg_endo 31.89 -84.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 1 C-N-CA 127.118 5.212 . . . . 1.0 115.611 -163.062 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.19 -7.84 22.75 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.95 1.833 . . . . 1.0 115.95 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -38.6 -41.22 0.66 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.577 1.325 . . . . 1.0 114.577 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.748 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -50.31 -37.79 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.139 -1.392 . . . . 1.0 111.253 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.49 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -100.84 6.81 43.87 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.111 -0.635 . . . . 1.0 109.329 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.411 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.75 -64.09 1.08 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -44.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.053 -1.459 . . . . 1.0 110.955 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 10.8 mtpt -61.68 -24.55 66.83 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.473 1.108 . . . . 1.0 109.044 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -90.91 -14.85 30.85 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.87 -0.732 . . . . 1.0 112.12 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -91.27 -26.31 19.05 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.664 -1.214 . . . . 1.0 109.08 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.13 -27.34 13.29 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.489 -0.884 . . . . 1.0 110.086 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -111.25 98.42 7.49 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.699 0 O-C-N 118.907 -2.37 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.609 0 N-CA-C 105.751 -2.94 . . . . 1.0 105.751 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 6' ' ' LEU . 1.7 pp -109.98 -10.12 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 CA-C-N 119.108 1.454 . . . . 1.0 113.349 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.593 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -6.62 -78.49 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.21 -5.64 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.263 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 23.6 t -63.19 -44.6 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 103.962 -2.607 . . . . 1.0 103.962 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 2' ' ' ILE . 15.5 mt -43.32 -47.71 6.73 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 123.028 1.394 . . . . 1.0 108.369 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 1.3 tptp -50.6 -47.38 58.21 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 112.365 -2.198 . . . . 1.0 110.699 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.566 HG13 ' CG ' ' A' ' 14' ' ' PRO . 51.0 t -53.99 -34.85 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.257 -1.338 . . . . 1.0 111.067 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.38 6.31 43.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 112.623 -2.08 . . . . 1.0 111.736 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -109.17 -3.7 17.09 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -118.62 -59.36 1.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.9 -114.61 1.18 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.335 -1.906 . . . . 1.0 108.335 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.4 mt 179.44 61.25 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 103.153 -2.906 . . . . 1.0 103.153 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.756 ' O ' HD11 ' A' ' 17' ' ' ILE 2.52 73.4 Cg_endo 50.92 -73.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 1 C-N-CA 125.483 4.122 . . . . 1.0 113.985 -178.643 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -101.87 -22.72 14.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.861 1.06 . . . . 1.0 113.861 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -45.38 -46.31 13.11 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.657 1.725 . . . . 1.0 115.657 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.756 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -62.75 -25.31 37.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.831 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 17' ' ' ILE . 68.6 m -101.53 3.12 39.83 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.895 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -71.33 0.71 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.98 -37.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 117.682 -1.607 . . . . 1.0 111.622 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.9 mtpt -71.77 -4.7 29.21 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 115.43 -2.508 . . . . 1.0 109.224 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -52.32 4.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -27.57 66.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 114.223 -1.353 . . . . 1.0 111.171 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -7.32 56.15 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.862 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -101.04 -48.84 4.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.727 1.267 . . . . 1.0 107.739 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 84.0 2.08 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.53 1.157 . . . . 1.0 110.611 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.686 0 O-C-N 118.569 -2.582 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.653 0 N-CA-C 105.769 -2.932 . . . . 1.0 105.769 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.4 pt -59.28 -39.97 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 118.806 1.303 . . . . 1.0 110.951 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -38.91 -28.7 0.07 OUTLIER Glycine 0 N--CA 1.508 3.474 0 O-C-N 123.914 0.759 . . . . 1.0 112.908 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -99.69 -52.15 3.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.1 t -49.48 -24.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 124.006 0.816 . . . . 1.0 111.851 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.62 -39.97 15.61 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -47.98 -45.08 31.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.96 1.362 . . . . 1.0 109.847 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 4' ' ' ALA . 1.6 t -54.15 -36.46 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 113.586 -1.643 . . . . 1.0 110.633 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -90.87 13.88 15.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 113.824 -1.534 . . . . 1.0 111.612 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -11.48 19.12 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.548 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -113.39 -68.11 0.95 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.537 -2.394 . . . . 1.0 104.537 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.33 -120.14 1.62 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.309 -2.317 . . . . 1.0 107.309 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -160.74 60.71 1.36 Allowed Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 107.343 -1.354 . . . . 1.0 107.343 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.523 15.9 Cg_endo 52.95 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.24 3.294 . . . . 1.0 112.658 174.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -102.39 -18.61 15.31 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -50.43 -46.24 56.36 Favored 'General case' 0 N--CA 1.515 2.799 0 CA-C-O 123.657 1.694 . . . . 1.0 113.405 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.827 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -60.77 -24.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.871 -2.422 . . . . 1.0 107.143 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.424 ' OG ' ' NH1' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -100.64 3.4 42.47 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.347 -1.297 . . . . 1.0 109.066 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -63.21 1.17 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.678 0.751 . . . . 1.0 109.469 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.68 -43.91 15.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 118.827 -1.149 . . . . 1.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.91 -19.43 65.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 117.513 -1.675 . . . . 1.0 108.439 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' NH1' ' OG ' ' A' ' 18' ' ' SER . 20.6 ttt180 -84.29 -19.92 32.98 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.92 -33.53 15.57 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.459 -1.246 . . . . 1.0 107.989 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.55 53.27 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.168 -0.613 . . . . 1.0 112.478 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.67 11.48 39.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.622 0.576 . . . . 1.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -120.66 143.06 48.9 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.22 -1.4 . . . . 1.0 107.22 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.633 0 O-C-N 118.215 -2.803 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.707 0 N-CA-C 105.203 -3.159 . . . . 1.0 105.203 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.5 pt -110.86 75.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 119.202 1.501 . . . . 1.0 112.013 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.84 -102.5 1.81 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 105.245 -3.142 . . . . 1.0 105.245 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -33.16 -44.83 0.13 Allowed 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 122.311 1.053 . . . . 1.0 112.588 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.57 -27.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.837 -1.983 . . . . 1.0 114.619 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.51 -7.83 54.11 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -100.2 -26.14 14.03 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 t -60.74 -34.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 122.865 1.317 . . . . 1.0 108.625 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 2.5 mt -71.52 -4.34 26.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.68 -1.6 . . . . 1.0 109.061 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -2.84 31.12 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -117.12 -45.59 2.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.01 -0.737 . . . . 1.0 109.01 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.32 -118.99 2.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.355 -2.298 . . . . 1.0 107.355 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.49 65.13 0.15 Allowed Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 103.3 -2.852 . . . . 1.0 103.3 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.593 ' O ' HD11 ' A' ' 17' ' ' ILE 2.524 59.4 Cg_endo 51.33 -78.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 1 C-N-CA 126.264 4.643 . . . . 1.0 112.71 -178.28 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.23 -21.8 14.82 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.452 -0.899 . . . . 1.0 113.338 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -40.61 -43.28 1.87 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.979 1.844 . . . . 1.0 115.979 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.701 HD12 ' H ' ' A' ' 18' ' ' SER . 0.5 OUTLIER -58.6 -37.55 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.701 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.7 m -91.3 6.01 46.96 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.117 -1.033 . . . . 1.0 109.144 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.08 -69.08 0.79 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -89.86 -38.93 11.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 118.331 -1.347 . . . . 1.0 111.095 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -26.59 65.55 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 117.11 -1.836 . . . . 1.0 108.684 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' NH1' ' O ' ' A' ' 18' ' ' SER . 4.3 ttp180 -67.83 -55.78 11.64 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -52.27 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.679 -1.601 . . . . 1.0 108.078 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -20.81 1.86 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.565 1.691 . . . . 1.0 115.565 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.56 3.62 42.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.975 0.797 . . . . 1.0 113.059 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -121.02 177.38 5.14 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.155 0.979 . . . . 1.0 110.482 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.473 0 O-C-N 119.247 -2.158 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.675 0 N-CA-C 105.688 -2.965 . . . . 1.0 105.688 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.02 -125.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-N 118.243 1.022 . . . . 1.0 110.223 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.4 -70.95 2.56 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.445 -1.862 . . . . 1.0 108.445 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.2 3.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.77 -1.215 . . . . 1.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 5' ' ' VAL . 2.1 t -35.53 -34.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 114.872 1.434 . . . . 1.0 114.872 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -86.55 -35.34 19.57 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.028 -1.469 . . . . 1.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -52.61 -41.67 63.88 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 123.774 1.75 . . . . 1.0 106.557 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' CD ' ' A' ' 14' ' ' PRO . 95.9 t -50.42 -43.54 22.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 111.596 -2.547 . . . . 1.0 108.458 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.61 8.52 33.78 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.031 -1.441 . . . . 1.0 114.7 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -30.15 6.45 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-O 121.868 0.842 . . . . 1.0 108.938 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -93.58 -13.03 28.19 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.09 -85.6 0.21 Allowed Glycine 0 N--CA 1.494 2.517 0 O-C-N 124.699 1.249 . . . . 1.0 111.557 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.05 69.43 0.13 Allowed Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 105.736 -1.95 . . . . 1.0 105.736 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.447 ' CD ' ' HA ' ' A' ' 8' ' ' VAL 2.525 73.1 Cg_endo 42.09 -76.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 1 C-N-CA 126.645 4.897 . . . . 1.0 114.002 -172.404 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.96 -14.48 17.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.265 1.58 . . . . 1.0 115.265 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -41.4 -43.24 2.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.736 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -55.23 -33.01 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.568 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -100.29 5.57 44.54 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.44 0.638 . . . . 1.0 109.85 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.98 -64.21 1.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -48.02 14.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 118.395 -1.322 . . . . 1.0 109.25 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -62.78 -9.82 10.78 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 117.235 -1.786 . . . . 1.0 110.352 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.96 -65.26 1.03 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -58.61 -31.13 67.79 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.347 -1.341 . . . . 1.0 111.137 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.82 -15.54 63.13 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.097 -1.441 . . . . 1.0 110.049 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -101.19 -41.6 6.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.636 0.731 . . . . 1.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -114.41 71.8 0.77 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.823 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.599 0 O-C-N 118.779 -2.45 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 N-CA-C 105.795 -2.922 . . . . 1.0 105.795 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp -111.01 -10.83 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 CA-C-N 119.285 1.543 . . . . 1.0 113.029 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.652 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -32.77 -52.17 0.47 Allowed Glycine 0 N--CA 1.503 3.122 0 N-CA-C 116.063 1.185 . . . . 1.0 116.063 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.32 4.67 44.2 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.001 -0.679 . . . . 1.0 112.319 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 26.1 t -92.02 -55.49 6.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 104.137 -2.542 . . . . 1.0 104.137 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 2' ' ' ILE . 56.7 mt -37.64 -60.9 0.66 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.833 0.708 . . . . 1.0 111.09 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -45.07 -49.18 11.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.046 -1.434 . . . . 1.0 110.738 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 5' ' ' VAL . 96.3 t -52.34 -49.71 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.939 0.876 . . . . 1.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 11.8 mt -63.4 -12.15 28.43 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 114.127 -1.397 . . . . 1.0 110.758 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.45 12.17 33.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.992 -1.485 . . . . 1.0 106.992 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -63.1 1.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 103.307 -2.849 . . . . 1.0 103.307 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.55 -131.99 2.01 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 105.205 -3.158 . . . . 1.0 105.205 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.6 mt -158.88 55.88 0.87 Allowed Pre-proline 0 N--CA 1.498 1.954 0 CA-C-N 111.795 -2.202 . . . . 1.0 107.768 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.642 ' O ' HD11 ' A' ' 17' ' ' ILE 2.529 59.1 Cg_endo 52.11 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 1 C-N-CA 125.789 4.326 . . . . 1.0 112.947 177.879 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 -15.12 17.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.07 1.137 . . . . 1.0 114.07 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -47.51 -47.27 27.78 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 122.208 1.004 . . . . 1.0 113.246 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.766 HD12 ' H ' ' A' ' 18' ' ' SER . 1.1 pp -56.11 -30.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 113.46 -1.7 . . . . 1.0 109.183 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.766 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.8 m -101.0 8.78 42.84 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.629 -0.828 . . . . 1.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -70.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -40.68 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 117.412 -1.715 . . . . 1.0 110.317 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -12.3 59.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 117.012 -1.875 . . . . 1.0 109.525 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 15.0 ttt180 -86.38 -55.81 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 101.83 -3.396 . . . . 1.0 101.83 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -46.26 -55.17 7.58 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.256 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -12.84 5.38 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.786 1.402 . . . . 1.0 114.786 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -101.54 6.39 42.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.476 0.485 . . . . 1.0 111.101 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -118.66 -37.85 3.21 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.362 1.077 . . . . 1.0 110.359 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.581 0 O-C-N 118.299 -2.751 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.791 0 N-CA-C 105.607 -2.997 . . . . 1.0 105.607 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.631 HD12 ' H ' ' A' ' 3' ' ' GLY . 1.3 pp -107.53 -28.91 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.464 0 CA-C-N 118.803 1.302 . . . . 1.0 113.145 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.631 ' H ' HD12 ' A' ' 2' ' ' ILE . . . -27.12 -36.89 0.01 OUTLIER Glycine 0 N--CA 1.506 3.354 0 N-CA-C 117.292 1.677 . . . . 1.0 117.292 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.05 -49.59 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.116 -1.439 . . . . 1.0 107.116 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 5' ' ' VAL . 14.0 t -40.13 -54.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 124.535 1.147 . . . . 1.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.6 mt -46.01 -50.83 14.53 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 122.345 1.069 . . . . 1.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -45.51 -47.14 14.22 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 112.869 -1.968 . . . . 1.0 110.171 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 t -54.38 -47.64 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 113.312 -1.767 . . . . 1.0 109.287 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.83 -5.12 19.05 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.35 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 8.75 34.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.225 -2.139 . . . . 1.0 105.225 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.83 -64.37 1.22 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.93 -126.24 2.37 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 106.434 -2.666 . . . . 1.0 106.434 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -171.09 60.53 0.32 Allowed Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 122.657 1.218 . . . . 1.0 108.405 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.582 ' O ' HD11 ' A' ' 17' ' ' ILE 2.522 95.9 Cg_endo 41.78 -82.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 1 C-N-CA 126.607 4.871 . . . . 1.0 114.006 -173.707 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.56 -12.8 17.5 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -47.67 -48.41 29.09 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.405 -1.318 . . . . 1.0 113.05 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -58.86 -42.24 85.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.5 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -71.66 -6.24 39.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.767 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.105 -0.952 . . . . 1.0 108.877 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -90.22 -36.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.693 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.25 -16.55 61.4 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.028 -1.869 . . . . 1.0 108.51 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 -24.35 20.35 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.466 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -91.1 -35.16 14.75 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.487 -0.885 . . . . 1.0 109.065 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -13.01 16.53 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.006 0.431 . . . . 1.0 111.805 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -100.98 8.08 43.21 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.296 -0.865 . . . . 1.0 109.848 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.93 178.35 4.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.517 0.675 . . . . 1.0 109.498 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.528 0 O-C-N 118.975 -2.328 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.783 0 N-CA-C 106.33 -2.708 . . . . 1.0 106.33 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.647 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -108.41 -34.47 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-N 118.32 1.06 . . . . 1.0 112.653 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -11.89 -56.02 0.01 OUTLIER Glycine 0 N--CA 1.509 3.562 0 N-CA-C 117.817 1.887 . . . . 1.0 117.817 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.84 -32.59 11.27 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.932 0.396 . . . . 1.0 111.095 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 5' ' ' VAL . 3.4 t -51.09 -49.07 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.8 mt -54.8 -19.2 5.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 113.596 -1.638 . . . . 1.0 112.661 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -96.67 -28.06 14.5 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.7 t -52.54 -50.03 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.5 6.16 0.23 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.947 -1.933 . . . . 1.0 113.409 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -102.13 -9.04 20.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.491 -1.3 . . . . 1.0 107.491 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m -115.52 -60.91 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.557 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.5 -113.55 0.76 Allowed Glycine 0 N--CA 1.503 3.148 0 C-N-CA 119.394 -1.384 . . . . 1.0 109.795 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -178.42 60.91 0.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 104.465 -2.42 . . . . 1.0 104.465 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 13' ' ' LEU 2.518 55.0 Cg_endo 53.87 -75.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 1 C-N-CA 125.744 4.296 . . . . 1.0 114.474 176.608 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.15 -21.97 14.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 115.367 1.618 . . . . 1.0 115.367 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -38.85 -40.29 0.62 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.448 2.018 . . . . 1.0 116.448 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.852 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -51.01 -39.5 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 113.164 -1.834 . . . . 1.0 111.673 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -101.08 9.89 41.59 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 1.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -66.73 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.886 -1.506 . . . . 1.0 108.783 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -35.61 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.189 -0.604 . . . . 1.0 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 10.5 mttt -76.73 -4.17 41.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.768 -1.573 . . . . 1.0 107.828 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -90.4 -76.59 0.43 Allowed 'General case' 0 C--N 1.306 -1.309 1 N-CA-C 95.734 -5.654 . . . . 1.0 95.734 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -37.33 -62.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 114.875 1.435 . . . . 1.0 114.875 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -22.05 32.79 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.38 -50.8 3.5 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -112.59 -2.59 14.54 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 113.48 0.918 . . . . 1.0 113.48 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.783 0 O-C-N 117.735 -3.103 . . . . 1.0 . . . . . . . . . . 0 0 . 1 stop_ save_